Role of CHRAC14 and histone methyltransferase

Su(var)3-9 in facilitating ectopic loading of CENP-A by Sharma, Abhishek
	 1	
	
	
	
	
Dissertation 
 submitted to the  
Combined Faculties for the Natural Sciences and for Mathematics  
of the Ruperto-Carola University of Heidelberg, Germany  
for the degree of  
Doctor of Natural Sciences 
	
	
	
	
	
	
Role	of	CHRAC14	and	histone	methyltransferase		
Su(var)3-9	in	facilitating	ectopic	loading	of	CENP-A	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Presented	by	
Abhishek	Sharma	
Born	in:	Lucknow,	India	
	
	
	
	
	
	
	
	
	 2	
Dissertation	
	submitted	to	the		
Combined	Faculties	for	the	Natural	Sciences	and	for	Mathematics		
of	the	Ruperto-Carola	University	of	Heidelberg,	Germany		
for	the	degree	of		
Doctor	of	Natural	Sciences	
	
	
	
	
	
	
Role	of	CHRAC14	and	histone	methyltransferase	
Su(var)3-9	in	facilitating	ectopic	loading	of	CENP-A	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Presented	by	
Abhishek	Sharma	
(M.Sc.	in	Genetic	Manipulation	and	Molecular	Cell	Biology)	
Born	in:	Lucknow,	India	
Date	of	oral-examination:	26	January	2017	
	
	
	
	 3	
	
	
	
	
	
	
	
	
	
Role	of	CHRAC14	and	histone	methyltransferase		
Su(var)3-9	in	facilitating	ectopic	loading	of	CENP-A.	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Referees:	
Prof.	Dr.	Elmar	Schiebel	
Dr.	Sylvia	Erhardt 
 
 
 
	
	
	
	 4	
	
Dedicated		
	
	
	
	
	
	
To	my	lovely	mom	Mrs.	Usha	Sharma	
and	dear	father	Mr.	Ashutosh	Sharma	
	
	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 5	
Acknowledgment	
First	 of	 all,	 I	 would	 like	 to	 thank	 my	 mentor	 Dr.	 Sylvia	 Erhardt	 for	 giving	 me	 the	
opportunity	to	work	 in	her	team	and	financially	supporting	me.	 I	am	thankful	for	her	
critical	and	supportive	suggestions	throughout	my	Ph.D.	Additionally,	I	am	thankful	for	
her	patience	and	valuable	time	she	put	in	correcting	my	thesis.		
I	would	also	like	to	thank	my	first	supervisor	Prof.	Dr.	Elmar	for	his	valuable	support	and	
suggestions	in	my	PhD	project.	Further,	I	am	thankful	to	my	TAC	member	Dr.	Karsten	
Rippe	for	his	inputs	in	my	project.	
Beside	my	 supervisors	 and	 TAC	members,	 I	 am	 thankful	 to	 all	 the	 current	 and	 past	
members	of	Dr.	Erhardt’s	lab.	Special	thanks	to	Anne-Laure	for	her	support	and	patience.	
Thanks	for	always	being	there	for	discussions,	suggestions	and	guidance,	which	often	
made	life	easy	in	the	lab.	I	am	also	thankful	to	all	the	technical	helps	provided	by	Andrea.	
Dear	Ana	and	Engin,	 I	am	thankful	to	you	guys	for	all	 the	scientific	and	non-scientific	
conversations	we	had	at	our	free	times.	You	guys	have	been	great	support	in	my	good	
and	bad	times.	It	would	have	been	harder	to	handle	the	stress	without	you	guys.		
Further,	I	would	like	to	thank	the	members	of	Elmar’s	lab,	especially	Gurkan,	Takumi,	
Marko	and	Shoji	for	their	support.	Further	thanks	to	all	my	friends	which	I	made	during	
my	stay	in	Heidelberg	University,	in	some	or	the	other	way,	everybody	of	you	have	made	
my	life	easier	and	nicer.	
	
In	the	end,	I	am	thankful	to	my	parents	and	siblings,	without	their	support	I	would	have	
never	made	it	so	far.	Their	motivation,	hard	work	and	love	always	keeps	me	motivated.	
	
	
	
	
	
	
	
	
	
	
	
	
	 6	
Summary	
Kinetochore	 formation	 is	 required	 for	 the	 attachment	 of	 microtubules	 to	 the	
chromosome	at	centromere	where	CENP-A	(also	known	as	CID	in	Drosophila)	is	the	key	
factor	 for	 the	 formation	 of	 kinetochore.	 CENP-A	 is	 a	 variant	 of	 histone	 H3	 and	 its	
accumulation	at	the	centromere	leads	to	the	initiation	of	kinetochore	formation.	CENP-
A	 localization	 to	 centromere	 in	 Drosophila	 requires	 CENP-C	 and	 CAL1.	 Ectopic	
localization	 of	 CENP-A	 has	 been	 reported	 to	 give	 rise	 to	 pseudo-kinetochore,	 which	
results	 in	 chromosome	 segregation	 defect	 and	 could	 lead	 to	 aneuploidy.	 Breast,	
prostate	and	colon	cancer	show	higher	level	of	CENP-A	with	ectopic	localization.	In	2014	
our	lab	reported	that	depletion	of	CHRAC14	leads	to	ectopic	localization	in	Drosophila	
cells.		CHRAC14	is	a	subunit	of	two	chromatin	remodelling	complex,	CHRAC	and	ATAC	
complex.	
	
In	 this	 study,	 we	 have	 investigated	 the	 potential	 role	 of	 CHRAC14	 in	 maintaining	
chromatin	structure	and	how	it’s	absence	lead	to	CENP-A	ectopic	localization.	We	show	
that	 depletion	 of	 CHRAC14	 leads	 to	 increase	 in	 transcript	 level	 of	 histone	
methyltransferase	Su(var)3-9.	Su(var)3-9	 is	responsible	for	histone	H3	lysine	9	(H3K9)	
methylation.	 Using	 Immunoblotting	 and	 immunofluorescence	 we	 show	 that	 lack	 of	
CHARC14	 leads	 to	 overall	 increase	 in	 histone	 H3	 lysine	 (H3K9)	 di	 methylation	 and	
reduction	 in	 H3K9	 acetylation,	 thereby	 highlighting	 the	 importance	 of	 CHRAC14	 in	
maintaining	heterochromatin	and	euchromatin	balance.		
	
Further,	we	examined	if	the	increase	in	Su(var)3-9	expression	level	could	lead	to	ectopic	
CENP-A	localization.	Using	Su(var)3-9	overexpressing	Drosophila	S2	cells,	we	show	that	
overexpression	 of	 Su(var)3-9	 can	 cause	 ectopic	 localization	 of	 CENP-A	 and	 CENP-C.	
Moreover,	live-cell	imaging	analysis	revealed	that	Su(var)3-9	overexpressing	cells	show	
cell	 segregation	 defect	 with	 delayed	 metaphase	 and	 lagging	 chromosome.	 Further	
analysis	 of	 the	 observed	 lagging	 chromosomes	 in	 Su(var)3-9	 overexpressing	 cells	
revealed	presence	of	higher	number	of	CENP-A	foci,	indicating	it	to	be	the	cause	of	cell	
segregation	defect.	Overall,	this	study	reveals	the	role	of	CHRAC14	in	maintaining	the	
chromatin	structure	and	highlights	the	significance	of	maintaining	the	physiological	level	
of	Su(var)3-9	for	proper	CENP-A	localization.	
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Zusammenfassung	
Kinetochore	bilden	die	strukturelle	Basis	für	das	Binden	von	Mikrotubuli	an	Zentromere.	
Zentromere	 werden	 durch	 den	 Schlüsselfaktor	 CENP-A	 (auch	 bekannt	 als	 CID	 in	
Drosophila)	 definiert.	 CENP-A	 ist	 eine	H3	Histonvariante	 und	 seine	Anreicherung	 am	
Zentromer	 führt	 zur	Ausbildung	des	Kinetochores.	 Für	 die	 Zentromerlokalisation	 von	
CENP-A	 sind	 in	Drosophila	 zwei	 Proteine	 sehr	wichtig:	 CENP-C	 und	 CAL1.	 Ektopische	
Lokalisation	von	CENP-A	führt	zu	Chromosomsegregations-Defekten	und	Aneuploidie.	
In	 Brust-,	 Darm-	 und	 Prostatakrebs	 ist	 das	 CENP-A	 Proteinlevel	 erhöht	 und	 CENP-A	
lokalisiert	zu	Regionen	außerhalb	des	Zentromeres.	2014	berichtete	unser	Labor,	dass	
in	 Drosophila-Zellen	 eine	 Reduzierung	 von	 CHRAC14	 ebenfalls	 zu	 ektopischer	
Lokalisation	 von	 CENP-A	 führt.	 CHRAC14	 bildet	 eine	 Untereinheit	 von	 jeweils	 zwei	
verschiedenen	Komplexen,	dem	ATAC	und	dem	CHRAC	Komplex.		
In	 dieser	 Doktorarbeit	 haben	 wir	 die	 Rolle	 von	 CHRAC14	 in	 Bezug	 auf	 die	
Aufrechterhaltung	 von	 Chromatin-Strukturen	 erforscht	 und	 wie	 das	 Fehlen	 von	
CHRAC14	ektopische	CENP-A	 Lokalisation	bedingen	 könnte.	Hier	 zeigen	wir,	 dass	 ein	
Mangel	an	CHRAC14	zum	Anstieg	des	Transkriptlevels	der	Methyltransferase	Su(var)3-9	
führt.	 Su(var)3-9	 ist	 für	 die	Methylierung	 von	 Histone	 H3	 an	 Lysin	 9	 verantwortlich.	
Durch	das	Anwenden	von	Immunoblotting	und	Immunfluoresenz	zeigen	wir,	dass	das	
Fehlen	von	CHRAC14	einen	globalen	Anstieg	von	H3	Lysin	Di-Methylierung	und	einen	
Abfall	 in	 H3K9	 Acetylierung	 bewirkt.	 Dieses	 Ergebnis	 betont	 die	 Bedeutung	 von	
CHRAC14	die	Balance	zwischen	Eu-	und	Heterochromatin	beizubehalten.		
Darüber	 hinaus	 untersuchten	 wir,	 ob	 der	 Anstieg	 des	 Su(var)3-9	 Expressionslevels	
möglicherweise	zu	ektopischer	CENP-A	Lokalisation	führen	könnte.	Indem	wir	Su(var)3-
9	 in	Drosophila-Zellen	über-exprimieren,	zeigen	wir,	dass	dies	ektopische	Lokalisation	
von	 CENP-A	 und	 CENP-C	 verursacht.	 Des	Weiteren	 deuten	 Lebend-Zell-Bildgebungs-
Experimente	darauf	hin,	dass	Su(var)3-9-Überexpression	 zu	Chromosomsegregations-
Defekten	 führt	 und	 durch	 eine	 verzögerte	 Metaphase	 wie	 auch	 durch	 ‚Lagging	
Chromsomes‘	gekennzeichnet	ist.	Eine	genaue	Untersuchung	der	observierten	‚Lagging	
Chromosomes‘	offenbart	zudem	eine	vergrößerte	Menge	an	CENiP-A	Foki	in	Su(var)3-9	
überexprimierenden	Zellen.	Dies	ist	möglicherweise	die	Grundlage	für	die	beobachteten	
Defekte.		
Zusammenfassend	zeigt	diese	Studie,	dass	CHRAC14	wichtig	für	die	Beibehaltung	von	
Chromatin-Strukturen	 ist	 und	 unterlegt	 dessen	 Bedeutung	 für	 die	 Aufrechterhaltung	
physiologischer	Su(var)3-9-Level,	sodass	CENP-A	korrekt	lokalisiert.				
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1. Introduction	
1.1. 	Chromatin	organization	
1.1.1 High	order	chromatin	structure	
Genetic	information	is	retained	in	DNA	sequence	which	makes	it	important	
for	cells	to	strictly	maintain	its	sequence	information.	The	length	of	DNA	is	
far	greater	than	what	could	fit	into	the	size	of	a	nucleus	(length	of	DNA	in	
human	chromosome	is	around	2	meters).	The	high	compaction	of	DNA	to	
chromatin	is	a	multistep	process	which	renders	the	cells	able	to	carry	and	
manage	the	flow	of	genetic	information.	First,	the	DNA	is	wrapped	around	
repeating	 units	 called	 nucleosomes	 as	 proposed	 by	 Roger	 D.	 Kornberg	
(Kornberg	1974).		These	repeating	units	are	composed	of	H2A,	H2B,	H3	and	
H4	histone	octamer	around	which	146	bp	DNA	sequence	is	wrapped	(Luger	
et	al.	1997).	DNA	that	connects	two	nucleosomes	is	called	linker	DNA	which	
is	10-80bp	and	nucleosomes	form	a	10nm	structure	resembling	beads	on	
a	 string.	 Histone	 H1	 binds	 to	 the	 linker	 DNA.	 Histone	 H1	 stabilizes	
nucleosomes	and	facilitates	the	higher	order	packing	of	nucleosomes	into	
30nm	 fibers	which	are	helical	 in	 structures	 (Bednar	et	 al.	 1998;	Olins	&	
Olins	1974)(Figure	1.1).	The	evidences	for	the	existence	of	30nm	fiber	are	
limited	(Maeshima	et	al.	2010;	Woodcock	1994;	Scheffer	et	al.	2011)	and	
might	not	be	present	uniformly	(Razin	&	Gavrilov	2014).	Nevertheless,	the	
30nm	fiber	 is	 further	folded	and	packed	into	the	final	structure	which	 is	
seen	in	metaphase	chromosome	(Hood	&	Galas	2003a).		
An	 ordered	 chromatin	 organization	 is	 necessary	 for	 packing	 all	 DNA	
information	 in	 the	 nucleus	 compartment.	 However,	 the	 DNA	 packaging	
changes	during	cellular	processes	 like	DNA	transcription,	 replication	and	
during	 different	 stress	 conditions	 like	 DNA	 damage	 with	 the	 help	 of	
chromatin	 remodelers	 (Swygert	 &	 Peterson	 2014;	 Peterson	 2002).	 The	
phenomenon	of	changing	the	chromatin	structure	in	response	to	different	
environmental	conditions	to	alter	the	expression	of	genes	without	altering	
the	 underlying	 DNA	 sequence	 is	 termed	 as	 epigenetic	 (Goldberg	 et	 al.	
2007).	Epigenetics	can	also	be	explained	as	change	in	phenotype	without	
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changing	 the	genotype	by	effecting	how	cells	 read	 the	gene.	Chromatin	
remodelers	play	a	crucial	role	in	changing	the	chromatin	structure.	These	
remodelers	 have	 five	 common	 properties:	 1)	 DNA	 dependent	 ATPase	
domain	which	 is	 required	 for	breaking	 the	DNA-histone	contact	 thereby	
helping	 in	 remodeling,	 2)	 domains/proteins	 that	 regulate	 the	 ATPase	
domain,	3)	domains	 that	 recognize	 the	 covalent	histone	modification	4)	
domains	or	subunits	that	help	to	interact	with	chromatin	associated	factors	
and	 5)	 affinity	 to	 nucleosome.	 Chromatin	 remodelers	 are	 classified	 into	
four	families	on	the	basis	of	their	distinct	domains	associated	with	ATPase	
domain.	These	families	are	a)	switching	defective/sucrose	non	fermenting	
(SWI/SNF)	 remodelers,	 b)	 imitation	 switch	 (ISWI)	 remodelers,	 c)	
chromodomain,	helicase,	DNA	binding	(CHD)	remodelers,	and	d)	 inositol	
requiring	80	(INO80).	Chromatin	remodelers	work	by	moving,	ejecting,	or	
re-structuring	the	composition	of	nucleosome	which	 is	well	explained	 in	
several	reviews		(Clapier	&	Cairns	2009;	Narlikar	et	al.	2013)	(Figure	1.2).	In	
general,	ATPase	domain	binds	to	DNA	at	the	site	 inside	the	nucleosome	
and	 is	 responsible	 for	 translocation.	 The	 ATPase	 translocation	 domain	
remains	attached	to	a	fixed	site	on	the	nucleosome	octamer	and	from	this	
site	 it	 conducts	 directional	 DNA	 translocation.	 This	 process	 can	 create	
transient	DNA	loops	on	the	nucleosome	which	then	propagate	around	the	
nucleosome.	 This	 loop	 propagation	 requires	 nucleosome	 sliding,	 or	
disruption	of	one	or	two	histones	from	the	nucleosome,	resulting	in	change	
in	 chromatin	 packing	 without	 changing	 the	 underlying	 sequence.	
Additionally,	certain	enzymes	alter	the	affinity	between	the	nucleosome	
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histones	and	DNA	through	posttranslational	modification	of	histone	amino	
acids.	Some	of	them	are	discussed	later	in	this	chapter.	
	
	
	
	
	
	
Figure	1.1:	Organization	of	DNA	into	chromatin	structure	(Hood	&	Galas	2003b).	The	picture	
represents	the	levels	of	chromatin	packaging	from	DNA	helix	to	arrangement	of	the	helix	on	a	
histone	octamer	(nucleosome)	to	30nm	fibers	and	resulting	 in	final	packaging	into	a	mitotic	
chromosome.	
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1.1.2 Heterochromatin	and	euchromatin	
In	 eukaryotes,	 traditionally,	 the	 chromatins	 are	 divided	 into	 two	
categories:	 heterochromatin	 and	 euchromatin.	 Heterochromatin	
represents	inactive	or	dense	chromatin	regions	and	comprises	10	to	25%	
of	 total	 chromatin	 depending	 on	 age,	 cell	 type	 and	 species	 (Yunis	 &	
Yasmineh	1971;	Gabor	et	al.	1979).	Heterochromatin	is	further	subdivided	
into	 two	 categories:	 constitutive	 and	 facultative.	 Constitutive	
heterochromatin	 is	 referred	 to	 the	 chromatin	 regions	 that	 stay	
transcriptionally	inert	throughout	the	cell	life.	Facultative	heterochromatin	
represents	a	region	of	euchromatin,	which	is	silenced	via	condensation	and	
can	 be	 transcriptionally	 active	 when	 required	 by	 cell	 conditions.	
Euchromatin	 comprises	 the	 active	 chromatin	 regions.	 In	 general,	
euchromatin	 contains	 several	 histone	 H3	 	 lysine	 (K)	 methylation	 and	
acetylation	modifications	like,	H3K4me2,	H3K4me3,	H3K27ac	and	H3K9ac	
whereas	 heterochromatin	 or	 inactive	 chromatin	 regions	 contain	
H3K9me2/3	and	H3K27me3	(Shilatifard	2008;	Wang	et	al.	2014;	Schneider	
Figure	1.2	 (Adapted	from	Clapier	&	Cairns	2009).	Mechanisms	utilized	by	different	chromatin	
remodelers	to	access	the	genomic	site	or	alter	the	composition	of	nucleosomes.	For	access	of	
genomic	 sites,	 remodelers	 (green)	 can	 change	 the	 chromatin	 structure	 by	moving	 already	
deposited	nucleosomes,	ejecting	the	histone	units	from	the	nucleosome,	unwrapping	the	DNA	
from	the	histone	octamer.	Remodelers	alter	the	composition	of	nucleosomes	by	histone	dimer	
exchange	with	histone	variants	(in	blue)	and	by	ejection	of	a	histone	dimer.	
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&	 Grosschedl	 2007;	 Hood	 &	 Galas	 2003b).	 These	 modifications	 are	
collective	 results	of	activities	of	histone	acetyltransferase	 (HAT),	histone	
deacetylase	 (HDAC),	 and	 histone	 methyltransferase	 (HMT).	
Heterochromatin	 and	 euchromatin	 is	 a	 simplified	 view	 of	 chromatin	
structure,	recent	studies	have	further	characterized	subtypes	of	chromatin	
structures	 based	 on	 associated	 proteins.	 According	 to	 Fillion	 and	
colleagues,	Drosophila	chromatin	can	be	divided	into	5	types,	which	gives	
further	insight	into	the	types	of	heterochromatin	and	euchromatin	(Filion	
et	al.	2010).	The	study	suggests	that	heterochromatin	can	be	divided	into	
three	types	1)	heterochromatin	protein	1	(HP1)	associated	chromatin,	2)	
polycomb	 group	 (PcG)-associated	 chromatin	 and	 3)	 predominantly	
associated	 with	 H1	 and	 suppressor	 of	 underreplication	 (Suur).	
Furthermore,	 they	divide	euchromatin	 into	2	 types:	1)	chromatin	region	
enriched	with	H3K36me3	and,	2)	active	chromatin	region	that	contains	no	
H3K36me3	 but	 is	 associated	 with	 Brahma	 which	 is	 a	 nucleosome	
remodeler.	 This	 gives	 a	 hint	 on	 specialized	 roles	 of	 different	 chromatin	
remodelers	 and	 histone	 modification	 enzymes	 in	 maintaining	 the	
chromatin	structure,	some	of	which	are	discussed	below.	
	
1.1.3 Histone	acetyltransferases	
HATs	are	enzymes	that	acetylate	histones.	Hyperacetylation	of	histones	is	
associated	with	active	or	accessible	chromatin	regions	(OIiva	et	al.	1990).	
Acetylation	of	the	lysine	residue	of	histones	removes	the	positive	charge	
and	 this	 in	 turn	 reduces	 the	 interaction	 of	 the	 histone	 with	 negatively	
charged	DNA	thereby	making	chromatin	relaxed.	This	in	combination	with	
other	 chromatin	 remodelers	 overall	 affect	 the	 chromatin	 assembly	 and	
structure	 (Eberharter	 &	 Becker	 2002),	 further	making	 DNA	 information	
available	for	the	transcription	machinery	(Bannister	&	Kouzarides	2011).	
HAT1	 and	 GCN5	 were	 the	 first	 two	 discovered	 HATs	 (Kleff	 et	 al.	 1995;	
Brownell	et	al.	1996),	since	then	a	number	of	HATs	has	been	identified	in	
various	organisms	(Table	1.1).	HATs	can	be	categorized	into	two	families,	
the	Gcn5	N-acetyltransferase	(GNAT)	and	MYST	HAT	family	(named	after	
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founding	members	MOZ,	Ybf2/Sas3,	Sas2	and	Tip60).	GNATs	can	be	sub-
categorized	into	following	a)	GCN5	containing,	b)	PCAF	containing,	c)	Hat1a	
containing	 d)	 Elp3	 containing	 and	 e)	 Hpa2	 containing	 HAT	 complexes.	
MYST	HATs	can	be	categorized	into	complexes	with	a	catalytic	subunit	a)	
Esa1	 b)	 Sas3	 c)	 Sas2	 d)	 TIP60	 e)	 HBO1	 f)	 MOZ/MORF	 g)	 MSL	 (Lee	 &	
Workman	2007).	Beside	these	HATs,	nejire	(KAT3)	is	the	single	Drosophila	
CBP/p300	homologue.	
Different	HAT	complexes	are	composed	of	many	different	subunits	with	
DNA-binding	 domains	which	 are	 important	 for	 HAT	 recruitment	 and	 its	
activity.	Multiple	functions	identified	for	HATs	explain	the	requirements	of	
many	 subunits.	 Associated	 subunits	 help	 HATs	 to	 be	 recruited	 to	 an	
appropriate	 genomic	 location	 and	 contain	 domains	 like	 bromodomain,	
chromodomains	(CD),	WD40	repeats,	Tudor	domain	and	PHD	fingers.		HATs	
have	been	reported	to	co-localize	with	H3K9ac	at	the	promoter	regions.	
Complementing	with	this,	HATs	are	important	for	transcription	activation,	
cell	 cycle	 and	 growth	 control	 (Carrozza	 et	 al.	 2003;	 Xue-Franzén	 et	 al.	
2013).	Loss	of	HATs	activity	impairs	the	DNA	damage	repair	ability	(Dinant	
et	al.	2008;	Carrozza	et	al.	2003).	Furthermore,	CBP	dependent	H3K56ac	is	
found	to	localize	at	the	DNA	damage	repair	sites	in	Drosophila	and	human	
cells.	The	deposition	of	H3K56ac	to	DNA	damage	repair	sites	is	mediated	
by	 chromatin	 assembly	 factor	 1(Caf1)	 	 (Das	 et	 al.	 2009).	 	 In	 a	 nutshell,	
current	 findings	 suggest	 a	 strong	 role	 for	 HATs	 mediated	 histone	
acetylation	in	maintaining	genome	stability	and	cell	cycle	progression	by	
changing	the	chromatin	structure.	
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GNAT	HATs	 MYST	HATs	
Catalytic	subunits	
found	in	GNAT	
family	HATs	
Associated	
complex	
Catalytic	subunits	
found	in	MYST	
family	HATs	
Associated	
complex	
GCN5	 SAGA,	ATAC,	SLIK,	
ADA.	HAT-A2,	
STAGA,	
Esa1	 NuA4	
PCAF	 PCAF	 Sas3	 NuA3	
Hat1a	 HATB	 Sas2	 SAS	
Elp3	 Elongator	 TIP60	 TIP60	
Hpa2	 Hpa2	 HBO1	 HBO1	
-	 -	 MOF	 MSL	
	
1.1.4 Histone	deacetylases	
Histone	 deacetylases	 (HDACs)	 catalyze	 the	 removal	 of	 functional	 acetyl	
groups	 (O=C-CH3)	 from	 histones.	 HDACs	 are	 metal	 dependent	 (Zn2+)	
enzymes	 that	 hydrolyze	 acetyl-L-lysine	 side	 chains	 in	 histones	 to	 yield	
lysine	and	acetate	(Lombardi	&	Cole	2011).	HDACs	in	eukaryotic	organisms	
have	been	classified	in	four	classes	(Class	I	–	IV)	based	on	shared	homology	
with	yeast	HDACs.	Class	 I	 represents	HDACs	which	share	homology	with	
Rpd3,	like	Rpd3,	HDAC1,	HDAC2	and	HDAC3	(Kasten	et	al.	1997).	Using	the	
Drosophila	model	system,	it	has	been	postulated	that	class	I	HDACs	play	a	
role	 in	 inactivation	 of	 genes	 via	 interaction	 with	 histone	
methyltransferases	(HMT)	(Czermin	et	al.	2001).	Class	II	HDACs	are	HDACs	
which	 share	 similarity	 with	 yeast	 Hda1	 and	 bind	 to	 MEF2	 family	 of	
transcription	factors	through	a	MEF2	binding	domain	(Wang	et	al.	1999;	
Miska	et	al.	2001).	HDAC4	from	class	II	has	also	been	shown	to	play	a	role	
Table	1.1	The	Histone	acetyltransferases	(HATs)	are	grouped	into	GNAT	(Gcn5	N-acetyltransferase)	
and	MYST	(Morf-Ybf2-Sas2-Tip60)	families.	This	table	represents	catalytic	subunits	of	various	HAT	
complexes	 from	 the	 two	 families.	 Further	details	on	HATs	 can	be	 found	 in	 the	 reviews.	 (Lee	&	
Workman	2007;	Carrozza	et	al.	2003;	Biterge	2016)	
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in	the	circadian	cycle	in	Drosophila	and	mammals	(Fogg	et	al.	2014).	Class	
III	 HDACs	 share	 similarity	 with	 yeast	 Sir2	 and	 play	 a	 role	 in	 longevity,	
apoptosis	 and	 skeletal	 myogenesis	 in	 yeast,	 C.	 elegans,	 Drosophila	 and	
mammals	(Luo	et	al.	2001;	Whitaker	et	al.	2013;	Guarente	2001;	Fulco	et	
al.	2003).	Class	IV	HDACs	are	a	new	class	of	HDACs	and	contain	only	one	
member	-	HDAC11.	This	newly	discovered	HDAC	is	exclusively	expressed	in	
brain,	 kidney	 and	 testis	 (Gao	 et	 al.	 2002)	 and	 plays	 a	 role	 in	 immune	
system.	In	Drosophila,	it	has	been	shown	that	individual	HDACs	modulate	
transcription	of	distinct	genes	(Cho	et	al.	2005).	
The	wide	variety	of	HDAC	functions	in	cell	proliferation,	cancer	and	other	
diseases	 (Ververis	 et	 al.	 2013)	 led	 to	 the	 need	 of	 HDAC	 inhibitors	 for	
research	 and	 clinical	 purposes.	 N-butyrate	 is	 the	 earliest	 discovered	
inhibitor,	which	causes	a	reversible	increase	in	histone	acetylation	(Riggs	
et	 al.	 1977).	 Trapoxin	 A	 (TPX)	 and	 trichostatin	 A	 (TSA)	were	 discovered	
following	N-butyrate	(Yoshidas	1990;	Kijima	et	al.	1993).	TSA	is	shown	to	
create	hyperacetylation	of	the	chromatin	environment	by	inhibiting	a	wide	
range	 of	 HDACs,	 in	 turn	 to	 reduce	 the	 heterochromatin	 environment	
concomitant	with	a	 reduction	 in	H3K9	methylation	 (Görisch	et	al.	 2005;	
Tóth	et	al.	2004;	Felisbino	et	al.	2016;	Wu	et	al.	2008).	TSA	is	one	of	the	
extensively	used	drugs	in	studying	the	overall	role	of	HDACs	in	chromatin	
change,	 DNA	 repair,	 gene	 activation,	 cell	 proliferation	 and	 cancer	
treatment	(Tao	et	al.	2004;	Pile	et	al.	2001;	Vigushin	et	al.	2001;	Kondo	et	
al.	2003;	Görisch	et	al.	2005;	Klement	et	al.	2014;	Taddei	et	al.	2005;	Szyf	
2003).	
	
1.1.5 Histone	methyltransferases		
Histone	 methyltransferases	 (HMTs)	 are	 a	 class	 of	 enzymes	 that	 add	 a	
methyl	 (CH3)	group	 to	histones.	HMTs	 transfer	CH3	 from	the	cofactor	S-
adenosylmethionine	(SAM)	to	the	terminal	amine	of	a	specific	substrate	
lysine	(K)	or	arginine	(R)	residue.	An	early	evidence	of	histone	methylation	
was	discovered	in	1960s,	were	the	importance	of	histone	methylation	in	
RNA	synthesis	was	shown	(Murray	1964;	Allfrey	et	al.	1964).	Su(var)3-9	is	
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the	first	reported	HMT	(Rea	et	al.	2000).	Most	of	the	HMTs	contain	a	SET	
domain	 that	 is	 a	 130	 amino	 acid	 catalytic	 domain	 initially	 found	 to	 be	
conserved	in	Su(var)3-9,	E(z)	(enhancer	of	zeste)	and	Trithorax	(Jenuwein	
2006).	 Su(var)3-9,	 E(z),	 and	 trithorax	 are	 lysine	 HMTs	 (KHMTs).	 Lysine	
methylation	on	histones	is	one	of	the	posttranslational	modifications	that	
regulate	 important	 epigenetical	 phenomena	 like	 gene	 silencing	 and	
heterochromatin	 formation.	 	 KHMTs	 can	 be	 divided	 into	 two	 groups:	
KHMTs	with	a	SET	domain	and	KHMTs	without	a	SET	domain	(Nguyen	&	
Zhang	2011b).	
Subsequently,	 I	 will	 focus	 on	 modifications	 catalyzed	 by	 SET	 domain	
containing	KHMTs,	their	substrates	and	their	significance	in	regulating	cell	
cycle	 progression	 and	 development.	 Methylation	 of	 lysine	 residues	 of	
Histone	 H3	 K4,	 K9,	 K27,	 K36	 and	 K79,	 and	 K20	 in	 H4	 histone	 are	well-
studied	sites	(Table	1.2)	and	reviewed	in	detail	by	Black	et	al.	2012	and	Izzo	
&	Schneider	2010.		Methylation	of	H3	K9,	K27	and	H4K20	plays	a	role	in	the	
formation	 of	 heterochromatin	 and	 transcriptional	 silencing,	 while	
methylation	 of	H3K4,	H3K36	 and	H3K79	 are	 important	 for	 transcription	
activation	(Black	et	al.	2012;	Biterge	2016).		
	
Table	1.2:	Substrate,	site	and	functions	of	SET	containing	KHMT	
Histone	
lysine	
Histone	Lysine	
methyltransferases	
Function/s	
H3K9	 Dm	Su(var)3-9,	Hs	and	Mm	
Su(var)3-9H1	and	Su(var)3-
9h2,	Sp	Clr4	
Heterochromatin	and	
euchromatin	silencing;	DNA	
methylation	(Lundberg	et	al.	
2013).	
Mm	and	Hs	G9a,	Hs	GLP1	 Euchromatin	silencing	and	DNA	
methylation	(Seum	et	al.	2007).	
Mm,	Dm	and	Hs	SETDB1	 Euchromatin	silencing	(Loyola	et	
al.	2009).	
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Nc	DIM-5	 Heterochromatin	silencing	and	
DNA	methylation	(Ruesch	et	al.	
2015).	
H3K27	 Dm	E(z);	Hs	EZH1	and	EZH2	
(catalytic	subunits	if	
Polycomb	repressive	
complex	2)	
Euchromatin	Silencing	(Gaydos	et	
al.	2014).	
Hs	and	Mm	G9a	 Euchromatin	Silencing	(Wu	et	al.	
2011).	
H3K4	 Hs	EZH2	(catalytic	subunits	
of	Polycomb	repressive	
complex	3)	
Transcriptional	silencing	
(Reinberg	2011).	
Dm	Trxk	Hs	MLL1,	MLL2	and	
MLL3	
Transcriptional	activation	
(Sandstrom	et	al.	2014;	Lee	et	al.	
2013).	
Hs	SET1,	Sc	SET1	 Transcriptional	activation	and	
elongation	(Thornton	et	al.	
2014).	
Hs	SET7/9	 Transcriptional	activation	(Gu	&	
Lee	2013).	
Dm	ASH1	 Transcriptional	activation	(Dillon	
et	al.	2005).	
H3K36	 Sc	SET2	 Transcriptional	silencing	and	
elongation	(Bell	et	al.	2007).	
Mm	NSD1	and	Dm	MES-4	 Transcriptional	regulation	
(Wagner	&	Carpenter	2012).	
H3K79	 Dm,	Hs	and	Mm	DOT1	
(KHMT	without	SET	domain)	
Demarcation	of	Euchromatin	
(Nguyen	&	Zhang	2011a).	
H4K20	 Dm,	and	Hs	SET8	 Cell	cycle-dependent	silencing,	
mitosis	and	cytokinesis	
(Jørgensen	et	al.	2013).	
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Dm,	Mm	and	Hs	Su(var)4-20	
H1	and	
Su(var)4-20	
Heterochromatin	silencing	
(Jørgensen	et	al.	2013).	
Mm	NSD1	 Transcription	regulation	
(Rayasam	et	al.	2003).	
Dm	ASH1	 Transcription	activation	(Beisel	
et	al.	2002).	
SpSET9	 Recruitment	of	checkpoint	
protein	Crb2	to	sites	of	DNA	
damage	(Sanders	et	al.	2004).	
H1K26	 Hs	and	Dm	EZH2	 Transcriptional	silencing	
(Kuzmichev	et	al.	2004).	
		
1.1.5.1 Histone	K9	methylation	
Among	heterochromatin	histone	modifications,	H3K9	methylation	is	
one	of	the	most	extensively	studied	histone	modification.		Su(var)3-
9,	G9a	and	SETDB1	are	the	predominant	HMTs	responsible	for	H3K9	
methylation	(Du	et	al.	2015).	Mono-	(H3K9me1),	di-	(H3K9me2)	or	tri-	
(H3K9me3)	methyl	groups	can	be	added	which	often	has	a	different	
function.	In	mammals,	H3K9me2	and	H3K9me3	represent	facultative	
and	constitutive	heterochromatin,	respectively	(Peters	et	al.	2003).	
This	H3	modification	has	been	shown	to	be	one	of	the	epigenetically	
inherited	modifications	in	yeast	via	cryptic	loci	regulator	4	(Clr4)	HMT	
(homolog	of	Su(var)3-9)	(Audergon	et	al.	2015).		In	the	study,	authors	
show	that	H3K9me	is	a	persistent	histone	modification	that	can	be	
stably	copied	through	meiosis	and	mitotic	cell	divisions	after	the	loss	
of	Clr4.	 Su(var)3-9	 is	demonstrated	 to	be	 conserved	 from	yeast	 to	
human.	Su(var)3-9h1	which	 is	a	homolog	of	Drosophila	Su(var)3-9,	
requires	 the	 H3K9me1	 modification	 by	 SETDB1	 for	 adding	
Table	 1.2:	 The	 Histone	 lysine	 methylation	 sites	 listed	 according	 to	 their	 lysine	 histone	
methyltransferase	 and	 function	 of	 the	 methylation.	 Species	 abbreviation:	 Dm:	 Drosophila	
melanogaster,	 Hs:	 Homo	 sapiens,	 Mm:	 Mus	 musculus,	 Nc:	 Neurospora	 crassa	 Sp:	
Schizosaccharomyces	pombe.	(Black	et	al.	2012;	Izzo	&	Schneider	2010)	
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H3K9me2/3	 at	 pericentric	 heterochromatin	 (Loyola	 et	 al.	 2009;	
Lundberg	et	al.	2013).	Su(var)3-9	physically	interacts	with	H1	linker	
histone	playing	a	key	role	in	formation	of	heterochromatin	(Lu	et	al.	
2013).	 H3K9me	 is	 important	 for	 maintaining	 constitutive	
heterochromatin,	while	it	is	also	important	for	silencing	euchromatin	
regions.	 In	 Drosophila,	 Su(var)3-9	 is	 the	 dominant	 HMT	 and	 is	
detected	 in	 all	 major	 heterochromatin	 regions	 and	 several	
euchromatin	regions	(Hwang	et	al.	2001;	Schotta	et	al.	2003).		Lack	of	
Su(var)3-9	 results	 in	 an	 aberrant	 chromosome	 segregation	 during	
meiosis	and	increases	genome	instability	 in	mammals	(Peters	et	al.	
2001;	Schotta	et	al.	2002).	Its	activity	is	important	for	peri-centric	and	
telomeric	 H3K9	 methylation.	 	 Overexpression	 of	 Su(var)3-9	 in	
mammals	causes	a	cell	segregation	defect	with	chromosome	bridges	
with	 micro-	 and	 poly-nuclei.	 Interestingly,	 Su(var)3-9	 double	 null	
murine	cells	also	show	similar	defects	during	mitosis	with	micro-	and	
poly-nuclei	 (Rea	 et	 al.	 2000).	 The	 Su(var)3-9	 mediated	 H3K9me	
formation	 is	 important	 for	maintaining	DNA	methylation	 (Du	et	al.	
2015).	It	is	important	to	note	that	DNA	methylation	is	not	present	in	
all	 the	 organisms	 or	 restricted	 to	 an	 early	 development	 stage,	 for	
instance,	in	Drosophila	melanogaster	(Lyko	et	al.	2000;	Raddatz	et	al.	
2013;	 Takayama	 et	 al.	 2014;	 Capuano	 et	 al.	 2014),	 indicating	 the	
presence	of	an	alternative	DNA	compaction	strategy,	possibly,	larger	
role	of	histone	methylation	in	DNA	compaction.		
Formation	 of	 heterochromatin	 requires	 H3K9me2/3	 by	 Su(var)3-9,	
which	 is	 followed	 by	 binding	 of	 Heterochromatin	 protein	 1	 (HP1)	
{also	termed	as	Su(var)2-5}	which	interacts	with		both	Su(var)3-9	and	
methylated	 H3K9	 and	 this	 provides	 a	 positive	 feedback	 loop	
mechanism	 for	 maintenance	 and	 spread	 of	 heterochromatin	
(Lachner	et	al.	2001;	Nielsen	et	al.	2002;	Schotta	et	al.	2003;	Lundberg	
et	al.	2013).	Su(var)3-9	and	HP1	both	bind	to	surrounding	common	
repetitive	regions	in	Drosophila	cells	(Greil	et	al.	2003).	In	addition,	
HP1	 interacts	with	both	H3K9me2	and	H3K9me3,	although	it	has	a	
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stronger	 affinity	 to	 bind	 to	 H3K9me3	 than	 H3K9me2	 via	 its	
chromodomain	 (Pérez-Toledo	et	al.	 2009;	 Fischle	et	al.	 2003).	HP1	
also	 interacts	 with	 CAF1	 chromatin-remodeler	 and	 regulates	 HP1	
mediated	heterochromatin	stability	(H.	Huang	et	al.	2010;	Quivy	et	
al.	2008).	Furthermore,	HP1	interacts	with	repetitive	RNAs	(Shareef	
et	al.	2001),	this	interaction	between	heterochromatin	elements	and	
non-coding	 repetitive	 RNA	 is	 postulated	 to	 be	 important	 for	
maintaining	 heterochromatin	 structure,	 as	 well	 as	 	 in	maintaining	
heterochromatin	 and	 euchromatin	 boundaries	 (Keller	 et	 al.	 2013;	
Blattes	et	al.	2006;	Zhou	et	al.	2009).	Recent	findings	also	suggest		a	
role	of	HP1	 in	 regulating	euchromatin	 regions	positively	 and	more	
evidences	 are	 emerging	 to	 show	 functions	 of	 HP1	 independent	 of	
H3K9me2/3,	 in	 positive	 regulation	 of	 gene	 expression	 (Yuan	 &	
O’Farrell	2016;	Liu	&	Zhang	2015).	
	
G9a,	 another	 SET	 domain	 containing	HMT	which	methylates	H3K9	
and	has	a	dominating	role	in	euchromatin	silencing	via	H3K9	mono-	
and	di-methylation	(Tachibana	et	al.	2001)	with	different	localization	
than	HMT	Su(var)3-9.	G9a	can	auto-methylate	itself	which	resembles	
H3K9me3.	 Auto-methylated	 G9a	 peptide	 interacts	 with	 HP1	 and	
shows	potential	of	recruiting	HDAC1	and	DNMT1	(Chin	et	al.	2007).	
G9a	also	methylates	many	transcription	factors,	which	 inhibit	 their	
transcription	activity,	 for	example,	CEBP-β	 is	methylated	at	K39	by	
G9a	which	interferes	with	transcription	of	myeloid	genes	(Leutz	et	al.	
2011).	G9a	also	methylates	p53	at	K373	leading	to	its	transcriptional	
inactivation	(J.	Huang	et	al.	2010).	In	addition,	G9a	also	contributes	
to	 H3K27	 methylation	 (Wu	 et	 al.	 2011).	 G9a	 is	 essential	 for	
embryogenesis	in	mammals	and	is	important	for	embryonic	stem	cell	
differentiation	(Yamamizu	et	al.	2012;	Chen	et	al.	2012).	Contrary	to	
this,	G9a	does	not	seem	to	be	essential	for	the	Drosophila	organism	
(Tachibana	et	al.	2002;	Seum	et	al.	2007).		
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1.2 CHRAC14	containing	complexes	and	their	role	in	chromatin	maintenance	
CHRAC14	 is	 a	 subunit	 of	 Ada2s-containing	 (ATAC)	 and	 chromatin	 accessibility	
(CHRAC)	chromatin	remodeling	complex	(Figure	1.3).	The	ATAC	complex	contains	
13	subunits	which	includes	two	HAT	subunits,	Gcn5	and	ATAC2	(Suganuma	et	al.	
2008;	 E.	 Vamos	 &	 Boros	 2012;	 Ciurciu	 et	 al.	 2008).	 CHRAC	 belongs	 to	 ISWI	
chromatin	 remodeling	 family.	 CHRAC	 contains	 ACF,	 CHRAC14	 and	 CHRAC16	
subunits	(Kukimoto	et	al.	2004;	Varga-Weisz	et	al.	1997;	Corona	et	al.	2000).	The	
presence	 of	 CHRACI4	 enhances	 the	 nucleosome	 sliding	 activity	 of	 CHRAC.	 The	
CHRAC14/16	subunit	also	helps	the	CHRAC	complex	to	bind	to	genomic	sites	on	the	
chromatin	 (Hartlepp	 et	 al.	 2005).	 In	 mammals,	 depletion	 of	 ACF1	 delays	 the	
replication	 of	 heterochromatin	 regions,	 indicating	 its	 role	 in	 opening	
heterochromatin	structures	(de	la	Serna	&	Imbalzano	2002;	Collins	et	al.	2002).	
	
	
In	accordance	with	the	idea	of	chromatin	opening/accessibility,	mammalian	Gcn5,	
which	is	a	catalytic	subunit	of	many	HAT	including	ATAC	complexes,	co-localizes	at	
DNA	damage	 sites	 upon	DNA	damage	 induced	with	 increased	H3K9	 acetylation	
(H3K9ac)	that	in	turn	recruits	DNA	repair	proteins	(Guo	et	al.	2011).	Further,	loss	
Figure	 1.3:	 Summary	 of	 CHRAC14	 containing	 chromatin-remodeling	 complexes.	 The	
arrangement	of	subunits	represents	only	to	date	identified	subunits,	not	necessarily	how	they	
interact	with	each	other	 in	the	complex.	References:	CHRAC	complex	(Längst	&	Becker	2001)	
ATAC	complex	(Ciurciu	et	al.	2008;	Guelman	et	al.	2009;	Spedale	et	al.	2012).	
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of	 Ada3,	which	 is	 another	 ATAC	 complex	 subunit,	 show	 impaired	 DNA	 damage	
repair	ability	upon	 Ionizing	 radiation	 (IR)	 treatment	 in	murine	cells	 (Mirza	et	al.	
2012).	Moreover,	Gcn5	containing	the	ATAC	complex	subunit	ADA2B	shows	genetic	
interaction	 with	 p53	 (Pankotai	 et	 al.	 2005)	 and	 absence	 of	 CHRAC14	 shows	
impaired	DNA	damage	repair	in	Drosophila	(Mathew	et	al.	2014).	Taken	together,	
these	 reports	 suggest	 a	 role	 for	 CHRAC14	 containing	 complexes	 in	maintaining	
chromatin	 structure	 in	need	of	 transcription	activation	and	accessibility	 to	DNA	
damage	sites.	However,	whether	CHRAC14	solely	or	as	a	part	of	ATAC	and	CHRAC	
complex	is	essential	for	maintaining	chromatin	structure	remains	to	be	elucidated.	
	
1.3 Centromere	and	its	DNA	
The	centromere	was	first	defined	as	a	primary	constriction	of	the	chromosome	by	
a	German	biologist	Walter	Flemming	in	1880s	(Flemming	1882).	The	centromere	is	
important	for	the	formation	of	the	kinetochore,	which	is	required	for	attachment	
of	microtubules	 and	 chromosome	 segregation	during	 cell	 division.	 Centromeres	
have	no	defined	sequence	and	are	enriched	in	satellite	repeats	in	all	animals	except	
the	yeast	S.	cerevisiae.	(Pardue	&	Gall	1970;	Rošić	&	Erhardt	2016).	Some	animals	
like	orangutan,	horse,	and	chicken	have	a	mixture	of	repetitive	and	non-repetitive	
sequences	(Montefalcone	et	al.	1999;	Piras	et	al.	2010;	Locke	et	al.	2011).	These	
repetitive	 sequences	 are	 not	 specifically	 conserved	 among	 species,	 although	
reports	on	human-specific	171bp	alpha-satellite	and	yeast	S.	pombe	centromere	
regions	 suggest	 a	 role	 in	 the	 de-novo	 specification	 of	 the	 centromere	
(Hahnenberger	et	al.	1989;	Haaf	et	al.	1992).	In	budding	yeast,	centromere	specific	
DNA	element	 III	sequence	 is	directly	recognized	by	Centromere	binding	factor	3	
(Cbf3)	 (Lechner	 &	 Carbon	 1991).	 In	 addition,	 human	 artificial	 chromosome	 is	
capable	 with	 an	 alpha	 satellite	 repeat	 of	 inducing	 de-novo	 assembly	 of	 active	
centromere/kinetochore	structure	(Masumoto	et	al.	1998).	
		
Converse	to	genetic	sequence,	centromeres	in	all	the	species	have	some	common	
features,	 which	 possibly	 make	 the	 centromeres	 unique	 for	 localization	 of	
kinetochore	 proteins.	 One	 of	 the	 common	 similarities	 is	 the	 presence	 of	
heterochromatin	 regions	 bordering	 the	 centromere	 from	 two	 sides.	 This	
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centromere	 flanking	heterochromatin	 is	 termed	as	pericentric-heterochromatin,	
which	 is	 a	 conserved	 epigenetic	 feature	 in	 both	 yeast	 and	 human.	 Pericentric-
heterochromatin	is	predominantly	marked	by	H3K9me2	(Sullivan	&	Karpen	2004),	
while	H3K9me3	is	present	on	only	one	side	as	seen	in	human	and	Drosophila	cells.	
Sullivan	 and	 Karpen’s	 study	 on	 mammalian	 and	 fruit	 fly	 cells	 reveals	 that	
centromeric	 DNA	 contains	 no	 heterochromatin	 modifications.	 Moreover,	
centromeric	DNA	does	not	contain	any	active	chromatin	mark	i.e.	no	detectable	H3	
or	H4	acetylation	mark	(Blower	et	al.	2002;	Sullivan	&	Karpen	2004)	reflecting	a	
hypoacetylated	region	at	the	centromere.		
Identity	and	functionality	of	centromere	can	also	be	addressed	by	localization	of	
kinetochore	 forming	 proteins	 or	 by	 the	 presence	 of	 a	 sequence	 that	 binds	 to	
kinetochore	 forming	 proteins.	 Because	 of	 variation	 in	 underlying	 centromere	
sequences	between	different	species,	it	is	challenging	to	study	the	potential	role	
of	 underlying	 centromere	 sequence.	 On	 the	 other	 hand,	 the	
centromere/kinetochore	interacting	proteins	are	widely	conserved	from	yeast	to	
human	and	have	been	extensively	used	in	understanding	centromere/kinetochore	
functionality.		
	
1.4 CENP-A	at	the	centromere	
Centromeric	protein-A	(CENP-A)	is	a	H3	histone	variant	specifically	localizing	to	the	
centromere.	 Other	 than	 pericentric-heterochromatin,	 what	 makes	 centromere	
very	 unique	 from	 rest	 of	 the	 chromosome	 sites	 is	 the	 presence	 of	 CENP-A	
containing	 nucleosome.	 CENP-A	 is	 conserved	 from	 yeast	 to	 human.	 In	 various	
organisms,	CENP-A	nucleosome	is	not	present	uniformly	but	shows	an	interspersed	
pattern	 (Blower	 et	 al.	 2002;	 Greaves	 et	 al.	 2007;	 Yan	 &	 Jiang	 2007).	 The	
composition	of	a	CENP-A	nucleosome	is	still	unclear.	However,	 in	vivo	studies	 in	
yeast	 and	 mammalian	 cells	 suggest	 presence	 of	 a	 tetramer	 nucleosome	 at	
centromere	i.e.	CENP-A	nucleosome	contains	one	of	each	H2A,	H2B,	CENP-A	and	
H4	 histone	 (Henikoff	 et	 al.	 2014;	 Bodor	 et	 al.	 2014;	 Tachiwana	 et	 al.	 2011;	
Padeganeh,	 De	 Rop,	 et	 al.	 2013;	 Sekulic	 et	 al.	 2010)	 that	 is	 also	 referred	 as	
hemisome.	Moreover,	cell	cycle	dependent	fluctuation	of	tetramer	to	octamer	has	
also	 been	 postulated	 (Bui	 et	 al.	 2012).	 By	 contrast,	 presence	 of	 hemisome	 and	
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tetramer	 to	 octamer	 fluctuation	 at	 centromere	 have	 been	 challenged	 by	many	
other	studies	(Padeganeh,	Ryan,	et	al.	2013;	Bassett	et	al.	2012;	Tachiwana	et	al.	
2011)	suggesting	the	presence	of	an	octamer	nucleosome	throughout	the	cell	cycle	
(Dunleavy	et	al.	2013).	
	
CENP-A	 is	 a	 key	 component	 for	 the	 establishment	 of	 a	 kinetochore	 at	 the	
centromere,	thereby	important	for	attachment	of	microtubule	and	chromosome	
segregation	in	anaphase	(Pauleau	&	Erhardt	2011).		CENP-A	has	a	CENP-A	targeting	
domain	(CATD),	which	is	required	for	CENP-A	centromeric	localization.	A	chimera	
of	 CENP-A	 CATD	 domain	 and	 canonical	 H3	 histone	 is	 sufficient	 to	 lead	 to	
centromeric	localization	(Black	et	al.	2007;	Vermaak	et	al.	2002).	Holliday	junction	
recognition	protein	(HJURP)	interacts	with	CENP-A	via	its	CATD	domain	and	plays	a	
role	as	CENP-A	assembly	factor	(Dunleavy	et	al.	2009).	CENP-A	is	also	known	as	CID	
(centromere	identifier)	in	Drosophila,	and	requires	Chromosome	alignment	defect	
1	 (CAL1)	 and	 Centromeric	 protein-C	 (CENP-C)	 for	 its	 localization	 at	 centromere	
(Dunleavy	et	al.	2009;	Erhardt	et	al.	2008;	Bassett	et	al.	2012).	Cal1	and	CENP-C	are	
hypothesized	to	have	a	similar	function	as	HJURP	and	M18BP1,	despite	the	lack	of	
sequence	 homology	 (Pauleau	 &	 Erhardt	 2011).	 CENP-A	 bears	 60%	 amino	 acid	
similarity	with	 canonical	 H3	 histone	 and	 it’s	 the	N-terminal	 tail	 part	 of	 CENP-A	
which	has	no	similarity	with	H3	(Malik	et	al.	2002;	Sullivan	et	al.	1994).	Further,	
CENP-A	has	an	interesting	unstructured	C-terminal	part	which	is	important	in	long	
term	maintenance	 of	 CENP-A	 centromere	 function	 (Fachinetti	 et	 al.	 2013)	 and	
interaction	with	CENP-C	(Saitoh	et	al.	1992;	Guse	et	al.	2011).	CENP-C	is	also	a	part	
of	the	core	centromere	and	interacts	with	CENP-A	and	kinetochore	proteins.	Lack	
of	CENP-C	affects	the	function	of	centromere	and	formation	of	kinetochore	(Orr	&	
Sunkel	2011).	CENP-C	possibly	plays	a	role	as	a	connecting	platform	between	CENP-
A	containing	nucleosome	and	core	kinetochore	component	(Przewloka	et	al.	2011;	
Samb	et	al.	2015;	Falk	et	al.	2016).	
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1.4.1 Regulation	of	CENP-A	
CENP-A	deposition	is	cell	cycle	dependent.	 In	Drosophila	cells,	CENP-A	is	
recruited	to	the	centromere	during	mitosis	after	degradation	of	Cyclin	A	
(Erhardt	 et	 al.	 2008;	 Mellone	 et	 al.	 2011).	 In	 human	 cells,	 CENP-A	 is	
recruited	to	the	centromere	in	G1	phase.	The	recruitment	is	regulated	by	
CDK	 dependent	 phosphorylation	 of	M18BP1	 that	 is	 a	 subunit	 of	MIS18	
complex	 (Silva	 et	 al.	 2012).	 Phosphorylation	 of	 M18BP1	 inhibits	 the	
recruitment	of	other	MIS18	complex	subunits	MIS18α	and	MIS18β	outside	
G1	phase,	which	is	important	for	CENP-A	assembly.	Additionally,	Polo-like	
kinase	 1	 promotes	 deposition	 of	 CENP-A	 by	 phosphorylating	 Mis18	
complex	 in	 G1	 phase	 (McKinley	 &	 Cheeseman	 2014).	 Although	 CENP-A	
defines	 a	 centromere	 and	 is	 essential	 for	 kinetochore	 formation,	 its	
assembly	factors	play	a	crucial	role	in	maintaining	functionality,	but	there	
are	certain	factors	which	further	ensure	a	proper	centromere	function	like	
Figure	1.4:	 (From	McKinley	&	Cheeseman	2016).	Overview	of	 so	far	reported	epigenetical	
modification	 in	 centromere	and	peri-centromeric	region.	 	Peri-centromeric	region	contains	
heterochromatin	 histone	 and	 DNA	 modification	 (DNA	 methylation,	 H3K9me2/3	 and	
H3K27me3).	 Centromeric	 canonical	 histone	 H3	 and	 H4	 contain	 H3K4me2,	 H3K36me2	 and	
H4K20me1	suggesting	transcriptionally	active	regions.	Centromere	specific	H3	variant	CENP-A	
is	 ubiquitylated	 at	 K124	 and	 acetylated	 at	 K124,	 phosphorylated	 at	 S7,	 S16,	 S18,	 and	
trimethylated	at	G1	for	proper	CENP-A	regulation,	centromeric	and	kinetochore	function.		
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posttranslational	 modifications	 of	 histones	 associated	 with	 the	
centromere	(Figure	1.4).		
Intermittent	 canonical	 histone	 H3	 present	 at	 centromere	 contains	
H3K36me2	 (Bergmann	 et	 al.	 2011)	 and	 H3K4me2	 (Ribeiro	 et	 al.	 2010;	
Sullivan	&	Karpen	2004;	Blower	et	al.	2002)	in	Drosophila	and	human	cells	
suggesting	 transcriptionally	 active	 sites	 at	 the	 centromere	 (Wang	 et	 al.	
2014).	 Adding	 to	 this,	 studies	 on	 chicken	 and	 human	 cells	 suggest	 the	
presence	of	H4K20	methylation	in	CENP-A	nucleosome	(Hori	et	al.	2014;	
Bailey	 et	 al.	 2015),	 which	 has	 been	 demonstrated	 to	 be	 part	 of	
transcriptionally	 active	 chromatin	 (Wang	 et	 al.	 2008).	 Recently,	 reports	
suggesting	 transcription	 at	 centromere	 have	 emerged	 and	 the	
transcription	 originating	 from	 centromere	 is	 important	 for	mitosis.	 RNA	
polymerase	 II	 and	many	 transcription	 factors	 have	been	 reported	 to	be	
localized	at	 centromere	during	mitosis	and	perturbation	of	 this	 leads	 to	
chromosome	 segregation	 defects	 (Chan	 et	 al.	 2012;	 Liu	 et	 al.	 2015).	 In	
addition,	 recently	 it	 was	 reported	 that	 non-coding	 RNA	 SatIII	 that	
originates	 from	peri-centromeric	 repeats	of	 x-chromosome	seems	 to	be	
playing	a	crucial	role	in	the	localization	of	CENP-A	in	Drosophila	cells	(Rošić	
et	al.	2014).	
	
In	human	cells,	phosphorylation	of	CENP-A	at	 the	NH2	 terminus	at	S7	 is	
important	for	its	CENP-C	interaction	and	functional	kinetochore	(Kunitoku	
et	 al.	 2003).	 This	 phosphorylation	 is	 Arora	 B	 dependent.	 Studies	 using	
CENP-A	S7	mutants	show	that	the	CENP-A	nucleosome	might	be	bridged	
by	CENP-C	via	phospho-binding	14-3-3	protein	(Goutte-Gattat	et	al.	2013).	
Furthermore,	 CENP-A	 is	 also	 phosphorylated	 at	 S68	 by	 CDK1	 (Cyclin-
dependent	kinase	1)	that	controls	its	recruitment	to	the	centromere	until	
onset	G1	phase.	 In	G1	phase,	CENP-A	S68	 is	dephosphorylated	by	PP1α	
(Protein	 phosphatase	 1	 alpha)	 leading	 to	 its	 centromeric	 recruitment	
(Zeitlin	et	al.	2001;	Yu	et	al.	2015).	Studies	also	show	that	CENP-A	K124	
ubiquitylation	 by	 CUL4A-RBX1-COPS8	 complex	 is	 important	 for	 CENP-A	
centromere	 localization	(Niikura	et	al.	2015).	 In	Drosophila,	CENP-A	gets	
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ubiquitylated	 by	 E3	 ligase	 CUL3/RDX	 in	 presence	 of	 CAL1	 and	 this	
modification	is	important	for	stabilization	of	CENP-A	and	its	maintenance	
at	 the	centromere	 (Bade	et	al.	2014).	 In	2012,	 it	was	also	 reported	that	
CENP-A	 K124	 and	H4K79	 in	 CENP-A	 nucleosome	 are	 acetylated	 at	G1/S	
phase,	 which	 could	 have	 structural	 consequences	 by	 neutralizing	 the	
positively	charged	lysine	surface	and	reducing	affinity	between	histone	and	
DNA.	This,	in	turn,	would	increase	the	accessibility	of	CENP-A	nucleosome	
interior	to	chromatin	modifiers	and	other	proteins	(Bui	et	al.	2012).	Human	
cells	have	also	been	shown	to	be	tri-methylated	at	the	α-amino	of	the	G1	
and	phosphorylated	at	S16	and	S18	on	the	N-terminal	tail	of	CENP-A	(Bailey	
et	al.	2013).	It	is	postulated	that	S16	and	S18	phosphorylations	affect	the	
chromatin	 organization	 thereby	 assisting	 inter-	 and	 intra-molecular	
interactions.	
In	yeast,	the	CENP-A	homolog	is	methylated	on	R27	and	this	methylation	
plays	 a	 crucial	 role	 in	 the	 localization	 of	 kinetochore	 components	 at	
centromere	 (Samel	 et	 al.	 2012).	 In	maize,	 a	 CENP-A	 homolog	 has	 been	
identified	to	be	phosphorylated	at	S50	and	reported	to	be	important	for	
chromosome	segregation,	alignment,	and	motility	(Zhang	et	al.	2005).		
	
1.4.2 Role	 of	 heterochromatin	 associated	 factors	 in	 CENP-A/kinetochore	
deposition	
CENP-A	 localizes	 precisely	 to	 centromeres	 and	 regulates	 the	position	of	
kinetochore	 formation	 in	wild-type	 (WT)	 conditions.	 	 Except	 in	 budding	
yeast	 (Folco	 et	 al.	 2008),	 until	 now,	 there	 is	 no	 sequence	 specificity	
identified	 at	 the	 centromere	 for	 localization	 of	 CENP-A.	 However,	 all	
organisms	 including	 yeast,	 show	 well	 defined	 epigenetic	 centromere	
flanking	pericentric-heterochromatin	marks	(Sullivan	&	Karpen	2004).	This	
pericentric-heterochromatin	 is	 heterochromatinized	 by	 Su(var)3-9	 and	
HP1	 (Aagaard	 et	 al.	 1999).	 Moreover,	 tethering	 of	 HP1	 via	 Lac-I/Lac-O	
system	in	Drosophila	cells	shows	deposition	of	CENP-A	and	it	is	known	that	
H3K9	methylation	is	vital	for	HP1	localization	(Olszak	et	al.	2011).	Whether	
Drosophila	Su(var)3-9	tethering	can	also	lead	to	similar	conclusions	is	still	
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unclear.	 Notably,	 localization	 of	 clr4	 in	 yeast	 is	 responsible	 for	 H3K9	
methylation	and	 causes	deposition	of	CENP-A	 (Kagansky	et	 al.	 2009).	 In	
contrast	to	yeast	and	Drosophila,	tethering	of	HP1	and	Su(var)3-9h1	using	
the	 HAC	 tetR-tetO	 system	 in	 mammalian	 cells	 disrupts	 kinetochore	 or	
reduces	CENP-A	deposition	(Ohzeki	et	al.	2016;	Nakano	et	al.	2008;	Ohzeki	
et	al.	2012).	Although,	tethering	of	another	HMT	G9a	in	mammals	using	
the	HAC	system	shows	de-novo	CENP-A	assembly	at	an	ectopic	site	(Shono	
et	 al.	 2015).	 In	 mammalian	 cells,	 centromeric	 protein	 CENP-B	 which	
interacts	with	Su(var)3-9h1	shows	a	dual	role	by	maintaining	the	H3K9me3	
DNA	 methylation	 while	 it	 also	 modulates	 the	 assembly	 of	 CENP-A	 on	
alphoid	DNA	(Okada	et	al.	2007).		So	far,	there	is	no	protein	identified	with	
a	similar	dual	functionality	in	Drosophila.		Beside	CENP-B,	CENP-T/CENP-W	
complex	in	human	cells	also	interacts	with	another	HMT	EZH2	(Prendergast	
et	al.	2016).	The	CENP-T/CENP-W	complex	is	known	to	have	a	key	role	in	
recruiting	 downstream	 constitutive	 centromere-associated	 network	
proteins	 (CCAN)	 which	 are	 essential	 for	 kinetochore	 formation.	
Importantly,	 CCAN	 is	 critical	 for	 KNL1/Mis12	 complex/Ndc80	 complex	
(KMN)	 network	 which	 acts	 as	 a	 microtubule-binding	 interface	 at	 the	
kinetochore	(Cheeseman	et	al.	2006).	No	direct	 interactions	of	any	HMT	
with	 any	 inner	 kinetochore	 associated	 proteins	 including	 CENP-A	 have	
been	reported,	yet,	in	Drosophila.			
	
Mislocalization	or	ectopic	localization	of	CENP-A	can	lead	to	the	formation	
of	a	functional	kinetochore	at	a	wrong	place	 in	Drosophila	cells	and	this	
gives	 rise	 to	 a	 delayed	 mitotic	 phase	 and	 anaphase	 with	 lagging	
chromosome	defects.	One	such	situation	of	ectopic	loading	of	CENP-A	can	
be	achieved	by	CENP-A	overexpression	(Heun	et	al.	2006).	Mislocalization	
of	 CENP-A	 also	 results	 in	 increased	 genomic	 instability	 as	 a	 result	 of	
chromosome	 segregation	 defects	 and	 is	 a	 known	 phenotype	 of	 many	
cancer	forms	(Tomonaga	et	al.	2003;	Lacoste	et	al.	2014;	Heun	et	al.	2006;	
McGovern	 et	 al.	 2012).	 Ectopic	 CENP-A	 predominantly	 localizes	 to	
heterochromatin	boundaries	and	preferentially	localizes	near	pericentric-
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heterochromatin	or	telomeres.	Moreover,	hyperacetylation	environment	
via	 TSA	 treatment	 can	 lead	 to	 a	 decrease	 in	 ectopic	 CENP-A	 sites	 in	
Drosophila	 (Olszak	 et	 al.	 2011).	 In	 conclusion,	 these	 studies	 suggest	 a	
potential	 role	 of	 heterochromatin-associated	 factors	 in	 the	 de-novo	
deposition	of	centromeric	and	ectopic	CENP-A	locations.		Although	it	is	still	
not	 clear	whether	 factors	 like	Su(var)3-9,	 SETDB1	and	G9a	can	 facilitate	
ectopic	CENP-A	localization	in	Drosophila	cells.	
	
1.5 Relationship	between	CHRAC14	and	CENP-A		
Recently,	 our	 lab	 discovered	 that	 depletion	of	 CHRAC14	 causes	 ectopic	 CENP-A	
localization	in	Drosophila	cells	and	that	depletion	of	CHRAC14	shows	endogenous	
accumulation	of	DNA	damage	and	G2-M	checkpoint	failure	upon	induction	of	DNA	
damage	 (Mathew	 et	 al.	 2014).	 Our	 lab	 has	 also	 reported	 in	 vivo	 and	 in	 vitro	
interaction	of	CENP-A	and	CHRAC14	upon	DNA	damage	suggesting	a	possible	role	
of	 CHRAC14	 in	 monitoring	 incorporation	 of	 CENP-A	 to	 ectopic	 sites	 upon	 DNA	
damage.		
	
1.6 Aim	of	the	study		
CHRAC14	 depletion	 leads	 to	 ectopic	 loading	 of	 CENP-A	 in	 combination	 with	
impaired	DNA	damage	repair	capacity	in	a	Drosophila	model	system.	During	this	
Ph.D.	study,	I	aimed	to	investigate	following	major	questions:	
1. Why	does	lack	of	CHRAC14	lead	to	CENP-A	ectopic	loading?	
2. Does	 Su(var)3-9	 histone	 methyltransferase	 play	 a	 role	 in	 ectopic	 CENP-A	
localization	 and	 could	 this	 ectopic	 CENP-A	 give	 rise	 to	 a	 functional	 ectopic	
kinetochore?	
3. Is	maintaining	the	level	of	Su(var)3-9	physiologically	important	for	Drosophila	
S2	cells?	
Until	now,	no	one	has	explored	the	role	of	Su(var)3-9	in	facilitating	ectopic	loading	
of	CENP-A	 in	Drosophila.	 In	 the	second	part	of	 this	study,	 I	explored	a	potential	
synergistic	 effect	 of	 increased	 histone	 methyltransferase	 levels	 and	 increased	
heterochromatin	on	ectopic	CENP-A.		
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2. Results	
2.2 CHRAC14	 knockdown	 changes	 the	 level	 of	 euchromatin	 and	 heterochromatin	
markers	
2.1.1 Depletion	of	CHRAC14	reduces	histone	H3	lysine	9	acetylation	
CHRAC14	 is	 a	 defined	 subunit	 of	 the	 ATAC	 complex.	 The	 ATAC	 complex	
contains	two	histone	acetyltransferases,	GCN5	and	ATAC2.	Disruption	of	the	
ATAC	 complex	 in	 GCN5	 mutants	 reduced	 the	 overall	 H3K9	 acetylation	
(Suganuma	et	al.	2008;	Ciurciu	et	al.	2008).	Further	CHRAC14	depletion	results	
in	CENP-A	ectopic	localization	(Mathew	et	al,	2014)	but	if	the	CHRAC	depletion	
effect	the	H3K9ac	was	never	investigated.	To	check	if	lack	of	CHRAC14	would	
give	a	similar	effect	on	H3K9	acetylation,	whole	fly	 lysates	from	CHRAC14-/-	
and	Oregon	R	(WT)	were	analyzed	by	immunoblotting	against	H3K9ac.	Results	
obtained	 suggest	 a	 decrease	 in	 H3K9ac	 (Figure	 2.1.A).	 To	 confirm	 these	
results,	CHRAC14	was	knocked	down	by	RNAi	 in	S2	cells,	histone	extracted	
and	analyzed	via	western	blot	using	H3K9ac	and	pan	H3	antibodies.	S2	cells	
treated	 with	 CHRAC14	 RNAi	 also	 show	 a	 decreased	 H3K9acetylation	 level	
Figure	2.1:	CHRAC14-/-	flies	show	reduced	H3K9	acetylation.	A)	Lysate	from	whole	adult	Oregon	R	(WT)	and	
CHRAC14	 -/-	Drosophila	were	analyzed	via	western	blot	and	probed	with	anti-H3K9ac	and	tubulin	(loading	
control).	B)		4	days	CHRAC14	RNAi-treated	S2	cells	along	with	control	(no	RNAi)	were	subjected	to	acid	histone	
extraction	and	analyzed	for	the	level	of	H3K9ac,	stripped	and	re-probed	for	H3	level	(loading	control).		
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(Figure	2.1B),	overall	suggesting	that	reduction	of	CHRAC14	influences	histone	
H3K9	acetylation	levels.	
2.1.2 Lack	 of	 CHRAC14	 results	 in	 an	 overall	 increase	 in	 histone	 H3	 lysine9	 di-
methylation	
Lack	 of	 ACF1,	 a	 subunit	 of	 the	 CHRAC	 complex,	 shows	 a	 reduction	 in	
heterochromatin	replication	(Collins	et	al.	2002).	ADA2A	and	GCN5	mutants,	
which	are	subunits	of	the	ATAC	complex,	show	enhanced	histone	H3K9me2	
modifications	 (Ciurciu	 et	 al.	 2008),	 which	 is	 a	marker	 of	 heterochromatin.	
Considering	that	CHRAC14	is	part	of	both	complexes,	a	depletion	of	CHRAC14	
may	 result	 in	 overall	 increased	 heterochromatin	 levels	 which	 also	
complements	my	observation	of	 reduced	H3K9ac,	as	deacetylation	of	K9	 is	
perquisite	 for	addition	of	a	methyl	 group	on	 the	 lysine	 residue	 (Park	et	al.	
2011).	Overall	this	would	raise	the	possibility	of	a	change	in	heterochromatin	
level.	Further,	 it	has	been	reported	that	heterochromatin	boundaries	are	a	
Figure	2.2:	CHRAC14	depletion	leads	to	enhanced	H3K9me2	staining	and	increase	CENP-A	foci	number.	A)	RT-
PCR	of	Chrac14-depleted	S2	cells.	B)	IF	of	CHRAC14	depleted	cells	stained	against	anti-H3K9me2	(green),	CENP-
A	(red)	and	DAPI	(DNA,	grey).	Bar=	5µM	C)	Quantification	of	CENP-A	foci	from	control	and	CHRAC14	RNAi	treated	
cells	from	3	or	more	biological	repeats.	Error	bars	represent	±SEM	and	a	p-value	<0.05.		
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hotspot	 of	 ectopic	 CENP-A	 localization	 (Olszak	 et	 al.	 2011).	Mathew	et.	 al.	
reported	 that	 CHRAC14	 depletion	 causes	 ectopic	 CENP-A	 localization	
(Mathew	et	al,	2014).	Considering	these	facts,	I	assessed	the	level	of	H3K9me2	
in	CHRAC14-depleted	S2	cells	via	immuno-fluorescence	(IF).	
Control	cells	show	H3K9me2	staining	and	CENP-A	foci	overlapping	with	the	
H3K9me2	staining.	Noticeably,	CHRAC14	RNAi-treated	cells	show	enhanced	
H3K9me2	staining	(Figure	2.2B)	and	an	increased	CENP-A	foci	number	(Figure	
2.2B	and	C),	indicating	a	correlation	between	H3K9	methylation	and	number	
of	CENP-A	foci.	To	confirm	the	observation	of	increased	H3K9me2,	the	level	
of	H3K9me2	using	whole	adult	fly	lysates	was	measured	via	western	blot,	and	
measured	a	1.5-fold	increased	H3K9me2	level	in	absence	of	CHRAC14	(Figure	
2.3A).		
	
An	increase	in	the	H3K9me2	levels	in	CHRAC14-/-	cells	indicates	an	elevated	
level	 of	 heterochromatin.	 Heterochromatin	 protein	 1	 (HP1)	 binds	 to	
methylated	H3K9	and	is	required	for	heterochromatin	formation	(Lachner	et	
al.	2001;	Schotta	et	al.	2002).	The	HP1	protein	level	in	CHRAC14-/-	and	Oregon	
Figure	2.3:	CHRAC14-/-	flies	show	increased	heterochromatin	marker.	A)	Lysate	from	whole	adult	
Oregon	R	(WT)	and	CHRAC14	-/-	flies	were	analyzed	via	western	blot.	The	blot	was	probed	with	anti-
H3K9me2	 and	 anti-Tubulin	 (loading	 control).	 B)	 CHRAC14-/-	 flies	 show	 increased	 HP1	 level.	
CHRAC14-/-	and	Oregon	R	(WT)	adult	fly	lysate	was	analyzed	for	HP1	protein	level	via	western	blot.	
The	 blot	 was	 probed	 against	 anti-HP1	 antibody	 and	 Actin	 (loading	 control).	 	 Pictures	 are	
representative	of	three	or	more	biological	replicates.	
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R	(control)	lysates	was	examined	via	immuno-blotting.	Results	suggest	more	
than	 a	 two-fold	 increase	 in	 the	 level	 of	 HP1	 (Figure	 2.3B),	 indicating	 that	
CHRAC14	depletion	might	lead	to	an	increase	in	heterochromatin	markers	in	
Drosophila	cells.	
	
2.1.3 Decrease	in	CHRAC14	level	leads	to	increased	Su(var)3-9	transcripts	
The	classic	process	for	formation	of	heterochromatin	includes	recruitment	of	
HP1	 by	 methylated	 H3K9	 which	 further	 recruits	 Su(var)3-9	 Histone	
methyltransferase.	 Su(var)3-9	 methylates	 more	 H3K9	 which	 recruits	 more	
HP1.	This	 leads	to	a	positive	feedback	 loop	mechanism	of	heterochromatin	
formation	and	maintenance	(Lachner	et	al.	2001;	Ebert	et	al.	2004).	Since	 I	
observed	 an	 increased	 level	 of	H3K9	methylation	 and	HP1,	 I	 tested	mRNA	
levels	of	the	Su(var)3-9	histone	methyltransferase.	
	
	
To	examine	the	level	of	Su(var)3-9	mRNA,	CHRAC14	RNAi	treated	and	control	
(no	RNAi)	S2	cells	were	subjected	to	semi-quantitative	RT-PCR	amplification	
Figure	2.4:	CHRAC14	kd	cells	show	an	increased	expression	of	histone	methyltransferase	Su(var)3-9.	A)	
RT	PCR	from	CHRAC14	RNAi	treated	and	control	(no	RNAi	treatment)	S2	cells	using	CHRAC14,	Su(var)3-9	
and	Actin	specific	primers.	Results	show	an	 increase	 in	Su(var)3-9	transcripts.	B)	Quantification	of	the	
average	Su(var)3-9	mRNA	level,	obtained	from	five	biological	repeats	via	RT	PCR	,	normalized	to	Actin.	
Error	bars	are	±SEM	and	a	p-value	<0.05	
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for	 CHRAC14,	 Su(var)3-9	 and	 Actin	 (control).	 The	 obtained	 results	 show	 a	
slight,	 though	 significant,	 increase	 in	 transcription	 level	 of	 Su(var)3-9	 in	
absence	of	CHRAC14	(Figure	2.4A	and	B).	The	 increased	expression	 level	of	
Su(var)3-9	 explains	 an	 increased	 level	 of	 H3K9me2	 in	 CHRAC14-/-	 	 and	
CHRAC14	kd	cells.	
	
2.2 Change	in	level	of	Su(var)3-9	and	histone	acetylation	in	CHRAC14	depleted	cells	
may	affect	CENP-A	localization	
2.2.1 Ectopic	CENP-A	foci	in	CHRAC14	depleted	cells	are	Su(var)3-9	dependent	
Mathew	et.al.	showed	that	CHRAC14	depletion	leads	to	ectopic	CENP-A	foci.	
The	 previous	 experiments	 show	 that	 a	 CHRAC14	 knockdown	 enhances	
H3K9me2	and	increases	Su(var)3-9	expression	concomitant	with	an	increase	
in	CENP-A	foci.	 It	has	been	reported	that	Su(var)3-9	does	not	play	a	role	 in	
maintaining	 centromeric	 CENP-A	 localization	 (Andreyeva	 et	 al.	 2007).	 I	
therefore	tested,	whether	increased	Su(var)3-9	transcripts	play	a	role	in	the	
ectopic	 loading	 of	 CENP-A	 in	 absence	 of	 CHRAC14	 by	 a	 co-depletion	 of	
Su(var)3-9	 with	 CHRAC14.	 As	 seen	 previously,	 CHRAC14	 depletion	 shows	
enhanced	regions	of	H3K9me2	overlapping	with	DAPI	region,	 in	addition	to	
increased	 CENP-A	 foci.	 Moreover,	 lack	 of	 Su(var)3-9	 did	 not	 affect	 the	
endogenous	CENP-A	foci	numbers,	i.e.	cells	retained	similar	numbers	of	CENP-
A	 foci	as	 in	 control	 (WT)	cells	 (Figure	2.5A,	 first	and	 third	panel	 from	top).	
However,	 as	 expected,	 cells	 treated	 with	 Su(var)3-9	 RNAi	 show	 reduced	
H3K9me2	staining	(Figure	2.5A,	third	panel	from	top).	Interestingly,	cells	co-
treated	with	CHRAC14	and	Su(var)3-9	RNAi	also	show	a	decrease	in	H3K9me2	
staining	 in	 the	 nucleus	 (Figure	 2.5A,	 last	 panel	 from	 top)	 indicating	 	 an	
antagonistic	role	of	Su(var)3-9	and	CHRAC14	in	maintaining	heterochromatin	
structures.	 Furthermore,	 I	quantified	 the	number	of	CENP-A	 foci	 in	 control	
(WT),	 CHRAC14	 RNAi,	 Su(var)3-9	 RNAi	 and	 co-CHRAC14/Su(var)3-9	 RNAi	
treated	 cells.	 As	 reported	earlier,	 CHRAC14	RNAi	 cells	 show	an	 increase	 in	
CENP-A	 foci	 when	 compared	 to	 WT	 and	 Su(var)3-9	 RNAi	 treated	 cells.	
Surprisingly,	cells	co-treated	with	Su(var)3-9	RNAi	and	CHRAC14	RNAi	show	a	
reduction	in	overall	CENP-A	foci	number	per	cell	(Figure	2.5B).	These	results	
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indicate	a	role	of	Su(var)3-9	in	ectopic	loading	of	CENP-A	in	CHRAC14	depleted	
cells.		
	
	
	
	
	
2.2.2 HDAC	inhibitor	TSA	reduces	the	CENP-A	foci	number	in	CHRAC14	depleted	
cells	
To	 further	 validate	 the	 rescue	 effect	 observed	 on	 CENP-A	 foci	 numbers	
obtained	by	co-depletion	of	Su(var)3-9	and	CHRAC14,	the	effect	of	the	histone	
deacetyltransferase	 (HDAC)	 inhibitor	 TSA	 (Trichostatin	 A)	 was	 analyzed.	
Deacetylation	of	acetylated	H3K9	is	prerequisite	for	its	methylation	(Park	et	
al.	 2011;	 O’Byrne	 et	 al.	 2011).	 HDAC	 removes	 H3K9	 acetylation,	 after	 the	
deacetylation	 event,	 histone	 methyltransferases	 like	 Su(var)3-9	 methylate	
Figure	2.5:	Increase	in	CENP-A	foci	in	CHRAC14	RNAi	treated	cells	is	Su(var)3-9	dependent.	A)	First,	second,	third	
and	fourth	panel	represent	control	 (no	RNAi	treatment),	CHRAC14	RNAi,	Su(var)3-9	RNAi	and	co-treatment	of	
CHARC14	 and	 Su(var)3-9	 RNAi	 treated	 S2	 cells,	 respectively.	 All	 samples	 were	 subjected	 to	 IF	 against	 anti-
H3K9me2	 antibody	 (green),	 CENP-A	 (red)	 and	 nuclei	 were	 co-stained	 with	 DAPI	 (grey).	 Bar=	 5µM.	 B)	
Quantification	of	average	CENP-A	foci	counts	from	50	cells/sample/three	biological	 repeats	of	Figure	A.	Error	
bars	represent	±SEM	and	a	p-value	<0.05.	
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H3K9	(Lombardi	&	Cole	2011).	Inhibition	of	HDAC	inhibits	deacetylation	and	
this	in	turn	prevents	spread	of	H3K9	methylation	(Taddei	et	al.	2001).	It	has	
been	shown	that	TSA	treatment	can	reduce	ectopic	CENP-A	islands	(Olszak	et	
al.	2011).	In	the	next	step,	it	was	tested	whether	the	HDAC	inhibitor	TSA	can	
affect	the	CENP-A	phenotype	observed	in	CHRAC14	depleted	cells.	To	address	
this,	I	treated	WT	(control)	and	CHRAC14	RNAi	cells	with	0.500nM	TSA	for	6	
hours	and	quantified	the	number	of	CENP-A	foci	in	TSA	untreated	and	treated	
cells.		
	
	
	
Figure	2.6:	TSA	treatment	 reduces	the	 increased	CENP-A	foci	 count	 in	CHRAC14	depleted	cells.	 IF	on	CHRAC14	RNAi	
treated	and	WT	(no	RNAi)	S2	cells	were	subjected	to	0.5	µM	TSA	for	6	hours,	controls	were	treated	with	DMSO	and	
stained	against	anti-CENP-A	(yellow)	and	DAPI	(grey).	Bar=	5µM.	B)	Quantification	of	the	average	CENP-A	foci	number.	
The	graph	is	a	compilation	of	three	repeats.	Error	bars	represent	±SEM	and	a	p-value	<0.05.	C)	Western	blot	of	cells	with	
and	without	CHRAC14	RNAi,	and	0.5	µM	TSA	treatment.	The	blot	was	probed	with	anti-CENP-A	and	anti-Actin	(loading	
control)	antibodies.	
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The	 average	 CENP-A	 foci	 number	 in	 control	 cells	 with	 and	 without	 TSA	
remains	unchanged.	Interestingly,	the	quantification	of	CHRAC14	RNAi	cells	
with	and	without	TSA	shows	a	significant	reduction	in	the	average	CENP-A	foci	
count	upon	TSA	treatment	(Figure	2.6A	and	B).		
Further,	 it	 was	 checked	 whether	 the	 effect	 observed	 via	 IF	 is	 because	 of	
reduction	 in	 overall	 CENP-A	 protein	 level.	 This	 was	 analyzed	 via	 CENP-A	
western	blot	on	whole	lysate	from	CHRAC14	RNAi	S2	cells	treated	with	and	
without	0.5	µM	TSA	along	with	the	controls.	Cells	with	no	RNAi	treatment	but	
TSA	 show	 an	 increase	 in	 CENP-A	 protein	 level	 (Figure	 2.6C).	 Moreover,	
western	blot	analysis	of	CHRAC14	RNAi	treated	cells	shows	a	reduction	in	level	
of	CENP-A	upon	TSA	treatment	in	CHRAC14	depleted	cells,	consistent	with	our	
observation	of	a	decreased	CENP-A	foci	number	in	CHRAC14	RNAi	TSA	treated	
cells	(Figure	2.6C).	Overall	results	suggest	that	the	HDAC	inhibitor	TSA	rescues	
the	average	effect	of	an	 increased	CENP-A	foci	count	 in	CHRAC14	depleted	
cells.		
	
2.2.3 Acetylation	of	CENP-A	in	CENP-A	overexpressing	S2	cells	
During	this	study,	it	was	observed	that	CENP-A	localization	is	affected	by	TSA	
treatment	 in	 CENP-A	 overexpressing	 cells	 (see	 Appendix	 6.3).	 Additionally,	
there	is	nothing	known	about	CENP-A	acetylation	in	Drosophila	cells.	This	led	
to	a	question	whether	CENP-A	is	potentially	acetylated.	For	this,	S2	cells	with	
pMT-CENP-A-V5-His	were	used.	pMT	is	a	metal	inducible	promoter	and	genes	
can	be	expressed	from	it	by	adding	CuSO4.	These	S2	cells	were	subjected	to	8	
hours’	induction	for	CENP-A-V5-His	overexpression	and	later	CENP-A-V5-His	
was	subjected	to	denaturing	immunoprecipitation	in	presence	and	absence	
of	TSA.	The	samples	were	probed	for	any	lysine	acetylation	using	Pan	acetyl-
lysine	antibody.	To	our	surprise,	samples	treated	with	TSA	showed	a	higher	
amount	of	acetylated	lysine	band	at	the	size	similar	to	CENP-A-V5-His	(Figure	
2.7).	The	same	membrane	was	then	re-probed	with	the	V5	antibody	to	check	
if	the	band	obtained	via	Pan	acetyl-lysine	antibody	overlaps	in	size	with	the	
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CENP-A-V5-His	band.	Interestingly,	bands	obtained	by	CENP-A	and	Pan-acetyl	
lysine	antibody	locate	at	the	same	size	on	membrane	projecting	CENP-A	as	a	
potential	acetylation	substrate	under	the	given	conditions	(Figure	2.7).	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	2.7:	CENP-A,	a	substrate	for	acetylation.	CENP-A-V5-His	was	overexpressed	under	control	of	pMT	
promoter	 in	S2	cells	and	 incubated	with/without	the	HDAC	inhibitor	TSA	1mM.	Lysates	were	 immuno-
precipitated	under	denaturing	 conditions.	 Thereafter,	 the	 IP	was	probed	with	V5	and	pan-acetyl	 lysine	
antibody.		
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2.3 Increase	in	Su(var)3-9	level	may	induce	ectopic	CENP-A	and	CENP-C	independent	
of	CHRAC14	depletion	
2.3.1 Su(var)3-9	overexpression	leads	to	increased	CENP-A	foci	
CHRAC14	 depletion	 shows	 an	 increase	 in	 Su(var)3-9	 mRNA	 levels	 with	 an	
increase	in	CENP-A	foci	number	and	ectopic	CENP-A	localization.	Additionally,	
co-depletion	 of	 CHRAC14	 and	 Su(var)3-9	 shows	 a	 decrease	 in	 CENP-A	 foci	
number.	It	was	therefore	tested,	whether	an	increased	Su(var)3-9	expression,	
irrespective	 of	 CHRAC14	 depletion,	 can	 lead	 to	 a	 similar	 effect	 on	 CENP-A	
localization.	
For	 this	 purpose,	 S2	 cells	 were	 transfected	 with	 a	 pMT-Su(var)3-9-V5-His	
construct.	Su(var)3-9	was	overexpressed	by	using	0.5mM	CuSO4	for	8	hours	
Figure	2.8:	 Su(var)3-9	overexpression	 leads	 to	an	 increase	 in	overall	CENP-A	 foci.	A)	 IF	on	 S2	 cells	with	and	
without	Su(var)3-9	overexpression	were	stained	with	anti-CENP-A	(red),	anti-H3K9me2	(green)	antibody	and	co-
stained	with	DAPI	(grey).	Bar=	5µm.	B)	Quantification	of	average	CENP-A	foci	count	from	control	and	Su(var)3-9	
overexpressing	cells	from	3	biological	replicates.	Error	bars	represent	±SEM	and	a	p-value	<0.05.	C)	Control	and	
Su(var)3-9	 overexpressing	 cells	were	 analyzed	 for	 increased	H3K9me2	 via	 western	 blot	 using	 anti-H3K9me2	
antibody	and	anti-Tubulin	antibody	(loading	control).	D)	Quantification	of	average	signal	intensity	of	H3K9me2	
from	control	and	Su(var)3-9	overexpressing	cells	from	three	IF	repeats.	Error	bars	represent	±SEM	and	a	p-value	
<0.05.		
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and	the	level	of	H3K9me2	checked	via	western	blot	and	IF	(Figure	2.8A,	C	and	
D).	As	expected,	western	blot	analysis	shows	an	increase	in	H3K9me2	levels	
upon	 Su(var)3-9	 overexpression.	 Cells	 with	 and	 without	 Su(var)3-9	
overexpression	were	further	analyzed	for	CENP-A	foci.	Comparative	analysis	
between	 control	 (no	 over-expression)	 and	 Su(var)3-9	 overexpressing	 cells	
show	overall	increased	CENP-A	foci	numbers	in	cells	with	increased	Su(var)3-
9	 expression	 (Figure	 2.8A	 and	 B).	 This	 indicates	 that	 elevated	 Su(var)3-9	
expression	 can	 lead	 to	 a	 similar	 phenotype	 as	 discovered	 in	 CHRAC14	
depleted	cells	(compare	Figure	2.2B	and	2.8A).	
	
2.3.2 An	elevated	Su(var)3-9	level	causes	ectopic	CENP-A	foci	
Overexpression	of	Su(var)3-9	increases	the	overall	CENP-A	foci	counts.	Every	
chromosome	has	an	endogenous	centromeric	CENP-A	site.	Increased	CENP-A	
foci	in	cells	as	analyzed	via	IF	could	mean	that	there	are	more	CENP-A	sites	on	
individual	chromosomes	suggesting	ectopic	CENP-A	localization	(Tomonaga	et	
al.	2003;	Mathew	et	al.	2014;	Heun	et	al.	2006;	Pauleau	&	Erhardt	2011)	.	To	
confirm	this	observation,	metaphase	chromosome	spreads	obtained	from	the	
cells	with	and	without	Su(var)3-9	overexpression	were	compared.	Metaphase	
spreads	 were	 fixed	 and	 co-stained	 with	 DAPI	 and	 CENP-A	 antibody.	 As	
expected,	metaphase	 spreads	 from	 control	 cells	 show	 two	 CENP-A	 foci	 at	
centromere	constrictions	of	sister	chromatids	reflecting	endogenous	WT	type	
localization	 of	 CENP-A	 (Figure	 2.9A	 upper	 panel	 lane).	 Su(var)3-9	
overexpressing	cells	show	CENP-A	at	endogenous	centromeric	constriction	as	
seen	in	control.	In	addition	to	centromeric	localization,	CENP-A	also	localizes	
to	metaphase	 chromosome	arms	 in	 Su(var)3-9	overexpressing	 cells	 (Figure	
2.9).	 Ectopic	 CENP-A	 foci	 were	 often	 sited	 near	 telomere	 ends	 which	 is	 a	
known	 predominant	 site	 for	 ectopic	 CENP-A	 loading	 (Olszak	 et	 al.	 2011)	
{Figure	 2.9A	 image	 zoomed	 from	 Su(var)3-9	 overexpression}.	 It	 was	
repeatedly	observed	that	ectopic	CENP-A	foci	were	less	intense	in	comparison	
to	centromeric	CENP-A.	
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Images	 were	 analyzed	 via	 ImageJ,	 brightness	 and	 contrast	 was	 adjusted	
accordingly	 to	 visualize	 ectopic	 CENP-A	 in	 the	 samples	 with	 and	 without	
Su(var)3-9	 overexpression.	 Nevertheless,	 only	 good	 quality	 metaphase	
spreads	from	Su(var)3-9	overexpressing	cells	(Figure	2.9A,	lower	panel).	
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Quantification	 of	 five	 biological	 replicates	 of	 the	 experiment	 suggests	 that	
around	 10%	 of	 chromosomes	 without	 Su(var)3-9	 overexpression	 show	
ectopic	 CENP-A	 foci.	 Intriguingly,	 metaphase	 chromosomes	 obtained	 from	
Su(var)3-9	overexpressing	cells	show	a	significant	increase	in	ectopic	CENP-A	
localization,	with	around	3	times	more	chromosomes	showing	ectopic	CENP-
A	localization.	(Figure	2.9B).	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	2.9:	Increased	Su(var)3-9	overexpression	causes	CENP-A	ectopic	localization.	A)	S2	cells	with	and	
without	 Su(var)3-9	 overexpression	 were	 inhibited	 in	 metaphase.	 Thereafter,	 chromosomes	 were	
subjected	 to	 IF	 with	 anti-CENP-A	 antibody	 (red)	 and	 DAPI	 (grey).	 Arrowheads	 indicate	 the	 zoomed	
metaphase	spread.	Size	bar=	2µm.	B)	Quantification	of	ectopic	CENP-A	on	metaphase	 chromosomes	
obtained	 from	WT	 (control	 with	 no	 Su(var)3-9	 overexpression)	 and	 Su(var)3-9	 overexpressing	 cells.	
Ectopic	CENP-A	on	chromosome	arms,	with	weak	signal	intensity	were	also	considered	in	quantification.	
The	total	number	of	chromosomes	screened	is	>100	from	5	repeats.	Error	bars	represent	±SEM	and	a	
p-value	<0.05.	Su(var)3-9	overexpressing	cells	show	a	3	times	increase	in	ectopic	CENP-A	sites.	
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2.3.3 Increased	Su(var)3-9	level	leads	to	ectopic	CENP-C	localization	
The	 centromere	 is	marked	 by	 CENP-A	 H3	 variant,	 however	 CENP-C	 is	 also	
essential	for	centromere	identity	(Orr	&	Sunkel	2011).	CENP-A	and	CENP-C	are	
incorporated	concomitantly	at	the	centromere	(Pauleau	&	Erhardt	2011)	and	
ectopic	CENP-A	and	CENP-C	 localization	has	been	 reported	 to	 result	 in	 cell	
segregation	 defects	 (Heun	 et	 al.	 2006).	 Therefore,	 it	 was	 analyzed	 next	
whether	 the	 elevated	 Su(var)3-9	 levels	 can	 also	 lead	 to	 ectopic	 CENP-C	
localization.	 For	 this	 question,	 the	metaphase	 spreads	were	 repeated	with	
and	 without	 Su(var)3-9	 overexpression,	 afterwards	 stained	 with	 CENP-C	
antibody	 and	 DAPI	 to	 visualize	 chromosomes.	 ImageJ	 analysis	 of	 the	 DAPI	
region	 (metaphase	 spreads)	 shows	 clear	 localization	 of	 CENP-C	 to	
centromeres	in	WT	{control	with	no	Su(var)3-9	overexpression},	however,	no	
CENP-C	 signal	was	 observed	 to	 be	 localized	 on	 the	 sister	 chromatid	 arms,	
suggesting	centromere-specific	CENP-C	localization	(Figure	2.10	upper	panel	
Figure	 2.10:	 Increased	 Su(var)3-9	 overexpression	 causes	 CENP-C	 ectopic	 localization.	 S2	 cells	with	 and	
without	Su(var)3-9	overexpression	inhibited	in	metaphase	and	the	metaphase	spread	were	subjected	to	IF	
with	 anti-CENP-C	 antibody	 (green)	 and	 DAPI	 (grey).	 The	 arrowheads	 indicate	 the	 zoomed	 metaphase	
spreads.	Size	bar=	2µm.		
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lane).	 Conversely,	 in	 metaphase	 chromosomes	 obtained	 from	 Su(var)3-9	
overexpressing	 cells,	 ectopic	 CENP-C	 signals	 were	 observed	 in	 addition	 to	
centromeric	CENP-C	 signals	 (Figure	2.10	 lower	panel	 lane,	 see	 the	 zoomed	
panel),	suggesting	increased	Su(var)3-9	level	can	lead	to	miss-localization	of	
centromeric	CENP-C	protein	(Figure	2.10).		
	
2.4 Increased	Su(var)3-9	level	lead	to	cell	segregation	defects	
2.4.1 Higher	 levels	 of	 Su(var)3-9	 show	 delay	 in	 mitotic	 phase	 and	 lagging	
chromosome	defects	
Ectopic	 CENP-A	 and	 CENP-C	 localization	 discovered	 under	 the	 influence	 of	
increased	 Su(var)3-9	 expression	 would	 indicate	 a	 functional	 kinetochore,	
which	 in	 turn	 should	 result	 in	 multiple	 microtubule	 attachments	 to	 a	
chromosome	 leading	 to	 cell	 segregation	 defects	 either	 with	 lagging	
chromosome	or	with	chromosome	breakage.		
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Figure	 2.11:	 Su(var)3-9	 overexpression	 leads	 to	 chromosome	 segregation	 defect.	A)	 Live-cell	 analysis	 of	
Su(var)3-9	 overexpressing	 cells.	 S2	 cells	 co-transfected	 with	 histone	 H2B-GFP	 (green),	 mCherry-Tubulin	
(red),	pMT-Su(var)3-9-V5-His	were	 imaged	every	15	minutes	for	12	hours.	WT	(no	CuSO4)	and	Su(var)3-9	
overexpression	(with	CuSO4).	WT	cells	show	normal	prophase	to	anaphase	progression.	Cells	with	Su(var)3-
9	overexpression	 show	 longer	metaphase	or	 lagging	 chromosome	defect	or	both.	Top	panel	 represents	
images	 from	 WT	 cells	 {with	 no	 Su(var)3-9	 overexpression}	 and	 bottom	 panel	 represents	 images	 from	
Su(var)3-9	 overexpressing	 cells.	 0	minutes	 represents	 the	 time	 point	 of	 alignment	 of	 chromosomes	 at	
metaphase	plate.	Size	bar	=	30µm.	B)	Quantification	of	chromosome	segregation	defect	in	WT	and	Su(var)3-
9	 overexpressing	 cells.	 A	 defect	 was	 categorized	 as	 longer	 metaphase	 (prolonged	 metaphase),	 lagging	
chromosome	and	prolonged	metaphase	with	 lagging	 chromosome	 (both)	n>30	 from	 three	 independent	
biological	experiments.	
	 39	
	
To	 check	 the	 occurrence	 of	 cell	 segregation	 defects	 in	 Su(var)3-9	
overexpressing	 cells,	 S2	 cells	were	 co-transfected	with	 H2B-GFP,	mCherry-
Tubulin	and	pMT-Su(var)3-9-V5-His.	These	cells	were	then	subjected	to	live-
cell	imaging	to	capture	any	cell	segregation	defect	in	absence	and	presence	of	
Su(var)3-9	 overexpression.	 WT	 cells	 show	 normal	 prophase	 to	 anaphase	
progression	with	an	average	duration	of	15	to	30	minutes	(Figure	2.11A	upper	
panel).	 As	 expected,	 Su(var)3-9	 overexpressing	 cells	 show	 cell	 segregation	
defects	 as	 observed	 during	 live-cell	 imaging	 (Figure	 2.11A	 lower	 panel).	
Defects	 observed	 include:	 a)	 longer	 metaphase,	 b)	 anaphase	 with	 lagging	
chromosomes,	c)	longer	metaphase	followed	by	lagging	chromosome	defect	
in	 anaphase	 (Figure	 2.11B).	 In	 this	 analysis,	 control	 cells	 show	 18%	 of	
segregations	 with	 lagging	 chromosome	 defects.	 Whereas,	 in	 Su(var)3-9	
overexpressing	cells,	a	total	of	45%	of	cell	segregations	observed	had	lagging	
chromosome	defects	(Figure	2.11B).	In	total,	the	quantification	is	showing	a	
2.5-fold	increase	in	lagging	chromosome	defects	which	is	complementary	to	
fold	 increase	 seen	 in	 ectopic	 CENP-A	 foci	 formation	 upon	 Su(var)3-9	
overexpression	(Figure	2.9B).	
	
2.4.2 Lagging	chromosomes	show	increased	CENP-A	foci	
Lagging	chromosomes	can	be	the	result	of	failure	of	microtubule	attachment	
to	kinetochore	or	 the	 result	of	multiple	microtubule	attachment	 sites	on	a	
chromosome	(Pauleau	&	Erhardt	2011;	Maiato	et	al.	2004).	Ectopic	CENP-A	
and	 CENP-C	 caused	 by	 Su(var)3-9	 overexpression	 as	 seen	 in	 earlier	
experiments	 could	 cause	 a	 segregation	 defect.	 To	 further	 validate	 the	
presence	and	role	of	ectopic	CENP-A	in	the	cell	segregation	defect	observed	
in	Su(var)3-9	overexpressing	cells,	the	presence	of	CENP-A	in	observed	lagging	
chromosomes	was	analyzed.	For	this	experiment,	Su(var)3-9	overexpressing	
cells	were	subjected	to	IF	along	with	control	(WT).	These	cells	were	stained	
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for	anti-Tubulin	(to	identify	the	late	anaphase	cells),	anti-CENP-A	and	DAPI	(to	
visualize	the	DNA).		
	
First,	the	overall	lagging	chromosomes	were	quantified	in	WT	and	Su(var)3-9	
overexpressing	cells,	where	only	anaphase	cells	were	used.	To	visualize	the	
lagging	chromosomes,	brightness	and	contrast	was	increased	via	Image	J.	WT	
cells	show	less	than	18%	lagging	chromosomes,	however,	cells	with	elevated	
Su(var)3-9	level	show	an	elevated	lagging	chromosome	defect,	with	around	
70%.	(Figure	2.12B).	 In	addition,	cells	which	showed	a	 lagging	chromosome	
were	 quantified	 using	 foci/spot	 detection	 plugin,	 and	 checked	 for	 the	
Figure	2.12:	Su(var)3-9	overexpression	leads	to	lagging	chromosomes	with	increased	CENP-A	foci.	A)	S2	cells	
with	normal	(WT)	and	overexpressed	Su(var)3-9	levels	were	plated	on	concanavalin	A	coated	glass	slides.	
Stained	with	CENP-A	(red),	Tubulin	(not	shown	in	this	picture)	and	DAPI	(grey).	Lagging	chromosomes	were	
visualized	by	adjusting	brightness	and	contrast.	Bar=5µm	B)	Quantification	of	total	anaphase	cells	screened	
for	 lagging	 chromosomes	 in	 WT	 and	 Su(var)3-9	 overexpressing	 cells.	 C)	 Quantification	 of	 lagging	
chromosomes	with	more	than	one	CENP-A	foci	observed	in	WT	and	Su(var)3-9	overexpressing	cells.	Error	
bars	represent	±SEM	and	a	p-value	<0.05,	n>40	from	three	independent	biological	replicates.	
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presence	of	a	CENP-A	signal	on	them.	To	avoid	the	reading	of	any	unspecific	
CENP-A	signal,	CENP-A	foci	co-localizing	with	both,	microtubule	signals	and	
lagging	chromosomes	(DAPI	signal)	were	taken	into	account.	Quantification	
of	CENP-A	on	lagging	chromosomes	revealed	that	lagging	chromosomes	have	
more	 than	 one	 CENP-A	 foci	 (Figure	 2.12	 A).	 In	 normal	 cells	 segregating	
chromosomes	in	anaphase	should	possess	a	single	CENP-A-kinetochore	site	
built	 at	 the	 centromere.	 Considering	 this,	 lagging	 chromosomes	 were	
categorized	between	a)	 Lagging	 chromosome	with	one	CENP-A	 foci	 and	b)	
Lagging	chromosomes	with	more	than	one	CENP-A	foci.	The	presence	of	more	
than	one	CENP-A	foci	on	a	lagging	chromosome	would	reflect	more	than	one	
potential	kinetochore	site.	Quantification	of	lagging	chromosomes	with	more	
than	one	CENP-A	foci	shows	that	WT	situation	includes	around	12%	of	lagging	
chromosomes	with	more	than	one	CENP-A	foci.	Interestingly,	60%	of	lagging	
chromosome	analyzed	from	Su(var)3-9	overexpressing	cells	show	more	than	
one	CENP-A	foci	(Figure	2.12	C),	the	remaining	10%	are	common	between	the	
two	 conditions	with	no	 increased	CENP-A	 foci.	Overall,	 this	 is	 suggesting	 a	
strong	 correlation	 between	 a	 lagging	 chromosome	 defect	 and	 increased	
CENP-A	foci	under	given	Su(var)3-9	conditions	(Compare	Figure	2.12	B	and	C).	
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2.4.3 Changed	Su(var)3-9	level	result	in	CENP-A	and	Su(var)3-9	interaction	
In	order	to	examine	the	interaction	between	Su(var)3-9	and	CENP-A,	a	pull-
down	 assay	 was	 performed	 using	 Su(var)3-9-V5-His	 overexpressing	 cells	
followed	by	western	blot.	A	V5	antibody	was	used	for	immunoprecipitation.	
Pulldown	of	Su(var)3-9-V5-His	showed	co-precipitation	of	methylated	H3K9	
which	is	known	to	interact	with	Su(var)3-9(not	shown	in	the	figure)	(Lachner	
et	al.	2001;	Schotta	et	al.	2002;	Al-Sady	et	al.	2013).	Interestingly,	I	observed	
co-precipitation	of	CENP-A	with	Su(var)3-9-V5-His	that	suggests	an	interaction	
between	 endogenous	 CENP-A	 and	 Su(var)3-9	 under	 given	 Su(var)3-9	
conditions	 (Figure	 2.13).	 Additionally,	 the	 pulldown	 of	 CENP-A	 in	 CENP-A	
overexpressing	 cells	 shows	 a	 potential	 direct/indirect	 interaction	 with	
Su(var)3-7	 {known	 interactor	 of	 Su(var)3-9}	 as	 analyzed	 via	 mass	
spectrometry	(Appendix	6.5).	
	
	
	
Figure	2.13:	Su(var)3-9	 interacts	with	endogenous	CENP-A	 in	Su(var)3-9	overexpression.	 S2	 cells	
with	Su(var)3-9-V5-His	overexpression	were	subjected	to	immunoprecipitation	using	a	V5	antibody	
and	 then	 analyzed	 for	 presence	 of	 Su(var)3-9-V5-His	 (V5	 antibody),	 CENP-A	 and	H3K9me2,	 using	
respective	antibodies.	The	picture	is	representative	of	more	than	3	repeats.	
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2.5 Effect	of	Su(var)3-9	overexpression	on	cell	cycle	progression	
Next,	 the	 effect	 of	 Su(var)3-9	 overexpression	 on	 cell	 cycle	 progression	 was	
addressed.	Propidium	iodide	(PI)	flow	cytometry	(FACS)	was	used	to	analyze	the	cell	
cycle	phases	in	WT	and	Su(var)3-9	overexpressing	cells.	The	results	obtained	show	
no	significant	change	in	different	G1,	S,	S2/M	and	SubG1	cell	cycle	phases	(Figure	
2.14	A	and	B).	
	
	
PI	 dependent	 FACS	 analysis	 cannot	 be	 used	 to	 differentiate	 between	G2	 and	M	
phase	 in	WT	and	Su(var)3-9	overexpressing	cells.	To	further	evaluate	the	mitotic	
index	of	 Su(var)3-9	overexpressing	 cells,	 it	was	decided	 to	 check	 for	 the	mitotic	
marker	 phospho-Histone	 3	 (PH3)	 (Goshima	 et	 al.	 2007).	 Cells	 with	 and	 without	
Figure	2.14:	High	Su(var)3-9	 level	in	S2	cells	does	not	affect	the	cell	cycle	progression.	A)	Flow	cytometric	analysis	
indicating	the	cell	cycle	profile	of	control	 (WT	upper	panel)	and	CHRAC14	RNAi	(lower	panel)	cells.	The	cells	from	
each	 sample	were	 collected	after	4	days	of	RNAi	treatment,	processed	and	analyzed	using	BD	FACS	Canto	 II.	The	
percentage	of	 each	 cell	 cycle	 stage	and	 the	number	of	 cells	used	 (10,000	 event	 count)	 in	both	 samples	were	as	
indicated	and	was	analyzed	using	FlowJo	 software.	The	cell	cycle	profile	and	the	frequency	of	each	 stage	 in	both	
samples	were	comparable	to	each	other.	B)	Quantification	of	average	of	three	biological	replicates	of	the	experiment	
represented	in	Figure	A.	Error	bars	represent	±SEM.		
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Su(var)3-9	 overexpression	were	 subjected	 to	 IF	 using	 an	 anti-PH3	 antibody	 and	
nuclei	were	stained	with	DAPI	(Figure	2.15).		
PH3	 positive	 cells	 were	 quantified	 and	 percentages	 measured.	 Results	 suggest	
around	 10%	 of	 mitotic	 cells	 present	 in	 unsynchronized	 WT	 and	 Su(var)3-9	
overexpressing	 S2	 cells,	 reflecting	 no	 significant	 difference	 in	 the	 mitotic	 index	
between	the	two	conditions	(Figure	2.15).	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	 2.15	 Elevated	 Su(var)3-9	 does	 not	 affect	 the	 mitotic	 index.	 S2	 cells	 with	 and	 without	 Su(var)3-9	
overexpression	were	subjected	to	IF	using	anti-phospho-Histone	3	(PH3)	and	co-stained	with	DAPI	(grey).	Bar=	
10µm.	The	graph	represents	the	percentage	of	PH3	positive	cells	from	control	and	Su(var)3-9	overexpressing	cells	
from	3	biological	independent	replicates.	Total	50	cells/repeat	were	counted.	Error	bars	represent	±SEM	and	a	
p-value	>0.05.	ns=non-significant	
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3 Discussion	
3.1 Role	of	CHRAC14	in	maintenance	of	heterochromatin		
In	this	study	I	show	that	depletion	of	CHRAC14	results	in	an	increase	of	H3K9me2	
which	suggests	an	overall	increase	in	heterochromatin	structure.	In	addition	to	this,	
the	CHRAC14	human	homolog	has	been	reported	to	enhance	nucleosome	sliding	
effect	in	in	vitro	experiments	(Kukimoto	et	al.	2004).	These	evidences	all	together	
suggest	 that	 CHARC14	 alone	 could	 play	 a	 crucial	 role	 in	 maintaining	 chromatin	
structure.	
	
In	mammalian	and	 in	yeast	cells,	 it	has	been	shown	that	a	defect	 in	nucleosome	
assembly	affects	the	replication,	transcription	and	genome	maintenance	(Lewis	et	
al.	2005;	Kukimoto	et	al.	2004;	Rocha	&	Verreault	2008;	Burgess	&	Zhang	2014).	
Further,	 CHRAC14	 in	 the	 CHRAC	 complex	 is	 reported	 to	 affect	 chromatin	
nucleosome	assembly	(Guelman	et	al.	2009;	Clapier	&	Cairns	2009).	Depletion	of	
ACF1	 (a	 CHRAC	 subunit)	 has	 also	 been	 shown	 to	 slow	 down	 the	 replication	 of	
heterochromatin	 region	 suggesting	 a	 role	 of	 the	 CHRAC	 complex	 in	 relaxing	
heterochromatin	structure	(Collins	et	al.	2002).	Additionally,	in	yeast	a	homolog	of	
CHRAC14	is	suggested	to	anchor	the	CHRAC	complex	to	specific	genomic	sites	(Dang	
et	 al.	 2007).	 It	 is	 possible	 that	 this	 role	 of	 CHRAC14	 is	 important	 in	 relaxing	
heterochromatin	and	could	be	one	of	the	reasons	why	CHRAC14	depletion	shows	
increased	heterochromatin	marker.	
	
Further,	another	CHRAC14	containing	complex,	ATAC	which	also	contains	two	HATs,	
has	 been	 shown	 to	 be	 important	 for	 maintenance	 of	 histone	 acetylation	 and	
thereby	maintaining	the	euchromatin	and	heterochromatin	balance	in	Drosophila	
(Ciurciu	et	al.	2008;	Ma	et	al.	2013;	Guelman	et	al.	2009).	Ciurciu	et.	al.	has	also	
reported	 that	 an	 absence	 of	 ATAC	 complex	 subunits	 can	 lead	 to	 enhanced	
heterochromatin	 structures	 (Ciurciu	 et	 al.	 2008).	 However,	 it	 has	 never	 been	
elucidated	whether	the	absence	of	CHRAC14	either	as	part	of	CHRAC	complex	or	
ATAC	 complex	 can	 impact	 the	 overall	 chromatin	 structure.	Our	 study,	 explicitly,	
show	 that	 the	 absence	 of	 CHRAC14	 lead	 to	 increased	H3K9me2	 and	HP1	 levels	
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suggesting	 that	 the	 presence	 of	 CHRAC14	 is	 required	 for	 maintaining	 the	
physiological	level	of	heterochromatin	and	euchromatin.	
We	have	also	observed	an	enhanced	expression	of	Su(var)3-9	mRNA	in	absence	of	
CHRAC14,	as	seen	via	RT-PCR.	The	increased	Su(var)3-9	expression	further	supports	
our	observation	of	enhanced	H3K9me2	level	in	CHRAC14	depleted	cells.	Moreover,	
ADA2A	 (subunit	 of	 ATAC	 complex)	 depletion	 shows	 enhanced	 H3K9me2	 (see	
appendix	6.2)	and	this	is	Su(var)3-9	dependent	(Ciurciu	et	al.	2008)	which	is	similar	
to	 the	CHRAC14-/-	 phenotype	observed	 in	our	 study.	 In	 addition	 to	 this,	we	also	
observed	 that	 the	 lack	 of	 CHRAC14	 shows	 reduced	 H3K9	 acetylation,	 which	
indicates	the	loss	of	HAT	activity.	One	possible	reason	could	be	that	the	presence	
of	 CHRAC14	 increases	 the	 DNA	 binding	 to	 ATAC	 complex	 that	 in	 turn	 becomes	
crucial	for	HAT	activity.	Another	possibility	could	be	that	an	absence	of	CHRAC14	
led	disruption	of	ATAC	complex	that	in	turn	affects	HAT	activity.	However,	a	precise	
understanding	CHRAC14	on	HAT	activity	is	a	subject	of	further	studies.		
It	would	be	interesting	to	analyze	the	in	vitro	efficiency	of	the	ATAC	complex	with	
and	without	 CHRAC14	 on	H3K9	 containing	 substrate.	Our	 results,	 together	with	
previous	 reports,	 indicate	 a	 possible	 disruption	 of	 the	 ATAC	 complex	 or	 a	
combination	of	 a	defect	 in	CHRAC	and	ATAC	 complex	 activity	which	 leads	 to	 an	
increase	in	heterochromatin	structure.		
	
3.2 Role	of	CHRAC14	in	DNA	damage	repair	
Increase	in	heterochromatin	and	decrease	in	H3K9	acetylation	have	been	shown	to	
impair	the	DNA	damage	repair	ability	of	cells	(Guo	et	al.	2011;	Klement	et	al.	2014;	
Dinant	et	al.	2008;	Chiolo	et	al.	2011;	Sulli	et	al.	2012;	Jakob	et	al.	2011).	Chromatin	
requires	a	balance	between	condensed	and	decondensed	chromatin	structures	in	
response	to	overcome	DNA	damage	stress	arising	due	to	biotic	and	abiotic	factors.	
It	 is	 easy	 to	 imagine	 that	 compact	 DNA	 structure	 can	 protect	 DNA	 against	 any	
endogenous	DNA	damaging	factors	like	reactive	oxygen	species	(ROS)	(Harikrishnan	
et	al.	2008;	Tsang	et	al.	2014).	However,	once	the	DNA	damage	occurs,	accessing	
the	 DNA	 damage	 sites	 by	 DNA	 repair	 proteins	 is	 the	 foremost	 step,	which	may	
involve	expansion	of	heterochromatin	along	with	moving	the	DNA	damage	site	out	
of	the	compact	structure	(Chiolo	et	al.	2011;	Jakob	et	al.	2011;	Guo	et	al.	2011).	The	
	 47	
repair	 system	may	 also	 involve	 chromatin	 relaxation	 by	 acetylation	 of	 histones	
(Tjeertes	 et	 al.	 2009;	 Guo	 et	 al.	 2011).	 We	 have	 observed	 that	 the	 CHRAC14	
knockdown	which	 shows	 reduced	H3K9ac	with	 an	 increase	 of	 H3K9me,	 suggest	
defective	chromatin	relaxing	machinery	with	increased	DNA	compaction.	This	could	
be	a	possible	reason	for	accumulation	of	DNA	damage	seen	in	absence	of	CHRAC14.	
In	addition	to	this,	a	previously,	our	research	group	showed	that	CHRAC14-/-	flies	
and	embryos	show	a	defect	in	hatching	upon	heavy	IR	treatment	(10	Gy	-30	Gy)	but	
hatch	normally	when	not	subjected	to	a	DNA	damaging	agent,	although	they	have	
low	 level	 of	 endogenous	DNA	 damage	 accumulation	 (Mathew	 et	 al.	 2014).	One	
possible	explanation	for	this	is	that	when	embryos	are	subjected	to	strong	dose	of	
DNA	 damaging	 agent/s,	 because	 of	 high	 DNA	 compaction	 it	 is	 not	 possible	 for	
embryos	to	cope	up	with	high	amounts	of	unrepaired	DNA	damage	and	this	leads	
to	their	death.	Altogether,	suggesting	an	important	role	of	CHRAC14	in	facilitating	
appropriate	chromatin	environment	for	the	repair	of	damaged	DNA.	
	
3.3 CENP-A,	a	potential	substrate	for	acetylation	
In	Drosophila,	global	inhibition	of	histone	deacetylation	with	TSA	leads	to	reduction	
in	ectopic	CENP-A	localization,	in	CENP-A	overexpressing	cells	(Olszak	et	al.	2011).	
Further,	our	analysis	suggests	that	TSA	treatment	reduces	the	overall	CENP-A	foci	
number	 in	 CHRAC14	 depleted	 cells	 when	 compared	 to	 CHRAC14	 depleted	 cells	
which	has	been	reported	to	have	high	CENP-A	foci	number	(Mathew	et	al.	2014).	
We	also	observe	that	the	nuclear	localization	of	CENP-A	is	negatively	affected	by	
TSA	treatment,	in	CENP-A	over	expressing	cells.	These	experiments,	indicating	two	
possibilities;	1)	either	acetylation/deacetylation	of	other	histones	(H4,	H2A,	H2B)	in	
CENP-A	 nucleosome	 plays	 role	 in	 CENP-A	 localization	 or	 2)	
acetylation/deacetylation	of	CENP-A	play	role	in	its	localization.	Recently	it	has	been	
reported	 that	 HAT1	 dependent	 H4	 K5	 and	 K12	 acetylation	 is	 important	 for	
centromeric	CENP-A	localization	in	chicken	cells	and	human	cells	(Shang	et	al.	2016).	
Similar	mechanism	is	also	possible	in	Drosophila	model	system	which	may	require	
CHRAC14	 containing	 complex	 like	 ATAC.	 Additionally,	 it	 is	 also	 possible	 that	
CHRAC14	depletion	also	affects	CENP-A	acetylation	which	in	turn	could	affect	the	
localization	in	combination	with	observed	reduced	H3K9	acetylation.				
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Very	 little	 is	 known	 about	 acetylation	 of	 CENP-A.	 Our	 preliminary	 experiments	
suggest	that	CENP-A	could	be	a	potential	acetylation	substrate.	Further,	I	attempted	
to	check	which	HAT	could	be	responsible	for	this.	For	this	purpose,	a	Sumo	tagged	
CENP-A	was	expressed	and	purified	from	a	bacterial	expression	system	as	described	
in	 a	 previous	 report	 (Bade	 et	 al.	 2014).	 Later,	 the	 in	 vitro	 acetylation	 assay	was	
performed	by	Renate	Voit	(lab	of	Prof.	Ingrid	Grummt).	Initial	results	suggested	that	
CENP-A	could	be	acetylated.	However,	we	also	 found	control	CENP-A	acetylated	
(without	 incubation	 with	 any	 HAT),	 suggesting	 acetylation	 via	 bacterial	 system	
(Linda	I.	et	al.	2010).	Nevertheless,	the	experiment	still	hints	that	CENP-A	could	be	
acetylated	but	whether	Drosophila	HATs	can	acetylate	it,	still	remains	a	question.	
Alternative	technique	like	in-vitro	translation	can	be	helpful	to	obtain	unmodified	
CENP-A	for	repetition	of	HAT	assay.	A	recent	study	suggests	that	Drosophila	CENP-
A	interacts	with	HAT1	but	does	not	acetylate	it	(Boltengagen	et	al.	2015).	Although	
the	 study	 detected	 acetylation	 of	 CENP-A	 at	 K105	 via	 mass	 spectrometry,	 the	
responsible	HAT	is	yet	to	be	discovered.	GCN5	and	ATAC2	are	two	HATs	associated	
with	 the	ATAC	complex	and	 it	 is	possible	 that	either	of	 these	HATs	could	be	the	
responsible	HAT	for	CENP-A	acetylation.	Additionally,	in	budding	yeast,	a	homolog	
of	 GCN5	 has	 been	 shown	 to	 interact	 with	 Cse4p	 (CENP-A	 homolog)	 and	 this	
interaction	 is	 important	 for	 kinetochore	 formation	 (Vernarecci	 et	 al.	 2008).	 This	
further	stresses	the	idea	of	GCN5	as	a	potential	HAT	for	CENP-A	acetylation.	It	would	
be	 interesting	 to	 further	 investigate	 the	 role	 of	 GCN5	 in	 CENP-A	 acetylation	 in	
Drosophila	 cells	 via	 in-vivo	 and	 in-vitro	 approaches.	 Further	 experiments	 in	 this	
direction	will	reveal	the	details	of	CENP-A	as	a	potential	acetylation	substrate	and	
its	significance	in	Drosophila	model	system.	
	
3.4 Role	of	Su(var)3-9	in	facilitating	ectopic	CENP-A	localization		
CHRAC14	depletion	leads	to	an	increase	in	CENP-A	foci	number	in	S2	cells	and	the	
increased	 foci	 were	 ectopic	 foci	 (Mathew	 et	 al.	 2014).	 Interestingly,	 during	 this	
study,	 we	 have	 observed	 that	 depletion	 of	 CHRAC14	 increases	 Su(var)3-9	 and	
H3K9me2,	 indicating	 an	 increase	 in	 heterochromatin.	 This	 was	 followed	 by	 the	
observation	that	raised	Su(var)3-9	expression	shows	potential	to	facilitate	ectopic	
CENP-A	and	CENP-C	localization.	Previously,	it	has	been	shown	that	tethering	of	HP1	
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which	 is	 downstream	 to	 Su(var)3-9	 in	 heterochromatin	 formation	 pathway,	 can	
lead	 to	 de-novo	 deposition	 of	 CENP-A	 at	 ectopic	 sites	 (Olszak	 et	 al.	 2011).	 It	 is	
possible	 that	 ectopic	 loading	 of	 CENP-A	 requires	 Su(var)3-9	 activity	 to	 create	
heterochromatin	boundaries	and	this	is	followed	by	HP1	recruitment.	Additionally,	
whether	 HP1	 and	 Su(var)3-9	 leads	 to	 ectopic	 loading	 of	 CENP-A	 via	 same	 the	
pathway	or	separate	is	a	subject	to	study	further.	It	will	also	be	interesting	to	ask	
whether	 the	 observed	 Su(var)3-9	 dependent	 CENP-A	 ectopic	 loading	 requires	
Satellite	 III,	 which	 has	 been	 reported	 to	 be	 important	 for	 centromeric	 CENP-A	
localization	(Rošić	et	al.	2014).		
Further,	 our	 live-cell	 image	 analysis	 on	 Su(var)3-9	 overexpressing	 cells	 show	 an	
enhanced	chromosome	segregation	defect	with	 lagging	chromosomes	and	 these	
lagging	 chromosomes	 show	 an	 increase	 in	 CENP-A	 foci	 count.	 These	 increased	
CENP-A	sites	on	chromosomes	could	be	the	possible	cause	of	a	lagging	chromosome	
defect	and	should	be	 further	characterize	 for	 the	presence	of	outer	kinetochore	
proteins.	Additionally,	further	investigation	by	analyzing	chromatin	bound	to	CENP-
A	using	chromatin	immunoprecipitation	(ChIP)	could	help	us	to	identify	a	possible	
increase	in	genomic	sites	for	ectopic	CENP-A	localization.	Additionally,	 it	will	also	
help	us	to	understand	whether	there	is	some	consistency	in	their	preferred	sites	
localization	 or	 it	 is	 random	 but	 more	 specific	 to	 the	 surrounding	 epigenetic	
environment.	 Previous	 reports	 suggest	 that	 heterochromatin	 boundaries	 are	
hotspots	for	CENP-A	ectopic	localization	(Olszak	et	al.	2011).	In	agreement	with	this,	
my	results	suggest	that	ectopic	CENP-A	foci	sites	in	Su(var)3-9	overexpressing	cells	
were	 more	 often	 near	 to	 the	 telomeres,	 which	 are	 known	 to	 be	 dominant	
heterochromatin	site.	This,	in	turn,	indicates	that	the	heterochromatin	boundaries	
might	also	be	favourable	sites	for	ectopic	CENP-A	localization	 in	given	Su(var)3-9	
conditions	 and	 would	 be	 interesting	 to	 investigate	 in	 future.	 It	 is	 possible	 that	
overexpression	of	Su(var)3-9	gives	rise	to	ectopic	heterochromatin	chromatin	sites	
by	 methylating	 H3K9	 slightly	 away	 from	 telomeric	 heterochromatin	 and	 this	 is	
followed	 by	 recruitment	 of	 HP1.	 This	 would	 lead	 to	 the	 formation	 of	 a	 non	
heterochromatinized	 chromatin	 region	 which	 is	 flanked	 by	 heterochromatin,	
similar	to	centromere	which	is	flanked	by	pericentric	heterochromatin.	Further,	this	
“ectopic	heterochromatin-non	heterochromatin-telomeric	heterochromatin”	region	
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at	telomere	might	be	recruiting	CENP-C	and	CENP-A,	and	other	kinetochore	related	
proteins	 leading	 to	 the	 formation	 of	 potential	 ectopic	 microtubule	 attachment	
sites.	 Later,	 this	 is	 resulting	 in	 a	 chromosome	 segregation	 defect	 with	 lagging	
chromosomes.		
	
In	mammalian	cells	it	has	been	shown	that	tethering	of	heterochromatin	forming	
factors	like	Su(var)3-9h1	and	HP1	does	not	favour	CENP-A	deposition	(Ohzeki	et	al.	
2016;	Ohzeki	et	al.	2012;	Nakano	et	al.	2008)	although	it	is	also	interesting	to	see	
that	tethering	of	G9a	{redundant	in	Drosophila,	its	role	is	taken	over	by	Su(var)3-9}	
shows	ectopic	CENP-A	deposition	 as	 seen	 in	HAC	 system	 (Shono	et	 al.	 2015).	 In	
yeast,	the	Su(var)3-9	homologue	Clr4	promotes	CENP-A	deposition	(Kagansky	et	al.	
2009)	and	in	Drosophila	HP1	tethering	promotes	ectopic	CENP-A	localization	which	
is	converse	to	the	mammalian	system	(Olszak	et	al.	2011).	Complementary	to	this	
my	results	showed	that	increased	Su(var)3-9	expression	can	cause	ectopic	CENP-A	
localization.	 In	 addition	 to	 this,	 in	 the	 preliminary	 data	 using	 the	 Lac-O/Lac-I	
tethering	system,	I	was	able	to	observe	that	the	tethering	of	Su(var)3-9	can	cause	
CENP-A	 deposition	 (see	 Appendix	 6.1).	 However,	 this	 data	 should	 further	 be	
validated	using	metaphase	spreads	since	there	is	a	possibility	that	it	is	not	due	to	
the	tethering	of	Su(var)3-9	but	due	to	the	overexpression	of	Su(var)3-9	that	causes	
CENP-A	deposition	at	the	Lac-O	site.	Nevertheless,	we	can	conclude	from	my	results	
that	the	Su(var)3-9	overexpression	is	capable	of	CENP-A	deposition	at	ectopic	sites	
in	S2	cells,	primarily	near	telomeres.	This	suggests	a	potential	role	of	Su(var)3-9	in	
facilitating	 ectopic	 loading	 of	 CENP-A	 in	 Drosophila	 cells	 by	 influencing	 the	
formation	 of	 heterochromatin	 structure	 and	 highlights	 the	 importance	 of	
maintaining	its	physiological	level	in	the	context	of	CENP-A	localization.					
	
3.5 Working	Model	
It	has	been	postulated	that	CHRAC14	monitors	CENP-A	miss-localization	in	presence	
of	DNA	damage,	possibly	by	formation	of	CHRAC14-CENP-A	complex	(Mathew	et	al.	
2014).	Moreover,	results	from	this	study	suggest	that	CHRAC14	depletion	also	leads	
to	an	increase	in	heterochromatin.	Considering	our	results	and	previous	reports,	we	
can	propose	that	in	addition	to	previously	reported	CHRAC14’s	role	in	monitoring	
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ectopic	CENP-A	localization;	CHRAC14	also	maintains	heterochromatin	level	and	its	
absence	 leads	 to	an	 increase	 in	 Su(var)3-9	expression	which	 is	upstream	 to	HP1	
localization	 in	 heterochromatin	 formation.	 Su(var)3-9	 rise	 leads	 to	 ectopic	
heterochromatin	formation	which	may	impair	the	DNA	damage	repair	ability	and	
also	 favor	 the	CENP-A	and	CENP-C	ectopic	 localization.	 This	 ectopic	CENP-A	and	
CENP-C	localization	may	require	SatIII?	The	non-centromeric	CENP-A	and	CENP-C	
may	 recruit	 kinetochore	 proteins	 leading	 to	 potential	 microtubule	 attachment	
site/s	 in	 addition	 to	 centromeric	 site,	 in	 metaphase	 cells.	 As	 a	 consequence,	
metaphase	chromosomes	with	more	than	one	microtubule	sites	results	as	lagging	
chromosome	defects,	which	in	turn	may	cause	genomic	instability	(Figure	3.1).		
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Figure	 3.1:	Working	Model:	 	 CHRAC14	 depletion	 leads	 to	 increase	 in	 Su(var)3-9	 expression,	 resulting	 in	 the	
formation	of	ectopic	heterochromatin	near	telomeres,	leading	to	the	non-heterochromatin	region	flanked	with	
heterochromatin	(similar	to	centromere).	Region	flanked	with	heterochromatin	near	telomere	may	favor	ectopic	
CENP-A	 localization	 and	 thereby	 recruiting	 kinetochore	 proteins.	 This	 would	 further	 lead	 to	 microtubule	
attachment	 of	 kinetochore	 in	 addition	 to	 centromeric	 attachment	 causing	 delayed	 metaphase	 and	 lagging	
chromosome	defect.		This	may	further	result	in	polyploidy	or	aneuploidy.		
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3.6 Histone	methyltransferases,	 the	 possible	missing-link	 between	 ectopic	 CENP-A	
and	cancer	
Reports	 on	 molecular	 biology	 of	 colon	 cancer	 suggests	 that	 the	 patients	 have	
elevated	 level	 of	 Su(var)3-9H1	 and	 G9a	 histone	methyltransferases	 (Kang	 et	 al.	
2007;	Zhang	et	al.	2015),	increased	H3K9me	level	(Nakazawa	et	al.	2012;	Tamagawa	
et	al.	2012),	defect	in	DNA	mismatch	repair	pathway	(Kerr,	D.J.	&	Midgley,	R.,	2010)	
and	non-centromeric	CENP-A	localization	(Tomonaga	et	al.	2003).	Interestingly,	in	
colon	cancer	cells	ectopic	CENP-A	has	been		mapped	at	sub-telomeric	sites	(Athwal	
et	 al.	 2015).	 Furthermore,	 HDAC	 inhibitors	 has	 been	 shown	 beneficial	 for	 the	
treatment	of	colorectal	cancer	(Barneda-Zahonero	&	Parra	2012;	Chou	et	al.	2011;	
Kondo	 et	 al.	 2003;	 Fang	 et	 al.	 2004;	 He	 et	 al.	 2013),	 possibly	 by	 promoting	
hyperacetylation	 environment.	 	 However,	 whether	 CENP-A	 non-centromeric	
localization	could	be	the	result	of	increased	level	of	HMT	and	H3K9me	has	never	
been	investigated	in	colon	cancer.	Here,	using	Drosophila	model	system,	we	present	
evidences	 which	 suggest	 possible	 link	 between	 raised	 HMT	 level,	 H3K9me	 and	
CENP-A	 miss-localization	 with	 potential	 impact	 on	 genome	 stability	 via	 cell	
chromosome	 segregation	 defects.	 It	 is	 possible	 that	 colon	 cancer	 cells	 which	
possess	combination	of	DNA	mismatch	repair	defect,	increased	HMT,	H3K9me	and	
non-centromeric	 CENP-A	 localization,	 altogether,	 creates	 tumour	 promoting	
environment.	 Our	 study,	 address	 the	 possible	 cause	 of	 CENP-A	 mislocalization	
observed	in	colorectal	cancer,	however	this	should	be	further	investigated	in	cancer	
cells.	
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4 Materials	
4.1 Chemicals	Used	in	this	study	
All	the	chemicals	used	in	this	study	were	purchased	from	Roth,	Applichem,	Merck,	
Invitrogen/Life	Technology	(Invitrogen),	Sigma	Aldrich	(Sigma)	and	Fluka.	Details	of	
the	specific	chemicals	are	in	the	table	below:	
Serial	No.	 Chemicals	 Chemical	provider	
1	 DAPI	 AppliChem	
2	 EDTA	 Roth	
3	 Formaldehyde	37%	
	
AppliChem	
4	 Ethanol	 AppliChem	
5	 2-Propanol	 AppliChem	
6	 Methanol	 ZMBH	
7	 Mounting	medium-	Aqua-
Polymount	
Poly	Sciences	
8	 Milk	Powder	 AppliChem	
9	 Triton	X-100	 Merck	
10	 Tween	20	 AppliChem	
11	 Trizol	 Invitrogen	
12	 Tris	 AppliChem	
13	 30%	Acrylamide	solution	 AppliChem	
14	 Albumin	Fraction	V	(pH	
7.0)	
Invitrogen	
15	 Phenol/Chloroform	 AppliChem	
16	 Phenylmethylsulfonyl	
fluoride	(PMSF)	
Sigma	
	
17	 TEMED	 AppliChem	
18	 Sodium	tetraborate	 Sigma	
19	 Sodium	chloride	 AppliChem	
20	 Sodium	citrate	 AppliChem	
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21	 Sodiumdodecylsulphate	
(SDS)	
AppliChem	
22	 Bromphenolblue	 AppliChem	
23	 Protease	inhibitor	cocktail	
complete	EDTA-free	
Roche	
24	 NP-40	 AppliChem	
25	 Agarose	Ultra	Pure	 Invitrogen	
26	 Calcium	Cloride	 Fluka	
	
4.2 Tissue	culture	reagents	
Serial	
No.	
Reagents	 Company/Provider	
1	 Schneider's	Drosophila	medium	 Invitrogen	
2	 Hygromycin	B	solution	 Invitrogen	
3	 Fetal	Bovine	Serum	(FBS)	 Biochrom	AG	and	Invitrogen	
4	 Colchemid	 PAA	
5	 Cellfectin	II	 Invitrogen	
6	 Trichostatin	A	 Sigma-Aldrich	
7	 Methy	methanesulfonate	(MMS)	 Sigma-Aldrich	
8	 CuSo4	 Applichem	
	
	
4.3 Buffers/Solutions	
Below	are	the	details	of	all	the	buffers	used	in	this	study	and	all	the	buffer	were	
prepared	using	double	distilled	water	(ddH2O)	
Serial	
No.	
Buffer	 Ingredients	
	 Buffers	used	in	SDS-PAGE	and	Western	Blot	
1	 Separation	gel	(10.5%)	 0.375	M	Tris-HCl	pH	8.8	
10.5%	acrylamide/bisacrylamide	
30:0.8%	
0.1%	SDS	
0.05%	APS	
0.05%	TEMED	
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in	ddH2	O	
2	 Stacking	gel	 0.123	M	Tris-HCl	pH	6.8	
4.4%	acrylamide/bisacrylamide	
30:0.8%	
0.1%	SDS	
0.03%	APS	
0.1%	TEMED	
in	ddH2	O	
3	 4x	Laemmli	sample	loading	buffer	 50	mM	Tris-HCl	pH	6.8	
10%	glycerol	
2%	SDS	
0.5%	ß-Mercaptoethanol	
0.02%	Bromphenolblue	
in	ddH2	O	
4	 1x	SDS	gel	running	buffer	 25	mM	Tris	
190	mM	glycine	
0.1%	SDS	
in	ddH2	O	
5	 Tris-glycine-methanol	transfer	buffer	 25	mM	TrisHCl	
0.192	M	glycine	
20%	methanol	absolute	
in	ddH2	O	
6	 20x	Borate	transfer	buffer	 20	mM	Boric	acid	
1	mM	EDTA	
0.1	mM	DTT	
pH	8.8	
in	ddH2	O	
7	 10x	TBS	 30	g/l	Tris	
88	g/l	NaCl	
2	g/l	KCl	
pH	7.5	
in	ddH2	O	
8	 PBS	buffer	 137	mM	NaCl	
2.7	mM	Kcl	
10	mM	Na2	HPO4	
1.7	mM	KH2	PO4	
adjusted	to	pH	7.5	(HCl)	
9	 Blocking	buffer	 1x	TBS/PBS	
0.1%	Tween-20	
5%	Milk	powder	
10	 Washing	buffer	 1x	TBS/PBS	
0-0.1%	Tween-20	
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11	 Ponçeau	 0.2%	Ponçeau	
3%	TCA	
12	 Lysis	buffer	for	whole	cell	extract	 50	mM	Tris	pH	7.5	
200	mM	NaCl	
1%	Triton	
0.5%	Sodium	dodecylsulfate	
0.1%	SDS	
2	mM	PMSF	
13	 Mild	stripping	buffer	 15	g/l	glycine	
0.1%	SDS	
1%	Tween-20	
pH	2.2	
in	ddH2	O	
	 Acid	Histone	Extraction	
14	 Triton	Extraction	Buffer	 0.5%	Triton	X	100	(v/v)	
@mM	PMSF,	
0.02%	NaNa3	
	 Buffers	and	Solution	used	in	Gel	electrophoresis	
15	 50x	Tris-acetate-EDTA	(TAE)	 242	g/l	Tris-HCl	
18.6	g/l	EDTA	
pH	7.7	adjusted	with	acetic	acid	
in	ddH2	O	
	 Immunofluorescence	
16	 4%	paraformaldehyde	(PFA)	PBS	
(50ml)	
2g	PFA	
75.7μ	l	1N	KOH	
45ml	H2	O	
+	
5ml	10X	PBS	
17	 PBS	premeabilization	solution	 1x	PBS	
0.1%/2	Triton	X	100	
18	 PBS	blocking	solution	 1x	PBS	
0.1%	Triton	X	100	
5%	Milk	powder/5%	BSA	Fraction	V	
19	 Metaphase	spreads	Hypotonic	swelling	
solution	
0.5	%	(w/v)	Sodium	citrate	
in	ddH2	O	
	 Immunoprecipitation	
20	 Standard	RIPA	cell	lysis	buffer	for	
whole	cell	
extracts	
50	mM	TrisHCl	(pH7.5)	
150	mM	NaCl	
1%	NP-40	
0.5%	Sodium	dodecylsulfate	
0.1%	SDS	
2	mM	PMSF	
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21	 Co-IP	buffer/wash	buffer	 50	mM	TrisHCl	(pH	7.5)	
200	mM	NaCl	
1%	NP-40	
2	mM	PMSF	
Roche	complete	protease	inhibitor	
cocktail	
22	 RIPA	high	salt	IP	buffer	 50	mM	TrisHCl	(pH7.5)	
250	mM	NaCl	
1%	NP-40	
0.5%	Sodium	dodecylsulfate	
0.1%	DOC	
2	mM	PMSF	
Roche	complete	protease	inhibitor	
cocktail	
10	mM	Na-fluoride	
1mM	Na-orthovanadate	
10	mM	N-ethylmalemide	
	
4.4 Equipment	and	lab	materials	
Serial	
No.	
Equipment/Material/Tools	 Provider/Company	
1	 Agarose	gel	trays	 Workshop	ZMBH	
2	 Balance	 Sartorius,	Kern	EG	
3	 Blotting	materials	 BioRad	
4	 Deltavision	microscope	 Olympus/GE	Healthcare	
5	 Film	development	system	SRX-101A	 Konica	Minolta	
6	 Tabletop	centrifuges	 Eppendorf	
7	 Micropipettes	 Gilson	
8	 PCR-cycler	 Biorad	
9	 Vortex	 Scientific	industries	
10	 -80°C	freezer	 Heraeus	
11	 pH-meter	 Sartorius	
12	 1.5	and	2	ml	reaction	tubes	 Sarstedt	
13	 15	and	50	ml	tubes	 Sarstedt	
14	 0.2	ml	PCR	reaction	tubes	 Sarstedt	
15	 25	cm2		flask	(cell	culture)	 Orange	Scientific	
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16	 75	cm2		flask	(cell	culture)	 Orange	Scientific	
17	 150	cm2		flask	(	cell	culture)	 Orange	Scientific	
18	 FUJI	Medical	X-Ray	Film	 Fujifilm	
19	 Pipette	tips	 Sarstedt,	TipOne,	Avant	Gμ	ard	
20	 Superfrost®		Plus	Slides	 Thermo	Scientific	
21	 Protein	gel	equipment	 Biorad	
22	 Coverslips	(18	x	18	mm)	 Thermo	Scientific	
23	 Nitrocellulose	membrane	(0.45	μ	m)	 Amersham	Biosciences	
24	 PVDF	transfer	membrane	 GE	Healthcare	
25	 UV	stratalinker	2400	 Stratagene	
26	 Power	supplies	 Biorad,	EMBL	PS143	
27	 Waterbath	 Memmert	
28	 Microwave	 Sharp	
29	 Micropipettes	 Gilson	
30	 Whatman	Paper	 Roth	
31	 Shandon	EZ	MegafunnelTM	 Thermo	Scientific	
32	 Shandon	EZ	Double	CytofunnelTM	 Thermo	Scientific	
33	 Bioruptor	 	
	
4.5 Protease,	Phosphate	and	HDAC	inhibitors	
Details	 of	 the	 protease	 and	 phosphatase	 inhibitors.	 These	 inhibitors	 were	 used	
mainly	in	preparing	samples	for	western	blot	or	Immunoprecipitation		
Serial	
No.	
Inhbitors	 Provider/Company	
1	 Aprotinin	 AppliChem	
2	 Leupeptin	 AppliChem	
3	 Pepstatin	 AppliChem	
4	 PMSF	 Sigma	
5	 NEM	 Sigma	
6	 NaF	 AppliChem	
7	 Protease	inhibitors	complete	 Roche	
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8	 Trichostatin	A	 Sigma	
	
4.6 Primary	and	Secondary	antibody	
List	 of	 all	 the	 primary	 and	 secondary	 antibody	 used	 in	 western	 blot	 (WB)	 and	
Immunofluorescence	(IF)	for	this	study.		
Serial	
No.	
Antibody-reacts	with	 Dilution	 Provider/Company	
1	 CID-anti	rabbit	 1:500	(for	WB)	 Active	motif	
2	 H3K9me2-anti	mouse	 1:500	(for	WB	
and	IF)	
Abcam	
3	 α-Tubulin-anti	mouse	 1:5000	(for	WB)	
1:1000	(for	IF)	
Sigma	
4	 Actin-anti	mouse	 1:5000	(for	WB)	 millipore	MAB1501	
	
5	 H3K9acetylation-anti	
rabbit	
1:1000	(for	WB	
and	IF)	
abcam	
6	 H3K9me3-anti	rabbit	 1:1000	(for	WB)	 abcam	
7	 H3-anti	rabbit	 1:1000	(for	WB)	 abcam	
8	 CENP-C-anti	Guinea	pig	 1:1000	(for	IF)	 Covance	
9	 Spc105-anti	sheep	 1:1000	(for	WB)	 David	M.	Glover	
10	 P55	 1:5000	(for	WB)	 	
11	 Pan-acetyl	Lysine-anti	
rabbit	
1:1000	(for	WB)	 Stoecklin	Lab	
12	 Histone	H2AvD	pS137-anti	
rabbit	
1:500	(for	WB	
and	IF)	
Rockland	
13	 V5-anti	mouse	 1:5000	(for	WB	
and	IF)	
Invitrogen	
14	 YFP-anti	rabbit	 1:2500	(for	WB)	 Bukau	Lab	
15	 CID	 1:200	(for	IF)	 P.Heun	
16	 Alexa	Fluor®	
647	goat	IgG-mouse	
1:500	(for	IF)	 Invitrogen	
17	 Alexa	Fluor®	 1:500	(for	IF)	 Invitrogen	
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647	goat	IgG-anti	rabbit	
18	 Alexa	Fluor®	
647	goat	IgG	
1:500	(for	IF)	 Invitrogen	
19	 Alexa	Fluor®	
546	goat	IgG-anti	rabbit	
1:500	(for	IF)	 Invitrogen	
20	 Alexa	Fluor®	
546	goat	IgG-anti	mouse	
1:500	(for	IF)	 Invitrogen	
21	 Alexa	Fluor®	
546	goat	IgG-anti	chicken	
1:500	(for	IF)	 Invitrogen	
22	 Alexa	Fluor®	
488	goat	IgG-anti	guinea	
pig	
1:500	(for	IF)	 Invitrogen	
23	 Alexa	Fluor®	
488	goat	IgG-anti	rabbit	
1:500	(for	IF)	 Invitrogen	
24	 Alexa	Fluor®	
488	goat	IgG-anti	mouse	
1:500	(for	IF)	 Invitrogen	
	
	
4.7 Kits	
Serial	
No.	
Kits	 Provider/Company	
1	 NucleoBond	PC	100	 Macherey-Nagel	
2	 MEGAscript	RNAi	Kit	 Ambion	
3	 RevertAidTM	H	Minus	First	Strand	cDNA	
synthesis	kit	
Fermentas	
4	 Gel	Extraction	Kit	 Fermentas	
5	 Plasmid	Mini	Kit	 Fermentas	
6	 Invisorb	Spin	Plasmid	Mini	Two	 Invisorb	
	
4.8 Plasmids	and	DNA	vectors	
Name	 Source	
pMT-CID-V5-His	 Matthias	Spiller-Becker	(Erhardt	lab)	
pCopia-Hygro	 Erhardt	et	al,	2008	
pCopia-LAP-CID	 Erhardt	et	al,	2008	
H2B-GFP	 Goshima	et	al,	2007	
mCherry	Tubulin	 Goshima	et	al,	2007	
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pMT-CHRAC14-V5-His	 Mathew	et	al,	2014	(Erhardt	lab)	
pMT-CID	S46A-V5-His	 This	Study	
pMT-CID	S46D-V5-His	 This	Study	
pMT-Su(var)3-9-V5-His	 This	study	
	
4.9 Primers	
Details	 of	 primers	 used	 in	 this	 study	 for	 RT	 PCR,	 preparation	 of	 dsRNA,	 gene	
amplification	and	molecular	cloning.		
Primer	Name	 Primer	Sequence	
CID	qPCR-fw	
CID	qPCR-rv	
TCACCGAAGGCGCCCTATTGG	
CTAAAATTGCCGACCCCGGTCGCAG	
CHRAC14qPCR-Fw	
CHRAC14qPCR-Rv	
AGACTTCGAAAGCTTCGTGCCC	
TCACTCGGGGGCTTCCTCTGCTG	
ATM-T7-R	
ATM-T7-F	
	
TAATACGACTCACTATAGGGGCGTTCTGCTGGAAGATG	
TAATACGACTCACTATAGGGGCTCATCCAAACTAGCGTAA	
CID-S46Dmut_Fw	
CID-S46Dmut_Rv	
TCGAATTCACCACCGACCAACTGACGCTTCAGGA	
TCCTGAAGCGTCAGTTGGTCGGTGGTGAATTCGA	
CID	S	46	A_	Fw	
CID	S	46	A_	Rv	
TCGAATTCACCACCGCCCAACTGACGCTTCAG	
CTGAAGCGTCAGTTGGGCGGTGGTGAATTCGA	
NotI_Suv3-9_Fw	
SacII_Suv3-9_Rv	
	
ATTTATTGGCGGCCGCATGGCCA	
GGGGCCGCGGAAAGAGGACCTTT	
Ada2a_1_Fw	
Ada2a_1_Rv	
	
CTAATACGACTCACTATAGGGAGACCGCAATAACCACGC
TTAC	
CTAATACGACTCACTATAGGGAGACTCTCAGACGCCTCG
TTGT	
	
ADA2A_4RT_Fw	
ADA2A_4RT_RV	
	
ACAACGAGGCGTCTGAGAGT	
AATTTGGCTCCGGAAAGAGT	
	
ATM	qPCR	Fw	
ATM	qPCR	Rv	
	
ACCACAGCAATCCGGTGAAG	
CCCGGAAAAAGCATGCAGAG	
	
Su(var)3-9_mid_Fw	 AGCATGCAAATCAAGCGGGCCCAATTTGTACG	
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T7-H2AV-FW	
T7-H2AV-RV	
CTAATACGACTCACTATAGGGAGGAAGGGCAACGTCATTC
TGT	
CTAATACGACTCACTATAGGGAGGTGAGTGTTGGGGAGAT
GCT	
Actin	D	Fw	
Actin	D	Rv	
ATGTGTGACGAAGAAGTTGC	
AGGATCTTCATCAGGTAGTC	
SpeI_Suv39_Fw	
NOTI_SUV39_RV	
	
AAGGTACTAGTATGGCCACGGCTGAAGCCC	
AAAGCGGCCGCTAAAGAGGACCTTTCTGCAA	
	
T7-WDS-Fw	
T7-WDS-Rv	
TAATACGACTCACTATAGGGCAACTTGAGCGTATTATCCAG	
TAATACGACTCACTATAGGGATCAAAATCTGGGGAGCATA
C	
T7-Su(var)3-9-Fw	
T7-Su(var)3-9-Rv	
TAATACGACTCACTATAGGGCAACGGCGCCTAGCAC	
TAATACGACTCACTATAGGGAGAGCCAGGCGAAAGAGC	
	
	
4.10 Drosophila	stocks	used	for	studies:	
Gene	 Source	 Genotype	
CHRAC14	 13190	 y1	w67c23;	P{SUPor-	
P}mus201KG01051	
Chrac-14KG01051	
ATM	 8625(referred	as	ATM3-/-)	 w[*];	
P{ry[+t7.2]=neoFRT}82B	
tefu[atm-3]	e[1]/TM6B,	
Tb[1]	
ATM	 8626	 w[*];	
P{ry[+t7.2]=neoFRT}82B	
tefu[atm-6]	e[1]/TM6B,	
Tb[1]	
Oregon	R	 Erhardt	Lab	 +/+	
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5 Methods	
5.1 Freezing	and	Thawing	Drosophila	S2	cells	
5.1.1 Freezing	S2	cells	
Freshly	 transfected	 cells	 were	 allowed	 to	 grow	 in	 selection	media	 for	 4-6	
weeks,	later	were	frozen	in	aliquots	as	soon	as	possible	at	-80	°C	or	-196	°C.	
S2	cells	were	grown	in	150	cm2	flask.	S2	cells	were	centrifuged	for	5	minutes	
at	1500	rpm.	S2	cell	pallet	was	resuspended	in	to	45	%	serum	medium,	45	%	
conditioned	medium	(medium	in	which	same	cell	line	have	been	previously	
grown	for	a	week)	and	10%	DMSO.			DMSO	serves	as	cryo-protectant.	Cells	
were	stored	in	1ml	aliquots	in	2ml	NUNC	tubes	and	stored	overnight	into	Mr.	
Freezer	with	fresh	2-propanol	at	-80°C.	For	term	storage	frozen	cells	can	be	
later	transferred	from	-80°C	to	-196	°C	in	liquid	Nitrogen.		This	storage	of	cells	
is	required	for	regular	replacement	of	running	stock	of	S2	cells	after	every	60	
to	90	days.		
	
5.1.2 Thawing	S2	cells	
Frozen	 S2	 cells	 stocks	were	 thawed	when	 required.	 Thawing	was	 done	 by	
quickly	subjecting	the	frozen	S2	cells	to	water	bath	at	30°C	for	short	1	to	2	
minutes.	Cells	were	 immediately	transferred	to	25	cm2	flask	with	5ml	fresh	
Serum	medium.	Cells	were	allowed	to	settle	for	10	to	20	minutes	and	then	
medium	was	 replaced	with	 fresh	5	ml	 serum	medium	 to	get	 rid	 to	DMSO.	
Freshly	 thawed	 S2	 cells	 usually	 took	 2	 to	 4	 weeks	 to	 recover	 from	
freezing/thawing	 process	 and	 thereafter	 they	 were	 used	 for	 planned	
experiments.	
	
5.2 Preparation	of	double	stranded	RNA	
Gene	of	interest	was	amplified	using	genomic	cDNA	obtained	from	Oregon	R	flies	
as	PCR	template	and	amplification	was	analyzed	on	1%	agarose	gel.	Amplified	gene	
was	used	to	make	dsRNA	using	reverse	transcriptase	from	Ambion	MEGAscript	kit.	
Protocol	provided	by	manufacturer	was	followed.	Prepared	dsRNA	was	aliquoted	
and	frozen	at	-20°C.	
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5.3 RNA	interference	in	S2	cells	
RNA	 interference	was	used	 to	 knockdown	 the	expression	of	 gene	of	 interest	 by	
introducing	double	stranded	RNA	(dsRNA)	of	150	to	500bp.	For	this,	1.5-2.0	x	106	S2	
cells	were	plated	in	six-well	plate,	were	allowed	to	settle	and	grow	for	overnight	
with	 2ml	 serum	 medium.	 Next	 day	 cells	 were	 washed	 thrice	 with	 serum	 free	
medium	and	further	incubated	for	1	hour	with	20	µg	dsRNA	containing	1ml	serum	
free	medium	(dsRNA	specific	to	gene	of	 interest).	After	1hour	 incubation,	2ml	of	
15%	of	serum	medium	was	added	and	cells	were	incubated	for	next	4days.	After	
4days	cells	were	used	for	planned	experiment	and	further	analysis.		
	
5.4 RNA	isolation	and	RT	PCR	
RNA	 isolation	 was	 done	 to	 check	 the	 gene	 specific	 mRNA	 level	 via	 reverse	
transcriptase	PCR.	To	achieve	this,	5	x	106	S2	cells	were	harvested	and	centrifuged	
for	5minutes	at	1000rpm	at	4°C.	Pallet	obtained	was	 resuspended	 in	1ml	Trizol.	
Samples	were	incubated	at	room	temperature	for	5	minutes,	then	supplemented	
with	200µl	ChCl3/Phenol	and	incubated	for	5minutes	at	room	temperature.	Samples	
were	further	mixed	for	1minute,	then	incubated	for	5minutes	at	room	temperature	
and	centrifuged	for	10	minutes	at	4°C	with	12000rpm.	Carefully	aqueous	phase	was	
then	 taken	and	mixed	with	500	µl	 isopropanol.	 This	was	 followed	by	10minutes	
incubation	at	 room	temperature	which	allows	RNA	to	precipitate.	Samples	were	
centrifuged	at	12000rpm	for	10minutes	at	4°C.	Samples	were	then,	washed	with	
75%	ethanol	and	centrifuged	at	12000rpm	at	4°C	for	10minutes.	The	pallet	obtained	
was	then	allowed	to	dry	and	later	resuspended	in	30	µl	double	distilled	H2O.	Later	
the	 isolated	 RNA	 concentration	 was	 measured	 by	 determining	 optical	 density	
(Nanodrop	A260).	
		
5.5 Transfection	in	S2	cells	
Transfection	of	S2	cells	with	plasmids	containing	gene	of	interest	was	performed	to	
make	 stable	 cell	 lines.	 In	 none	of	 the	 cases,	 transient	 transfection	was	 used	 for	
experiments.	For	stable	transfection,	1.5	x	10	6	S2	cells	were	plated	 into	six	well	
plate	with	 2ml	 serum	medium	 for	 overnight.	 Prior	 to	 transfection	 two	 solutions	
were	prepared	1)	200µl	serum	free	medium	with	4µl	Celfectin	II	and	2)	200µl	serum	
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free	medium	with	5µg	of	DNA	to	be	transfected	(plasmid/s	with	gene	of	interest	+	
pCopia-Hygro).	Both	 the	solutions	were	mixed	and	 incubated	 for	30-45	minutes,	
thereafter	600µl	 serum	free	medium	was	added	to	make	upto	1ml	 (transfection	
solution).	 S2	 cells	 were	 thrice	 washed	with	 fresh	 serum	 free	medium	 and	 then	
incubated	for	4hours	with	transfection	solution	(DNA,	Celfectin	II	and	serum	free	
medium	mixture).	After	which,	1ml	of	20%	serum	medium	was	added	to	the	cells	
and	incubated	for	overnight.	Next	day,	1ml	of	10%	serum	medium	was	added	and	
cells	were	grown	for	next	3	to	4dyas.	Following	which	250µg/ml	Hygromycin-B	was	
added	and	cells	were	grown	in	the	same	plate	for	next	3-6	weeks	depending	upon	
their	 recovery	 rate	 and	 are	 continuously	 checked	under	white	 field	microscope.	
Media	was	replaced	every	week	and	cells	were	throughout	grown	in	Hygromycin-B	
containing	medium.	Expression	of	transfected	gene/s	was	tested	by	western	blot	
and	further	cells	were	frozen	to	keep	stock	and	running	cells	were	passaged	1-2	
times	every	week.	
	
5.6 Immunofluorescence	using	S2	cells	and	Larvae	tissues	
S2	cells	were	platted	on	positively	charged	glass	slides	and	allowed	to	settle	for	10-
15	minutes.	Cells	were	then	fixed	by	subjecting	to	4%	PFA/PBS	for	10minutes.	Fixed	
cells	were	washed	3	times	with	PBS,	each	wash	was	done	by	10minutes	incubation	
at	 room	temperature.	Then	cells	were	permeablized	by	treating	them	with	0.1%	
Triton	for	10-15minutes,	 thereafter	cells	were	blocked	using	5%BSA-0.1%	Triton-
PBS	for	30	minutes	to	get	rid	of	unspecific	binding.	This	was	followed	by	overnight	
incubation	with	primary	antibody	solution	(Primary	Antibody-0.1%Triton-5%BSA	in	
PBS)	in	moist	chamber	at	4°C.	Primary	incubation	was	followed	by	3	times	washes	
with	PBS,	then	cells	were	incubated	with	secondary	antibody	solution	(Secondary	
Antibody-0.1%Triton-5%BSA	in	PBS)	for	1hour	in	dark.	Cells	were	again	washed	3	
times	with	 PBS	which	was	 then	 followed	 by	 10minutes	 incubation	with	DAPI	 (1	
µg/µl)	 in	PBS,	washed	once	with	PBS.	Further	cells	on	slides	were	mounted	with	
mounting	medium	(Aqua/polymount),	covered	with	cover	slip	(1.5),	allowed	to	dry	
completely	 and	 further	 stored	 at	 4°C	 in	dark	moist	 chamber.	 Cells	were	 imaged	
using	Delta	Vision(R)	core	system.	
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5.7 Metaphase	spreads	
Mitotic	 spreads	were	used	 to	 analyze	 localization	of	proteins	 at	 chromosome	 in	
metaphase.	2x105	S2	cells	were	plated	 in	six	well	plate	and	grown	for	overnight.	
Next	day,	cells	were	arrested	in	metaphase	via	3.3	µg/	µl	Colcemid	(1:3	dilution)	for	
30-90	minutes.	Cells	were	 then	centrifuged	 for	5-10minutes	at	2000	rpm	at	4°C.	
Subsequently	 cells	 were	 resuspended	 in	 1ml	 hypotonic	 sodium	 citrate	 solution	
(0.5%	Na3C6H5O7	in	ddH2O)	and	 incubated	 for	7.5	minutes	at	 room	temperature,	
this	makes	them	cells	swelled.	500	µl	of	swelled	cells	were	subjected	to	cytospin	
with	900	rpm,	high	acceleration	for	10	minutes	on	positively	charged	slides.	This	
was	 followed	 by	 fixing	 by	 4%	 PFA/PBS	 for	 10	minutes	 and	 then	 subjected	 to	 IF	
according	to	section	5.6.	
		
5.8 Microscope	and	Imaging	
Images	were	taken	by	Delta	Vision	(R)	Core	system	(Applied	Precision)	microscope.	
Olympus	UPlanSApo	 100x	 and	 60x	 objective	 (n.a.	 1.4),	 2x2	 binning	was	 used	 to	
acquire	images	(for	IF	and	metaphase	spreads).	For	live	cell	imaging,	60x	objective	
was	used.	Images	were	taken	as	z-stacks,	each	z-stack	ranging	between	0.2-0.4µm	
thickness.	If	not	mentioned	specifically,	all	the	images	were	deconvolved,	maximum	
projected	 and	 threshold	 using	 the	 Applied	 Precisions	 soft	 WoRx	 3.7.1	 suite.	
Deconvolution	was	done	using	enhanced	aggressive	or	 conserved,	10	cycles	and	
high	noise	filtering.	Further	the	images	were	processes	either	by	Applied	Precisions	
softWoRx	3.7.1	suite	or	by	ImageJ	software.		
	
5.9 Quantitative	and	Qualitative	Analysis	using	ImageJ	
Images	taken	by	microscope	were	later	analyzed	by	Image	J	software.	Deconvoled	
and	quick	projected	images	(Images	with	“.dv.prj”	extension)	were	opened	in	Image	
J	software.	If	not	mentioned,	then	all	the	cases	only	DAPI	stained	regions	were	taken	
into	 consideration	 for	 any	 kind	of	 quantification.	 These	 regions	were	marked	as	
region	 of	 interest	 (ROI)	 via	 ImageJ	 and	 further	 used	 as	 reference	 area	 for	 the	
channel	of	interest.	The	mean	intensities	of	the	signals	in	the	selected	regions	were	
then	calculated	by	adjusting	the	threshold	of	the	intensities	by	default	setting	and	
by	analyzing	the	mean	intensities	relative	to	the	saved	ROIs	areas.	
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Foci/spot	detection	plugin	was	used	for	determining	the	number	and	the	intensities	
of	 CENP-A,	 CENP-C	 and	 other	 centromeric/kinetochore	 proteins	 signals	 in	 DPAI	
regions	 marked	 as	 ROI.	 Spots	 in	 the	 ROI	 were	 enhanced	 using	 the	 DoG	 spot	
enhancer	 plugin.	 Thereafter	 threshold	 was	 adjusted	 using	 “Li”.	 The	 numbers	
obtained	 by	 this	 approach	 were	 saved	 on	 Excel	 sheet	 and	 then	 the	 average	 of	
spots/nucleus	(spot/DAPI)	was	taken	into	account	for	compiling	average	of	three	or	
more	biological	 repeats.	The	 final	graph	presented	 in	 results	and	appendix	were	
plotted	in	Microsoft	Excel.	The	statistical	significance	of	the	results	was	analyzed	
with	the	student	T-test.		
	
5.10 Sample	preparation	for	western	blot	from	S2	cells	and	adult	flies	
To	analyze	the	protein	levels	in	S2	cells	from	whole	cell	extract,	106-	107	cells	were	
washed	2-3	times	with	PBS	and	resuspended	in	in	RIPA	buffer	for	5-10minutes	for	
lysis.	Cells	were	later	sonicated	in	Bioruptor	(3-5	cycles	with	30	sec	sonication/30	
sec	break	at	level	5).	Further,	the	lysed	cells	were	mixed	with	4x	SDS	laemmli	loading	
buffer	and	boiled	at	95°C	 for	5	minutes.	 Samples	were	either	 stored	 in	 -20°C	or	
directly	 loading	 on	 10-15%	 SDS	 PAGE	 gel	 for	 further	 analysis	 of	 proteins	 as	 per	
requirement	of	experiments.	
To	prepare	sample	from	adult	flies,	flies	were	homogenized	and	lysed	in	40	µl	RIPA	
buffer	 using	 piston.	 Thereafter	 the	 lysate	 was	 subjected	 to	 sonication	 using	
Bioruptor	(15	cycle,	30	sec	sonication/30sec	off	at	level	5).	Lysate	was	later	treated	
with	Benzonase	(125U).	Thereafter	mixed	with	4x	SDS	laemmli	buffer	and	boiled	at	
95°C	for	10	minutes.	Later	samples	were	either	stored	at	-20°C	or	directly	loaded	
on	10-15%	gel	for	protein	analysis.		
	
5.11 SDS	PAGE	and	Western	Blot	
Protein	 levels	 were	 analyzed	 using	 western	 blot	 techniques	 and	 this	 requires	
Sodium	dodecyl-sulfate	(SDS)	poly-acrylamide	gel	electrophoresis	(PAGE).	Samples	
were	loaded	on	8-15%	SDS	poly-acrylamide	gel	with	Biorad	Tetracell	system	and	run	
at	 constant	 100Volt	 for	 1-1.5hours.	 Resolved	 proteins	were	 then	 transferred	 to	
nitrocellulose	membrane	with	0.45µm	thickness	using	transfer	buffer	(Tris-glycine-
methanol)	at	constant	100Volt	for	1-1.5hours	at	4°C	via	Biorad	wet-transfer	system.	
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Transfer	involved	gel	and	nitrocellulose	membrane	sandwiched	between	Whatman	
paper	 (cathode,	 Whatman	 paper,	 gel,	 membrane,	 Whatman	 paper,	 anode).	 To	
check	successful	transfer,	membrane	was	incubated	with	Ponceau	for	10	minutes	
at	 room	 temperature.	 The	 membrane	 with	 successful	 protein	 transferred	 was	
washed	2-3	times	with	PBST	(0.1%	Tween-20	in	PBS)	and	thereafter	incubated	with	
5%	skimmed	dry	milk	 in	PBST	to	get	 rid	of	unspecific	antibody	binding.	This	was	
followed	 by	 overnight	 incubation	 with	 primary	 antibody	 at	 4°C.	 Next	 day,	
membrane	was	washed	3	times	with	PBST,	each	wash	10	minutes	to	remove	the	
residual	primary	antibody.	Membrane	was	then	incubated	with	secondary	antibody	
for	1hour	at	room	temperature	with	5%	skimmed	dry	milk	in	PBST.	Later,	secondary	
antibody	 was	 coupled	 with	 horseradish	 peroxidase	 (HRP).	 Membrane	 was	 later	
incubated	with	chemi-luminescence	(HRP-ECL)	solution	for	1	to	3	minutes	at	room	
temperature.	Membrane	was	exposed	to	Fuji	X-ray	medical	film	in	dark	and	signals	
were	detected	by	developed	with	Konica	Minolta	film	developing	machine.	
	
5.12 Co-Immunoprecipitation	
Co-immunoprecipitation	was	performed	to	see	potential	interaction	between	two	
or	more	proteins,	atleast	one	of	which	was	fused	with	V5	tag.	V5	tag	was	used	at	
bait	to	pulldown.	This	was	achieved	by	cross-linking	of	V5-antibody	to	Agarose	G	
beads	from	Roche.		For	this,	Agarose	G	beads	were	washed	2-3	times	with	PBS.	After	
washing,	 beads	were	mixed	with	V5	 antibody	 (2µg/20µl	 of	 dry	 bead	 volume)	 in	
250µl	PBS	and	incubated	at	room	temperature	on	rotating	platform	for	30	minutes.	
Beads	were	 then	washed	 twice	with	 0.2M	 sodium	 tetraborate	 pH	 9.	 Afterward,	
bound	antibody	and	beads	were	cross-linked	by	 incubating	with	5.2mg	Dimethyl	
pimelimidate	(DMP	Sigma)	mixed	in	0.2M	sodium	tetraborate	pH	9	PBS	solution	for	
30	minutes	at	room	temperature.	This	step	was	repeated.	Cross-linked	beads	were	
centrifuged	at	1000rpm	4°C,	resuspended	in	0.1M	Glycine	pH	7.0	and	incubated	for	
30	minutes	at	room	temperature,	this	quenches	the	reaction.	Unbound	antibody	
were	removed	my	washing	beads	with	0.1M	glycine	pH2.5.	Afterwards,	either	the	
antibody	bound	beads	were	stored	in	PBS	supplemented	with	0.02%	sodium	azide	
to	prevent	bacterial	growth	or	directly	used	to	for	immunoprecipitation.	
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(Co)-Immunoprecipitation	of	V5-tagged	proteins	
For	 immunoprecipitation,	 S2	 cells	 with	 pMT-protein-V5-His	 containing	 construct	
were	induced	with	1mM	CuSo4	for	overnight.	1.5-2.0	x	108	S2	cells	expressing	V5-
tagged	proteins	were	washed	with	cold	PBS	and	then	lysed	with	Co-IP	buffer	(See	
section	 5.3	 Buffer/Solution,	 serial	 no.	 21).	 Lysis	 buffer	 was	 supplemented	 with	
proteasome	inhibitors.	Cells	were	incubated	with	lysis	buffer	for	20	minutes	at	4°C.	
Cells	were	 then	 centrifuged	 for	30	minutes	 at	 13000rpm.	 Supernatant	was	 then	
transferred	to	precooled	tube	containing	20	µl	of	beads	coupled	with	V5	antibody.	
Supernatant+beads	were	incubated	at	4°C	for	3-5hours	on	rotating	platform.	Beads	
were	 then	 collected	 by	 centrifugation,	 1000rpm	 at	 4°C.	 Thereafter	 beads	 were	
washed	6	 times	 in	1o	bed	volume	of	 lysis	buffer.	 Proteins	were	eluted	 in	2	bed	
volume	and	then	mixed	with	2x	SDS	laemmili	buffer.	Followed	by	5	minutes	boiling	
at	95°C	and	separated	by	SDS-PAGE	analyzed	by	western	blot.	
	
5.13 Denaturing	Immunoprecipitation	
Denaturing	 immunoprecipitation	 was	 performed	 to	 get	 rid	 of	 potential	 indirect	
interaction	between	the	proteins.	1.5	x	108	S2	cells	were	supplemented	with	20mM	
NEM	and	centrifuged	at	3000rpm	for	5minutes	and	the	supernatant	was	discarded.	
Cells	were	washed	with	cold	PBS	and	pallet	was	resuspended	in	100µl	1x	lysis	buffer	
(denaturing,	with	1%	SDS).	Lysate	was	sonicated	using	Bioruptor	(10	cycles,	30sec	
sonication/30sec	off	at	level	5).	Further	the	lysates	were	supplemented	with	50mM	
DTT.	Samples	were	boiled	at	97°C	for	10minutes.	Lysates	were	then	diluted	with	
cold	 RIPA	 buffer	 (1:10)	 and	 supplemented	with	 10mM	NEM.	 Lysates	were	 then	
centrifuged	 at	 13000rpm	 at	 4°C	 for	 30minutes	 and	 later	 the	 supernatant	 were	
subjected	to	beads	coupled	with	antibody	as	mentioned	in	section	5.12.	
	
5.14 Nuclear	Fractionation	
For	analysis	of	protein	levels	in	nuclear	and	cytoplasmic	compartment,	S2	cells	were	
subjected	 to	 nuclear	 fractionation.	 106	 -107	 S2	 cells	 were	 harvested	 and	
resuspended	in	RIPA	lysis	buffer	with	protease	inhibitors	for	10minutes	on	ice.	Cells	
were	then	centrifuged	at	13000rpm	for	30	minutes	at	4°C.	Supernatant	was	kept	as	
soluble	 fraction.	 Pallet	 was	 resuspended	 into	 same	 volume	 of	 lysis	 buffer+	
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Benzonase,	later	sonicated	via	Bioruptor	(5	cycles,	30	sec	sonication/	30	sec	off	at	
level	5)	and	mixed	with	4x	SDS	laemmli	buffer.	Samples	were	either	stored	in	-20°C	
or	directly	loaded	on	10-15%	SDS.	
	
5.15 Acid	histone	extraction	from	S2	cells.	
4	x	106	S2	cells	were	subjected	to	lysis	using	Triton	Extraction	Buffer	(TEB)	(see	5.3	
serial	no.	14)	for	10	minutes	at	4°C	with	gentle	stirring.	Cells	were	then	centrifuged	
at	2000	rpm	for	10	minutes	at	4°C.	After	removal	of	supernatant,	cells	pallet	was	
washed	once	with	TEB	and	centrifuged	at	2000rpm	at	4°C.	Pallet	was	resuspended	
in	0.2N	HCl	at	the	density	of	4	x	107	cells/ml	and	incubated	at	4°C	for	overnight.	Next	
day	 cells	 were	 subjected	 to	 centrifuged	 at	 6600g	 for	 10	 minutes.	 Obtained	
supernatant	was	then	mixed	with	2x	SDS	laemmli	buffer	and	boiled	at	95°C	for	5	
minutes	and	then	either	stored	at	-20°C	or	directly	analyzed	via	western	blot	using	
15%	SDS	PAGE	gel.	
	
5.16 Molecular	cloning		
All	the	standard	techniques	were	essentially	performed	as	described	in	Molecular	
cloning:	A	Laboratory	Manual	by	Sambrook	and	Russell.		
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6 Appendix	
6.1 Tethering	of	Su(var)3-9	leads	to	CENP-A	deposition	
HP1	 can	 interact	 with	 H3K9me	 and	 Su(var)3-9	 (Schotta	 et	 al.	 2002).	 Further,	
tethering	of	HP1	results	 in	recruitment	of	CENP-A	as	seen	via	Lac-o/Lac-I	system	
developed	for	S2	cells	(Olszak	et	al.	2011).	In	order	to	probe	whether	Lac-I-Su(var)3-
9-GFP	tethering	 is	 involved	 in	CENP-A	recruitment	at	the	site	of	Lac-O	 in	S2	cells	
(Lac-O	 cells	 courtesy	 of	 Patrick	 Heuns’s	 Lab),	 Lac-O/pMT-Lac-I-Su(var)3-9-GFP	
containing	S2	 cells	were	examined	 for	CENP-A	 foci	 at	GFP	 sites.	 The	preliminary	
experiments	suggest	the	presence	of	CENP-A	spots	in	the	vicinity	of	GFP	(Figure	6.1).	
In	contrary,	the	tethering	of	Lac-I-GFP	did	not	show	recruitment	of	CENP-A	(Figure	
6.1),	indicating	either	that	Su(var)3-9	tethering	can	facilitate	CENP-A	recruitment	at	
the	ectopic	site	or	overexpression	of	Su(var)3-9	can	lead	to	CENP-A	deposition	at	
Lac-O	site.	It	is	important	to	note	that	these	are	preliminary	experiments	and	need	
to	be	repeated	for	a	quantitative	analysis.	
	
	
	
	
Figure	6.1:	Lac-I-Su(var)3-9-GFP	expression	causes	CENP-A	deposition	at	GFP	sites.	Lac-O	containing	S2	cells	
were	transfected	with	a	control	plasmid	(pMT-Lac-I-empty-GFP)	and	pMT-Lac-I-Su(var)3-9-GFP.	The	cells	were	
subjected	to	IF	using	GFP	(green)	and	CENP-A	(red)	antibody	and	nuclei	were	co-stained	with	DAPI	(blue).	Cells	
with	GFP	foci	were	imaged.	Upper	two	lanes	of	control	and	Lac-I-Su(var)3-9-GFP	expressing	cells	represent	quick	
projection	of	all	the	z-stacks.	Lower	panel	represents	single	z-stack.	Bar=2µm.	
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6.2 Depletion	of	ADA2A	leads	to	increase	in	CENP-A	foci	and	H3K9me2	
Depletion	of	CHRAC16,	which	is	another	subunit	of	CHRAC	complex,	does	not	affect	
the	CENP-A	localization	(unpublished	data	from	Dr.	Veena	Mathew’s	work	in	our	
lab).	 I	 further	examined	whether	ATAC	complex	 specific	 subunit	depletion	 could	
lead	to	a	similar	phenotype	as	CHRAC14	knockdown.	For	this	purpose,	I	used	ADA2A	
since	it	is	only	found	in	the	ATAC	complex.	Knockdown	of	ADA2A	in	S2	cells	showed	
increase	in	H3K9me2	(in	accordance	with	Ciurciu	et	al.	2008)	as	seen	in	CHRAC14	
depleted	cells	and	also	 increased	CENP-A	foci	as	seen	via	 IF	 (Figure	6.2	and	6.3),	
indicating	 the	 significance	 of	 the	ATAC	 complex	 in	maintaining	 heterochromatin	
structure	and	CENP-A	localization.		
	
	 74	
	
Figure	6.2:	Depletion	of	ADA2A	affects	the	H3K9me2	and	CENP-A	spots.	CHRAC14,	ADA2A	and	WDS	RNAi	
treated	S2	cells	were	subjected	to	IF	using	H3K9me2	(green)	and	CENP-A	(red)	antibody	and	nuclei	were	
co-stained	with	DAPI.	CHRAC14	RNAi	(represented	as	CHRAC14	kd),	ADA2A	RNAi	(represented	as	ADA2A	
kd),	WDS	RNAi	(represented	as	WDS	kd).		Bar=5µm	
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Figure	6.3:	Lack	of	ATAC	complex	subunits	increases	the	CENP-A	foci	number	in	S2	cells.	Quantification	
of	average	CENP-A	foci	number	 count	from	the	experiment	shown	in	Figure	6.2.	Total	50	 cells/repeat	
were	counted;	bar	represent	average	from	3	biological	replicates.	Error	bars	represent	±SEM	and	a	p-
value	>0.05,	ns=non-significant.	
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6.3 Effect	of	TSA	on	CENP-A	localization	in	CENP-A	overexpressing	S2	cells	
		
Overexpression	of	CENP-A	leads	to	CENP-A	ectopic	loading	and	when	analyzed	by	
IF	it	is	known	that	CENP-A	localized	throughout	the	chromatin	or	nucleus	reflecting	
ectopic	 loading	 throughout	 the	 chromatin	 (Pauleau	&	 Erhardt	 2011;	Heun	et	 al.	
2006).	 The	 HDAC	 inhibitor	 TSA	 is	 known	 to	 create	 hyperacetylated	 chromatin	
environment	in	Drosophila	and	mammalian	cells	(Foglietti	et	al.	2006;	Taddei	et	al.	
2001)	Considering	this	I	studied	whether	TSA	would	affect	the	CENP-A	localization	
in	CENP-A	overexpressing	cells.		
	
Cells	 with	 pMT-CENP-A-V5-His	 construct	 were	 incubated	 with	 1mM	 CuSO4	
overnight	for	overexpression	of	CENP-A.	Additionally,	cells	were	treated	with	0.5	
µM	 TSA	 overnight.	 These	 cells	were	 subjected	 to	 IF	 and	 later	 analyzed	 under	 a	
microscope.	As	expected,	S2	cells	with	no	CENP-A	overexpression	only	showed	a	
CENP-A	signal	at	chromocenter	(near	bright	DAPI	region)	(Figure	6.4	A).	In	contrast,	
CENP-A	overexpressing	 cells	 showed	 a	 CENP-A	 signal	 throughout	 the	 nucleus	 or	
Figure	6.4:	TSA	affects	the	CENP-A	nuclear	localization	in	CENP-A	overexpressing	cells	.	A)	S2	cells	without	
CENP-A	 overexpression	 (WT)	 and	 with	 CENP-A	 overexpression	 (CENP-A	 oe)	 were	 subjected	 to	 IF.	
Additionally,	CENP-Aoe	cells	treated	with	0.5	µM	TSA	were	subjected	to	IF.	B)	TSA	treatment	reduces	the	
level	of	nuclear	CENP-A	in	CENP-A	overexpressing	cells.	Nuclear	fractionation	on	S2	cells	without	expression	
of	CENP-A-V5-His	(WT)	and	with	CENP-A-V5-His	overexpression	was	performed.	Additionally,	the	effect	of	
0.5	µM	TSA	treatment	was	analyzed.	S2	cells	after	nuclear	fractionation	were	analyzed	via	western	blot	using	
V5	antibody	for	detection	of	CENP-A-V5-His	and	Histone	H3	antibody	(loading	control).	Size	bar=	10	µm	
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DAPI	 stained	 region	 suggesting	 ectopic	 CENP-A	 localization	 (Figure	 6.4	 A).	
Furthermore,	careful	observation	of	TSA	treatment	of	CENP-A	overexpressing	cells	
shows	less	CENP-A	in	DAPI	region	(Figure	6.4	A).	This	suggested	that	TSA	treatment	
affects	 the	 localization	 of	 CENP-A.	 In	 other	 words,	 hyperacetylation	 is	 not	
favourable	for	CENP-A	localization	throughout	the	nucleus.		
	
In	order	to	further	validate	the	above	observations,	CENP-A-V5-His	overexpressing	
S2	 cells	with	 and	without	 TSA	were	 subjected	 to	nuclear	 fractionation	 and	 later	
analyzed	by	 immune	blotting	using	V5	 antibody.	 Control	with	no	CENP-A-V5-His	
expression	did	not	show	any	band,	while	cells	induced	with	CuSO4	show	a	high	level	
of	CENP-A-V5-His.	Interestingly,	the	addition	of	TSA	to	these	cells	reduces	the	CENP-
A-V5-His	 level	 in	observed	nucleus	 (Figure	6.4	B).	Further	stressing	 the	 idea	 that	
inhibition	of	HDAC/	hyperacetylation	reduces	the	CENP-A	nuclear	localization.	
	
6.4 Identifying	 interacting	partner	of	CENP-A	with	and	without	DNA	damage	upon	
CENP-A	overexpression	
Ectopic	loading	of	CENP-A	can	also	be	seen	by	CENP-A	overexpression.	DNA	damage	
can	enhance	CENP-A	ectopic	localization	to	DNA	damage	sites	(Mathew	et	al.	2014).	
To	get	the	better	understanding	of	the	situation,	I	checked	all	the	direct	and	indirect	
CENP-A	interacting	protein	partners.	This	was	achieved	by	immunoprecipitation	of	
CENP-A	using	CENP-A	overexpressing	cells,	with	and	without	MMS	 induced	DNA	
damage	 (0.4%	MMS).	 The	 samples	were	 analyzed	using	Mass	 Spectrometry	 and	
Proteomics	 at	 ZMBH	 core	 facilities.	 This	 provided	 several	 potential	 protein	
candidates	 that	 interact	 directly/indirectly	 with	 CENP-A/kinetochore	 in	 the	
mentioned	condition	of	cells.		Moreover,	many	interacting	proteins	also	showed	a	
change	in	protein	level	as	detected	by	peptide	hits.	A	list	of	the	interacting	proteins	
that	resulted	from	mass	spectrometry	are	in	section	6.7	(for	the	complete	list	see	
Appendix	 6.7).	 However,	 it	 should	 be	 noted	 that	 few	 of	 the	 known	 CENP-A	
interacting	partners	 could	not	be	detected,	 for	example,	CAL1,	possibly	because	
their	interaction	is	transient	or	because	its	occurring	in	specific	cell	cycle	phase/s.	
Nevertheless,	many	interesting	interacting	proteins	were	detected	in	two	biological	
repeats	and	three	independent	mass	spectrometry	analysis	are	listed	in	table	1.3.	
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Few	interesting	
potential	
interacting	
proteins	
Function/s	 Control	
Protein	
coverage	
%(peptide	
count)	
0.4%	MMS.	
Protein	
coverage%(
peptide	
count)	
Chromatin	
assembly	factor	1	
(p55)	
Chromatin	assembly,	repression	of		
genes	(Anderson	et	al.	2011;	
Loyola	et	al.	2009)	
6%(13)	 6%(15)	
Suppressor	of	
variegation	3-7	
Positive	regulator	of	
heterochromatin	and	gene	
silencing	(Cléard	&	Spierer	2001)	
6%(3)	 6%(2)	
Topoisomerase-2	 Accession	of	DNA	for	transcription	
and	replication	machinery.	
Chromosome	condensation	(Soret	
et	al.	2003).	
3%(4)	 2.3%(2)	
Minichromosome	
maintenance	
complex	
component	5	
DNA	replication	initiation	and	
elongation	(Forsburg	2004).	
4.6%(3)	 2.2%(1)	
Histone-lysine	N-
methyltransferase	
trithorax	
	
Methylates	H3K4	and	tags	for	
transcription	activation	(Wang	&	
Zhu	2008).	
1.5%(3)	 3.4%(5)	
Ataxia	
telangiectasia	
mutated	
Serine/threonine-protein	kinase	
(Shiloh	&	Ziv	2013).	
1.8%(4)	 3.3%(4)	
Zeste	White	10	 Kinetochore	protein,	essential	for	
mitotic	checkpoint	(Karess	2005).	
4.6%(1)	 7.6%(3)	
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6.5 Effect	of	ATM	depletion	on	CENP-A	
Results	from	mass	spectrometry	revealed	ATM	as	one	of	the	potential	interacting	
partners	of	CENP-A.	Following	the	mass	spectrometry	results,	 I	checked	whether	
ATM	 depletion	 has	 any	 effect	 on	 CENP-A.	 Knockdown	 of	 ATM	 in	 S2	 cells	 upon	
addition	of	MMS	shows	increased	CENP-A	levels	as	seen	via	western	blot	(Figure	
6.5).	However,	caffeine	treatment	of	S2	cells	shows	increased	CENP-A	level	without	
any	DNA	damaging	agent.	This	was	further	checked	in	ATM	mutant	Drosophila	flies,	
the	 results	of	which	 suggests	an	 increase	 in	 the	 level	of	CENP-A	 in	ATM	mutant	
Drosophila	fly.	
Table	 1.3:	 Interesting	 CENP-A	 interacting	 proteins	 obtained	 in	 mass	 spectrometry	 analysis.	 The	 table	
represents	selected	interacting	proteins	detected	in	mass	spectrometry	approach.	CAF1(p55),	Top-2	and	ZW10	
have	been	reported	previously	by	other	members	in	the	lab.	Su(var)3-7,	ATM,	MCM5	and	TXR	were	few	of	the	
potentially	 interesting	 interacting	 proteins.	 The	 candidates	 presented	 in	 table	 are	 found	 in	 two	 or	more	
independent	mass	 spectrometry	analysis	 from	 two	biological	 repeats.	 Protein	peptide	 counts	and	protein	
coverage	numbers	are	presented	from	one	analysis,	however	were	detected	in	two	or	more	independent	mass	
spectrometry	analyses	from	two	biological	replicates.		
Figure	6.5:	Absence	of	ATM	elevates	the	level	of	CENP-A.	A)	S2	cells	after	4	days	treatment	with	ATM	RNAi	
were	 treated	 with	 0.4%	MMS	 for	 1	 hour	 and	 then	 analyzed	 by	 western	 blot	 using	 anti-Tubulin	 (loading	
control)	and	CENP-A.	ATM	depletion	increases	CENP-A	level	upon	MMS	treatment.	B)	S2	cells	were	treated	
with	Caffeine	and	 later	analyzed	via	western	blot	using	Tubulin	(loading	 control)	and	CENP-A	antibody.	C)	
Whole	adult	fly	lysate	from	Oregon-R	and	ATM-/-	were	subjected	to	western	blot	and	analyzed	using	Tubulin	
and	CENP-A	antibody.	ATM-/-	flies	show	increase	in	CENP-A	level.	
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6.6 List	 of	 CENP-A	 interacting	 proteins	 detected	 by	 mass	 spectrometry	 in	
presence/absence	of	DNA	damage	
To	 identify	CENP-A	 interacting	proteins	with	 and	without	 genotoxic	 stress	 (0.4%	
MMS	 1	 hour	 treatment),	 CENP-A-V5-His	 overexpressing	 cells	 were	 subjected	 to	
Immunoprecipitation	with	a	V5	antibody	and	samples	were	then	further	analysed	
by	Mass	Spectrometry	and	Proteomics	ZMBH	core	facilities.	Below	is	the	list	of	few	
interesting	proteins	(82	out	of	357)	sorted	by	unique	peptide	counts,	found	in	one	
of	 the	mass	 spectrometry	 analysis.	 Proteins	 presented	 in	 the	 list	 are	 related	 to	
transcription,	replication,	phosphorylation,	acetylation,	chromatin	remodelling	and	
DNA	damage	repair	and	could	be	potential	player/s	in	regulation	and	maintenance	
of	CENP-A	in	Drosophila	cells.		
Identified	Proteins	(82)	 Accession	
Number	
Molecular	
Weight	
Peptide	
count	
No	
MMS	
Peptide	
count	
0.4%	
MMS	
14-3-3	protein	epsilon	OS=Drosophila	
melanogaster	GN=14-3-3epsilon	PE=1	
SV=2	
1433E_DRO
ME	
30	kDa	 3	 2	
14-3-3	protein	zeta	OS=Drosophila	
melanogaster	GN=14-3-3zeta	PE=1	
SV=1	
1433Z_DRO
ME	
28	kDa	 3	 2	
Serine/threonine-protein	phosphatase	
PP2A	65	kDa	regulatory	subunit	
OS=Drosophila	melanogaster	
2AAA_DRO
ME	
65	kDa	 3	 4	
Protein	argonaute-2	OS=Drosophila	
melanogaster	GN=AGO2	PE=1	SV=3	
AGO2_DRO
ME	
137	kDa	 53	 55	
Serine/threonine-protein	kinase	ATM	
OS=Drosophila	melanogaster	GN=tefu	
PE=2	SV=1	
ATM_DRO
ME	
318	kDa	 2	 1	
Serine/threonine-protein	kinase	ATR	
OS=Drosophila	melanogaster	GN=mei-
41	PE=1	SV=2	
ATR_DROM
E	
289	kDa	 0	 2	
Ataxin-2	homolog	OS=Drosophila	
melanogaster	GN=Atx2	PE=1	SV=1	
ATX2_DRO
ME	
118	kDa	 7	 4	
Probable	histone-binding	protein	Caf1	
OS=Drosophila	melanogaster	GN=Caf1	
PE=1	SV=1	
CAF1_DRO
ME	
49	kDa	 13	 15	
Chromodomain-helicase-DNA-binding	
protein	Mi-2	homolog	OS=Drosophila	
melanogaster	GN=Mi-2	PE=1	SV=2	
CHDM_DRO
ME	
224	kDa	 2	 2	
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Histone	H3-like	centromeric	protein	cid	
OS=Drosophila	melanogaster	GN=cid	
PE=1	SV=2	
CID_DROM
E	
26	kDa	 3	 2	
ATP-dependent	RNA	helicase	p62	
OS=Drosophila	melanogaster	GN=Rm62	
PE=1	SV=3	
DDX17_DR
OME	
79	kDa	 11	 12	
ATP-dependent	RNA	helicase	bel	
OS=Drosophila	melanogaster	GN=bel	
PE=1	SV=1	
DDX3_DRO
ME	
85	kDa	 35	 28	
Elongation	factor	1-alpha	1	
OS=Drosophila	melanogaster	
GN=Ef1alpha48D	PE=1	SV=2	
EF1A1_DRO
ME	
50	kDa	 20	 19	
Probable	elongation	factor	1-beta	
OS=Drosophila	melanogaster	
GN=Ef1beta	PE=1	SV=3	
EF1B_DRO
ME	
24	kDa	 2	 0	
Probable	elongation	factor	1-delta	
OS=Drosophila	melanogaster	
GN=eEF1delta	PE=1	SV=1	
EF1D_DRO
ME	
29	kDa	 1	 2	
Elongation	factor	1-gamma	
OS=Drosophila	melanogaster	
GN=Ef1gamma	PE=2	SV=2	
EF1G_DRO
ME	
49	kDa	 5	 6	
Elongation	factor	2	OS=Drosophila	
melanogaster	GN=Ef2b	PE=1	SV=4	
EF2_DROM
E	
94	kDa	 21	 23	
Eukaryotic	translation	initiation	factor	3	
subunit	D-1	OS=Drosophila	virilis	
GN=eIF-3p66	PE=3	SV=1	
EI3D1_DRO
VI	
64	kDa	 4	 0	
Eukaryotic	translation	initiation	factor	3	
subunit	A	OS=Drosophila	melanogaster	
GN=eIF3-S10	PE=1	SV=1	
EIF3A_DRO
ME	
134	kDa	 6	 11	
Eukaryotic	translation	initiation	factor	3	
subunit	B	OS=Drosophila	virilis	
GN=eIF3-S9	PE=3	SV=1	
EIF3B_DRO
VI	
80	kDa	 2	 1	
Eukaryotic	translation	initiation	factor	3	
subunit	C	OS=Drosophila	erecta	
GN=eIF3-S8	PE=3	SV=1	
EIF3C_DRO
ER	
106	kDa	 9	 4	
Eukaryotic	translation	initiation	factor	3	
subunit	L	OS=Drosophila	mojavensis	
GN=GI12903	PE=3	SV=1	
EIF3L_DRO
MO	
63	kDa	 2	 1	
Putative	elongator	complex	protein	1	
OS=Drosophila	melanogaster	GN=Elp1	
PE=1	SV=2	
ELP1_DRO
ME	
143	kDa	 1	 2	
Probable	ubiquitin	carboxyl-terminal	
hydrolase	FAF	OS=Drosophila	
melanogaster	GN=faf	PE=1	SV=2	
FAF_DROM
E	
311	kDa	 2	 1	
Cadherin-related	tumor	suppressor	
OS=Drosophila	melanogaster	GN=ft	
PE=1	SV=3	
FAT_DROM
E	
565	kDa	 2	 1	
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WD	repeat-containing	and	planar	cell	
polarity	effector	protein	fritz	
OS=Drosophila	melanogaster	GN=frtz	
PE=2	SV=1	
FRITZ_DRO
ME	
106	kDa	 2	 0	
Zinc	finger	protein	hangover	
OS=Drosophila	melanogaster	GN=hang	
PE=1	SV=3	
HANG_DRO
ME	
210	kDa	 2	 1	
E3	ubiquitin-protein	ligase	highwire	
OS=Drosophila	melanogaster	GN=hiw	
PE=1	SV=2	
HIW_DROM
E	
566	kDa	 3	 3	
Protein	hu-li	tai	shao	OS=Drosophila	
melanogaster	GN=hts	PE=1	SV=2	
HTS_DROM
E	
128	kDa	 21	 24	
E3	ubiquitin-protein	ligase	hyd	
OS=Drosophila	melanogaster	GN=hyd	
PE=1	SV=3	
HYD_DROM
E	
319	kDa	 2	 1	
Eukaryotic	translation	initiation	factor	2	
subunit	1	OS=Drosophila	melanogaster	
GN=eIF-2alpha	PE=2	SV=1	
IF2A_DROM
E	
39	kDa	 2	 1	
Eukaryotic	translation	initiation	factor	2	
subunit	2	OS=Drosophila	melanogaster	
GN=eIF-2beta	PE=1	SV=1	
IF2B_DROM
E	
35	kDa	 2	 1	
Eukaryotic	translation	initiation	factor	2	
subunit	3	OS=Drosophila	melanogaster	
GN=eIF-2gamma	PE=2	SV=1	
IF2G_DRO
ME	
51	kDa	 0	 2	
Eukaryotic	initiation	factor	4A	
OS=Drosophila	melanogaster	GN=eIF-
4a	PE=1	SV=3	
IF4A_DROM
E	
46	kDa	 4	 7	
Inhibitor	of	nuclear	factor	kappa-B	
kinase	subunit	beta	OS=Drosophila	
melanogaster	GN=ird5	PE=1	SV=2	
IKKB_DRO
ME	
86	kDa	 4	 3	
Importin	subunit	alpha	OS=Drosophila	
melanogaster	GN=Pen	PE=1	SV=2	
IMA_DROM
E	
58	kDa	 2	 1	
Inositol-3-phosphate	synthase	
OS=Drosophila	melanogaster	GN=Inos	
PE=1	SV=1	
INO1_DRO
ME	
62	kDa	 7	 4	
Arginine	kinase	OS=Drosophila	
melanogaster	GN=Argk	PE=2	SV=2	
KARG_DRO
ME	
40	kDa	 3	 5	
Kinesin-like	protein	Klp10A	
OS=Drosophila	melanogaster	
GN=Klp10A	PE=1	SV=1	
KI10A_DRO
ME	
89	kDa	 3	 4	
Pyruvate	kinase	OS=Drosophila	
melanogaster	GN=PyK	PE=2	SV=2	
KPYK_DRO
ME	
57	kDa	 6	 7	
Lamin	Dm0	OS=Drosophila	
melanogaster	GN=Lam	PE=1	SV=4	
LAM0_DRO
ME	
71	kDa	 1	 2	
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RNA-binding	protein	lark	
OS=Drosophila	melanogaster	GN=lark	
PE=1	SV=1	
LARK_DRO
ME	
40	kDa	 3	 2	
DNA	replication	licensing	factor	Mcm5	
OS=Drosophila	melanogaster	
GN=Mcm5	PE=1	SV=1	
MCM5_DR
OME	
82	kDa	 2	 1	
Mediator	of	RNA	polymerase	II	
transcription	subunit	12	OS=Drosophila	
melanogaster	GN=kto	PE=1	SV=2	
MED12_DR
OME	
279	kDa	 5	 1	
Mediator	of	RNA	polymerase	II	
transcription	subunit	13	OS=Drosophila	
melanogaster	GN=skd	PE=1	SV=1	
MED13_DR
OME	
280	kDa	 5	 2	
Mediator	of	RNA	polymerase	II	
transcription	subunit	14	OS=Drosophila	
melanogaster	GN=MED14	PE=1	SV=4	
MED14_DR
OME	
172	kDa	 2	 1	
Mediator	of	RNA	polymerase	II	
transcription	subunit	15	OS=Drosophila	
melanogaster	GN=MED15	PE=2	SV=1	
MED15_DR
OME	
81	kDa	 4	 3	
Mediator	of	RNA	polymerase	II	
transcription	subunit	16	OS=Drosophila	
melanogaster	GN=MED16	PE=1	SV=2	
MED16_DR
OME	
90	kDa	 1	 2	
Mediator	of	RNA	polymerase	II	
transcription	subunit	17	OS=Drosophila	
melanogaster	GN=MED17	PE=1	SV=1	
MED17_DR
OME	
72	kDa	 4	 1	
Mediator	of	RNA	polymerase	II	
transcription	subunit	23	OS=Drosophila	
melanogaster	GN=MED23	PE=1	SV=1	
MED23_DR
OME	
167	kDa	 2	 2	
Mediator	of	RNA	polymerase	II	
transcription	subunit	25	OS=Drosophila	
melanogaster	GN=MED25	PE=2	SV=1	
MED25_DR
OME	
97	kDa	 2	 1	
Mediator	of	RNA	polymerase	II	
transcription	subunit	26	OS=Drosophila	
melanogaster	GN=MED26	PE=1	SV=2	
MED26_DR
OME	
166	kDa	 1	 2	
Mediator	of	RNA	polymerase	II	
transcription	subunit	26	OS=Drosophila	
p	
MED26_DR
OPS	
178	kDa	 2	 1	
Mediator	of	RNA	polymerase	II	
transcription	subunit	27	OS=Drosophila	
melanogaster	GN=MED27	PE=1	SV=1	
MED27_DR
OME	
34	kDa	 1	 2	
DNA	mismatch	repair	protein	
spellchecker	1	OS=Drosophila	
melanogaster	GN=spel1	PE=3	SV=4	
MSH2_DRO
ME	
103	kDa	 1	 2	
Probable	DNA	mismatch	repair	protein	
Msh6	OS=Drosophila	melanogaster	
GN=Msh6	PE=1	SV=2	
MSH6_DRO
ME	
133	kDa	 0	 2	
Methyltransferase-like	protein	13	
OS=Drosophila	pseudoobscura	
MTE13_DR
OPS	
76	kDa	 2	 0	
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pseudoobscura	GN=GA15401	PE=3	
SV=1	
Zinc	finger	protein	on	ecdysone	puffs	
OS=Drosophila	melanogaster	GN=Pep	
PE=1	SV=1	
PEP_DROM
E	
78	kDa	 5	 4	
Serine/threonine-protein	kinase	N	
OS=Drosophila	melanogaster	GN=Pkn	
PE=1	SV=1	
PKN_DROM
E	
132	kDa	 0	 2	
Serine/threonine-protein	kinase	polo	
OS=Drosophila	melanogaster	GN=polo	
PE=1	SV=2	
POLO_DRO
ME	
67	kDa	 2	 2	
Serine/threonine-protein	phosphatase	
alpha-2	isoform	OS=Drosophila	
melanogaster	GN=Pp1-87B	PE=1	SV=1	
PP12_DRO
ME	
35	kDa	 1	 2	
Regulator	of	nonsense	transcripts	1	
homolog	OS=Drosophila	melanogaster	
GN=Upf1	PE=1	SV=2	
RENT1_DRO
ME	
130	kDa	 4	 6	
Replication	protein	A	70	kDa	DNA-
binding	subunit	OS=Drosophila	
melanogaster	GN=RpA-70	PE=1	SV=1	
RFA1_DRO
ME	
67	kDa	 4	 0	
Regulator	of	telomere	elongation	
helicase	1	homolog	OS=Drosophila	
virilis	GN=GJ16649	PE=3	SV=1	
RTEL1_DRO
VI	
112	kDa	 1	 2	
Transcription	elongation	factor	SPT5	
OS=Drosophila	melanogaster	GN=Spt5	
PE=1	SV=1	
SPT5H_DRO
ME	
119	kDa	 1	 2	
Transcription	elongation	factor	SPT6	
OS=Drosophila	melanogaster	GN=Spt6	
PE=1	SV=1	
SPT6H_DRO
ME	
209	kDa	 2	 1	
Serine-arginine	protein	55	
OS=Drosophila	melanogaster	GN=B52	
PE=1	SV=4	
SRR55_DRO
ME	
43	kDa	 1	 2	
Protein	suppressor	of	variegation	3-7	
OS=Drosophila	melanogaster	
GN=Su(var)3-7	PE=1	SV=4	
SUV37_DRO
ME	
140	kDa	 2	 1	
Polycomb	protein	Su(z)12	
OS=Drosophila	melanogaster	
GN=Su(z)12	PE=1	SV=1	
SUZ12_DRO
ME	
100	kDa	 0	 2	
Alanine--tRNA	ligase,	cytoplasmic	
OS=Drosophila	melanogaster	GN=Aats-
ala	PE=2	SV=1	
SYAC_DRO
ME	
108	kDa	 9	 8	
Probable	glutamine--tRNA	ligase	
OS=Drosophila	melanogaster	GN=Aats-
gln	PE=1	SV=1	
SYQ_DROM
E	
88	kDa	 2	 2	
Probable	arginine--tRNA	ligase,	
cytoplasmic	OS=Drosophila	
melanogaster	GN=Aats-arg	PE=2	SV=1	
SYRC_DRO
ME	
76	kDa	 2	 1	
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General	transcription	factor	IIH	subunit	
1	OS=Drosophila	melanogaster	
GN=Tfb1	PE=2	SV=1	
TF2H1_DRO
ME	
66	kDa	 1	 2	
DNA	topoisomerase	2	OS=Drosophila	
melanogaster	GN=Top2	PE=1	SV=1	
TOP2_DRO
ME	
164	kDa	 4	 1	
Histone-lysine	N-methyltransferase	
trithorax	OS=Drosophila	virilis	GN=trx	
PE=3	SV=1	
TRX_DROVI	 414	kDa	 2	 1	
Transcription	termination	factor	2	
OS=Drosophila	melanogaster	GN=lds	
PE=1	SV=2	
TTF2_DRO
ME	
118	kDa	 3	 1	
E3	UFM1-protein	ligase	1	homolog	
OS=Drosophila	melanogaster	
GN=CG1104	PE=1	SV=1	
UFL1_DRO
ME	
87	kDa	 2	 1	
WD	repeat-containing	protein	on	Y	
chromosome	OS=Drosophila	virilis	
GN=WDY	PE=4	SV=1	
WDY_DROV
I	
133	kDa	 2	 1	
5'-3'	exoribonuclease	2	homolog	
OS=Drosophila	melanogaster	GN=Rat1	
PE=1	SV=2	
XRN2_DRO
ME	
104	kDa	 10	 6	
Zinc	finger	protein	CG2199	
OS=Drosophila	melanogaster	
GN=CG2199	PE=1	SV=1	
Y2199_DRO
ME	
82	kDa	 2	 2	
Zinc	finger	protein	423	homolog	
OS=Drosophila	melanogaster	GN=Oaz	
PE=2	SV=2	
ZN423_DRO
ME	
134	kDa	 0	 2	
Centromere/kinetochore	protein	zw10	
OS=Drosophila	melanogaster	
GN=mit(1)15	PE=1	SV=2	
ZW10_DRO
ME	
82	kDa	 0	 2	
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8 Abbreviations	
	
Ac	 Acetylation	
ACF	 assembly	and	remodeling	
factor	
Asf1	 anti-silencing	factor	
CAF-1	 Chromatin	assembly	factor	1	
CATD	 CENP-A	targeting	domain	
CCAN	 Constitutive	centromere	
associated	complex	
CenH3	 Centromeric	histone	H3	
CENP	 Centromere	protein	
CHD	 Chromodomain,	helicase,	
DNA	binding	
ChIP	 Chromatin	Immunoprecipitation	
CHRAC	 Chromatin	accessibility	
complex	
CID	 Centromere	identifier	
DDR	 DNA	damage	response	
DNA	 Deoxyribonucleic	acid	
ds	 Double	stranded	
DSBs	 DNA	Double	Stranded	Breaks	
E	(z)	 Enhancer	of	Zeste	
FACT	 facilitates	chromatin	
transcription	
GFP	 Green	fluorescent	protein	
h	 hour	
H2A	 Histone	2A	
H2B	 Histone	2B	
H3	 Histone	3	
H4	 Histone	4	
HAC	 Human	artificial	chromosome	
HAT	 Histone	acetyltransferase	
HDAC1/2	 Histone	deacetylase	1/2	
HJURP	 Holliday	Junction	Recognition	
Protein	
HP1	 Heterochromatin	protein	1	
IF	 Immunofluorescence	
IN080	 Inositol	Requiring	80	
IP	 Immunoprecipitated	
ISWI	 Imitation	SWI	
K	 Lysine	
Me	 Methylation	
min	 Minutes	
MMS	 Methy	Methane	Sulfonate	
P	 Phosphorylation	
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PEV	 Position	effect	variegation	
R	 Arginine	
S	 Serine	
Scm3	 Scm3	
Su(var)	 Suppressor	of	variegation	
SWI/	SNF	 switching	defective/sucrose	
nonfermenting	
T	 Threonine	
Tip60	 Tat-interactive	protein	60	
Trx	 Trithorax	
WDS	 will	die	slowly	
μl	 micro	litre	
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